mirId|Cancer|Profile|Article
hsa-let-7a|acute myeloid leukemia|up|Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-let-7a|breast cancer|down|Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
hsa-let-7a|breast cancer|down|MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
hsa-let-7a|breast cancer|down|The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7a|breast cancer|down|Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.
hsa-let-7a|breast cancer|down|Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
hsa-let-7a|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-let-7a|colorectal cancer|down|Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
hsa-let-7a|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-let-7a|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-let-7a|esophageal squamous cell carcinoma|down|[Expressions and correlations of let-7a and IL-6 in esophageal squamous cell carcinoma].
hsa-let-7a|gastric cancer|down|Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis.
hsa-let-7a|gastric cancer|down|Circulating microRNAs in plasma of patients with gastric cancers.
hsa-let-7a|gastric cancer|down|Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo.
hsa-let-7a|gastric cancer|down|Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.
hsa-let-7a|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-let-7a|gastric cancer|down|Investigation and identification of let-7a related functional proteins in gastric carcinoma by proteomics.
hsa-let-7a|glioma|down|Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN.
hsa-let-7a|nasopharyngeal carcinoma|down|Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
hsa-let-7a|nasopharyngeal carcinoma|down|Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells.
hsa-let-7a|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-let-7a|oral squamous cell carcinoma|down|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7a|osteosarcoma|down|Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
hsa-let-7a|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-let-7a|renal cell carcinoma|down|Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
hsa-let-7a-1|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-1|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-1|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-1|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-1|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-1|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-1|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-1|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-1|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-1|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-1|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-1|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-2|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-2|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-2|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-2|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-2|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-2|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-2|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-2|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-2|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-2|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-2|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-2|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-3|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-3|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-3|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-3|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-3|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-3|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-3|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-3|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-3|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-3|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-3|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-3|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-3p|prostate cancer|down|The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells.
hsa-let-7b|acute lymphoblastic leukemia|down|Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.
hsa-let-7b|breast cancer|down|The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7b|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-let-7b|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7b|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7b|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7b|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7b|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7b|gastric cancer|down|let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.
hsa-let-7b|gastric cancer|down|Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.
hsa-let-7b|gastric cancer|down|MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1.
hsa-let-7b|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7b|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7b|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7b|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7b|malignant melanoma|down|MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
hsa-let-7b|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7b|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7b|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7b|renal clear cell carcinoma|down|let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
hsa-let-7c|acute myeloid leukemia|down|miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.
hsa-let-7c|acute promyelocytic leukemia|down|A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-let-7c|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7c|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7c|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7c|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7c|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7c|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7c|hepatocellular carcinoma|down|MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
hsa-let-7c|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7c|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7c|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7c|nasopharyngeal carcinoma|down|Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.
hsa-let-7c|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7c|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7c|non-small cell lung cancer|down|MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
hsa-let-7c|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7c|prostate cancer|down|MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
hsa-let-7c|prostate cancer|down|MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
hsa-let-7c|renal clear cell carcinoma|down|let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
hsa-let-7d|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7d|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7d|chronic myelogenous leukemia|down|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-let-7d|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7d|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7d|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7d|head and neck squamous cell carcinoma|down|Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-let-7d|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7d|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7d|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7d|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7d|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7d|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7d|oral cancer|down|Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
hsa-let-7d|oral squamous cell carcinoma|down|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7d|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7d|pancreatic ductal adenocarcinoma|down|MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-let-7d|renal cell carcinoma|down|Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.
hsa-let-7e|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7e|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7e|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7e|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7e|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7e|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7e|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7e|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7e|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7e|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7e|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7e|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7e|papillary thyroid carcinoma|up|Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-let-7f|glioma|down|Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.
hsa-let-7f|hepatocellular carcinoma|down|Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-let-7f|oral squamous cell carcinoma|down|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7f-1|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7f-1|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7f-1|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7f-1|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7f-1|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7f-1|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7f-1|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7f-1|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7f-1|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7f-1|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7f-1|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7f-1|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7f-2|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7f-2|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7f-2|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7f-2|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7f-2|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7f-2|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7f-2|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7f-2|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7f-2|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7f-2|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7f-2|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7f-2|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7g|breast cancer|down|The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7g|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7g|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7g|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7g|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7g|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7g|gastric cancer|down|let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.
hsa-let-7g|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7g|hepatocellular carcinoma|down|MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.
hsa-let-7g|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7g|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7g|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7g|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7g|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7g|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7g-5p|glioblastoma|down|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-let-7i|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7i|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7i|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7i|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7i|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7i|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7i|hepatocellular carcinoma|down|MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.
hsa-let-7i|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7i|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7i|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7i|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7i|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7i|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-let-7i|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-mir-1|acute myeloid leukemia|up|Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-mir-1|bladder cancer|down|Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.
hsa-mir-1|bladder cancer|down|The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-1|breast cancer|down|Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
hsa-mir-1|chordoma|down|Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.
hsa-mir-1|chordoma|down|MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.
hsa-mir-1|colorectal cancer|down|Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.
hsa-mir-1|esophageal squamous cell carcinoma|down|Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion.
hsa-mir-1|gastric cancer|down|MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.
hsa-mir-1|head and neck squamous cell carcinoma|down|Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
hsa-mir-1|head and neck squamous cell carcinoma|down|Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-1|head and neck squamous cell carcinoma|down|miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
hsa-mir-1|hepatocellular carcinoma|down|Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
hsa-mir-1|hepatocellular carcinoma|down|MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.
hsa-mir-1|kidney cancer|down|MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
hsa-mir-1|lung cancer|down|Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
hsa-mir-1|mucinous cystadenocarcinoma|down|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-1|nasopharyngeal carcinoma|down|EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.
hsa-mir-1|nasopharyngeal carcinoma|down|miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
hsa-mir-1|non-small cell lung cancer|down|MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
hsa-mir-1|osteosarcoma|down|MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31.
hsa-mir-1|renal cell carcinoma|down|The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-100|bladder cancer|down|Prognostic role of microRNA-100 in patients with bladder cancer.
hsa-mir-100|breast cancer|down|miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
hsa-mir-100|breast cancer|down|miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion.
hsa-mir-100|breast cancer|down|MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/?-catenin signaling pathway.
hsa-mir-100|cervical carcinoma|down|miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-100|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-100|chondrosarcoma|down|MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR.
hsa-mir-100|colon cancer|down|MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells.
hsa-mir-100|colorectal cancer|down|MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B.
hsa-mir-100|colorectal cancer|down|Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
hsa-mir-100|esophageal squamous cell carcinoma|down|MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-100|esophageal squamous cell carcinoma|up|MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma.
hsa-mir-100|esophageal squamous cell carcinoma|down|Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
hsa-mir-100|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-100|gastric cancer|down|C/EBP?-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
hsa-mir-100|glioblastoma|down|Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3.
hsa-mir-100|glioblastoma|down|microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models.
hsa-mir-100|hepatocellular carcinoma|down|Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-100|hepatocellular carcinoma|down|Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
hsa-mir-100|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-100|non-small cell lung cancer|down|MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
hsa-mir-100|non-small cell lung cancer|down|Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.
hsa-mir-100|oral squamous cell carcinoma|down|Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-100|osteosarcoma|down|MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.
hsa-mir-100|osteosarcoma|down|MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
hsa-mir-100|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-100|ovarian carcinoma|down|Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
hsa-mir-100|prostate cancer|down|Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
hsa-mir-100|renal cell carcinoma|up|Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma.
hsa-mir-100-5p|gastric cancer|down|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-101|bladder cancer|down|MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
hsa-mir-101|bladder cancer|down|miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.
hsa-mir-101|breast cancer|down|MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
hsa-mir-101|breast cancer|down|MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1? mediated apoptosis and cell cycle arrest in normoxia condition.
hsa-mir-101|cervical cancer|down|MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
hsa-mir-101|cervical carcinoma|down|MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.
hsa-mir-101|cholangiocarcinoma|down|miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).
hsa-mir-101|cholangiocarcinoma|down|miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).
hsa-mir-101|colon cancer|down|Loss of miR-101 Expression Promotes Wnt/?-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells.
hsa-mir-101|colon cancer|down|MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-101|colorectal cancer|down|Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-101|colorectal cancer|down|MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.
hsa-mir-101|endometrial cancer|down|MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.
hsa-mir-101|endometrial cancer|down|MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.
hsa-mir-101|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-101|esophageal squamous cell carcinoma|down|Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.
hsa-mir-101|esophageal squamous cell carcinoma|down|miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
hsa-mir-101|gastric cancer|down|Down-regulation of miR-101 in gastric cancer correlates with COX-2 overexpression and tumor growth.
hsa-mir-101|gastric cancer|down|MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-101|gastric cancer|down|MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101|gastric cancer|down|MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101|gastric cancer|down|Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.
hsa-mir-101|glioblastoma|down|miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
hsa-mir-101|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-101|glioma|down|miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.
hsa-mir-101|hepatocellular carcinoma|down|miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin.
hsa-mir-101|hepatocellular carcinoma|down|Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets.
hsa-mir-101|hepatocellular carcinoma|down|PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
hsa-mir-101|hepatocellular carcinoma|down|Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-101|hepatocellular carcinoma|down|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-101|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-101|hepatocellular carcinoma|down|miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
hsa-mir-101|hepatocellular carcinoma|down|MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells.
hsa-mir-101|hepatocellular carcinoma|down|MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
hsa-mir-101|laryngeal squamous cell carcinoma|down|MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
hsa-mir-101|liver cancer|down|MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer.
hsa-mir-101|lung cancer|down|The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer.
hsa-mir-101|lung cancer|down|microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.
hsa-mir-101|lung cancer|down|Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2.
hsa-mir-101|malignant melanoma|down|MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
hsa-mir-101|nasopharyngeal carcinoma|down|miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.
hsa-mir-101|non-small cell lung cancer|down|MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.
hsa-mir-101|non-small cell lung cancer|down|MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
hsa-mir-101|osteosarcoma|down|Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.
hsa-mir-101|ovarian cancer|down|miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2.
hsa-mir-101|ovarian carcinoma|down|MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
hsa-mir-101|pancreatic cancer|down|miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells.
hsa-mir-101|papillary thyroid carcinoma|down|miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.
hsa-mir-101|papillary thyroid carcinoma|down|Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.
hsa-mir-101|prostate cancer|down|Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.
hsa-mir-101|retinoblastoma|down|miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
hsa-mir-101-3p|esophageal squamous cell carcinoma|down|Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway.
hsa-mir-103|colorectal cancer|up|MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN.
hsa-mir-103|colorectal cancer|up|PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro.
hsa-mir-103|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-103|hepatocellular carcinoma|up|MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
hsa-mir-103|prostate cancer|down|MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
hsa-mir-103a|gastric cancer|down|MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.
hsa-mir-103a-3p|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-105|hepatocellular carcinoma|down|MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
hsa-mir-105|prostate cancer|down|miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels.
hsa-mir-106a|cervical squamous cell carcinoma|down|MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-106a|colorectal cancer|up|Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-106a|colorectal cancer|up|[Expression of plasma miR-106a in colorectal cancer and its clinical significance].
hsa-mir-106a|endometrial cancer|up|TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-106a|gastric cancer|up|Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106a|gastric cancer|up|miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells.
hsa-mir-106a|gastric cancer|up|MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.
hsa-mir-106a|gastric cancer|up|MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.
hsa-mir-106a|gastric cancer|up|Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106a|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-106a|gastric cancer|up|miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.
hsa-mir-106a|gastric cancer|up|Diagnostic significance of miR-106a in gastric cancer.
hsa-mir-106a|glioblastoma|down|Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
hsa-mir-106a|glioma|up|microRNA-106a induces the proliferation and apoptosis of glioma cells through regulating JNK/MAPK pathway.
hsa-mir-106a|glioma|down|MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
hsa-mir-106a|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-106a|non-small cell lung cancer|up|miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
hsa-mir-106a|ovarian cancer|up|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-106a*|follicular lymphoma|down|miR-106a* inhibits the proliferation of esophageal carcinoma cells by targeting CDK2-associated Cullin 1 (CACUL1).
hsa-mir-106a*|renal cell carcinoma|down|miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
hsa-mir-106a-5p|clear cell renal cell cancer|down|Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-106b|cervical carcinoma|up|MicroRNA-106b is involved in transforming growth factor ?1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
hsa-mir-106b|colorectal cancer|up|MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
hsa-mir-106b|endometrial cancer|down|Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
hsa-mir-106b|gastric cancer|up|Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106b|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-106b|gastric cancer|up|Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106b|glioma|up|Down-regulation of miR-106b suppresses the growth of human glioma cells.
hsa-mir-106b|head and neck squamous cell carcinoma|up|Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-106b|hepatocellular carcinoma|up|Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
hsa-mir-106b|hepatocellular carcinoma|up|Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
hsa-mir-106b|hepatocellular carcinoma|down|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-106b|laryngeal carcinoma|up|MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
hsa-mir-106b|laryngeal carcinoma|up|MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells.
hsa-mir-106b|medulloblastoma|up|miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.
hsa-mir-106b|pituitary carcinoma|up|MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-106b|renal cell carcinoma|up|MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
hsa-mir-106b|thyroid cancer|down|microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.
hsa-mir-106b-5p|glioma|up|MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
hsa-mir-107|acute promyelocytic leukemia|down|A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-107|breast cancer|down|MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.
hsa-mir-107|gastric cancer|up|MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
hsa-mir-107|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-107|gastric cancer|up|Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.
hsa-mir-107|gastric cancer|up|MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8.
hsa-mir-107|gastric cancer|up|Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia.
hsa-mir-107|glioma|down|P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2.
hsa-mir-107|glioma|down|MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.
hsa-mir-107|glioma|down|Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
hsa-mir-107|glioma|down|Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.
hsa-mir-107|head and neck squamous cell carcinoma|down|Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
hsa-mir-107|head and neck squamous cell carcinoma|down|microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C?
hsa-mir-107|hepatocellular carcinoma|up|miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
hsa-mir-107|non-small cell lung cancer|down|Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
hsa-mir-107|prostate carcinoma|down|Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group.
hsa-mir-10a|breast cancer|down|MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
hsa-mir-10a|cervical cancer|up|MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
hsa-mir-10a|cervical cancer|up|Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.
hsa-mir-10a|chronic myelogenous leukemia|down|Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-10a|gastric cancer|up|miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes.
hsa-mir-10a|gastric cancer|down|MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells.
hsa-mir-10a|non-small cell lung cancer|up|MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.
hsa-mir-10a|pancreatic cancer|up|MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-10b|bladder cancer|up|MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
hsa-mir-10b|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-10b|breast cancer|up|Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
hsa-mir-10b|breast cancer|up|Critical role of miR-10b in transforming growth factor-?1-induced epithelial-mesenchymal transition in breast cancer.
hsa-mir-10b|colorectal cancer|up|MicroRNA-10b is upregulated and has an invasive role in colorectal cancer through enhanced Rhoc expression.
hsa-mir-10b|esophageal cancer|up|MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.
hsa-mir-10b|gastric cancer|up|miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
hsa-mir-10b|gastric cancer|up|Clinicopathologic significance of miR-10b expression in gastric carcinoma.
hsa-mir-10b|gastric cancer|down|DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.
hsa-mir-10b|gastric cancer|up|Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma.
hsa-mir-10b|gastric cancer|up|MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
hsa-mir-10b|glioblastoma|up|Oncogenic effects of miR-10b in glioblastoma stem cells.
hsa-mir-10b|glioblastoma|up|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-10b|glioma|up|MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
hsa-mir-10b|hepatocellular carcinoma|up|miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs.
hsa-mir-10b|hepatocellular carcinoma|up|MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.
hsa-mir-10b|lung cancer|up|microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
hsa-mir-10b|malignant melanoma|down|The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis.
hsa-mir-10b|medulloblastoma|up|microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma.
hsa-mir-10b|nasopharyngeal carcinoma|up|miR-10b Promotes Migration and Invasion in Nasopharyngeal Carcinoma Cells.
hsa-mir-10b|nasopharyngeal carcinoma|up|Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.
hsa-mir-10b|non-small cell lung cancer|up|MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.
hsa-mir-10b|non-small cell lung cancer|up|microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
hsa-mir-10b|oral cancer|up|Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
hsa-mir-10b|pancreatic cancer|up|MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
hsa-mir-10b|pancreatic cancer|up|MicroRNA-10b is overexpressed in pancreatic cancer.
hsa-mir-10b|pancreatic ductal adenocarcinoma|up|microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma.
hsa-mir-10b|pancreatic ductal adenocarcinoma|up|microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-? actions.
hsa-mir-1179|colorectal cancer|up|MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-1179|esophageal squamous cell carcinoma|up|miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma.
hsa-mir-1180|bladder cancer|down|Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1180|hepatocellular carcinoma|up|MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-?B signaling pathway.
hsa-mir-1181|ovarian cancer|up|Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer.
hsa-mir-1181|pancreatic cancer|down|MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
hsa-mir-1207|ovarian cancer|up|MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/?-catenin signaling pathway.
hsa-mir-1207-5p|gastric cancer|down|miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
hsa-mir-122|breast cancer|down|MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R.
hsa-mir-122|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-mir-122|gallbladder carcinoma|down|miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.
hsa-mir-122|gastric cancer|down|Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
hsa-mir-122|glioma|down|miR-122/Wnt/?-catenin regulatory circuitry sustains glioma progression.
hsa-mir-122|hepatocellular carcinoma|up|Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-122|hepatocellular carcinoma|down|miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3.
hsa-mir-122|hepatocellular carcinoma|down|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-122|hepatocellular carcinoma|down|MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
hsa-mir-122|hepatocellular carcinoma|down|MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
hsa-mir-122|hepatocellular carcinoma|up|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-122|hepatocellular carcinoma|down|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-122|hepatocellular carcinoma|down|miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
hsa-mir-122|hepatocellular carcinoma|down|MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway.
hsa-mir-122|hepatocellular carcinoma|down|microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.
hsa-mir-122|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-122|hepatocellular carcinoma|down|A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
hsa-mir-122|hepatocellular carcinoma|up|Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells.
hsa-mir-122|liver cancer|down|MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
hsa-mir-122|osteosarcoma|down|Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-122|pituitary carcinoma|up|MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-122|renal clear cell carcinoma|up|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-1225-5p|gastric cancer|down|MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?-catenin signaling.
hsa-mir-1228|breast cancer|up|MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
hsa-mir-1228|hepatocellular carcinoma|up|miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
hsa-mir-1228*|gastric cancer|down|Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.
hsa-mir-1229|breast cancer|up|MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/?-catenin signaling in breast cancer.
hsa-mir-1229|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-122a|gastrointestinal cancer|down|MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.
hsa-mir-122a|hepatocellular carcinoma|down|Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
hsa-mir-122a|hepatocellular carcinoma|down|[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-122a|hepatocellular carcinoma|down|Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
hsa-mir-1233|renal cell carcinoma|up|MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
hsa-mir-1236|bladder cancer|down|Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1236|hepatocellular carcinoma|down|miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
hsa-mir-1236|renal cell carcinoma|down|Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
hsa-mir-1238|non-small cell lung cancer|down|miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
hsa-mir-124|anaplastic astrocytoma|down|miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124|bladder cancer|down|MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.
hsa-mir-124|breast cancer|down|miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
hsa-mir-124|breast cancer|down|miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
hsa-mir-124|breast cancer|down|Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-124|breast cancer|down|MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
hsa-mir-124|breast cancer|down|MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.
hsa-mir-124|breast cancer|down|Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.
hsa-mir-124|breast cancer|down|MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.
hsa-mir-124|breast cancer|down|Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
hsa-mir-124|cervical cancer|down|Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-124|cervical squamous cell carcinoma|down|Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-124|colorectal cancer|down|KITENIN-targeting MicroRNA-124 Suppresses Colorectal Cancer Cell Motility and Tumorigenesis.
hsa-mir-124|colorectal cancer|down|Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-124|colorectal cancer|down|Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.
hsa-mir-124|colorectal cancer|down|MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
hsa-mir-124|colorectal cancer|down|MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by Targeting iASPP.
hsa-mir-124|colorectal cancer|down|Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.
hsa-mir-124|colorectal cancer|down|MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3.
hsa-mir-124|colorectal cancer|down|MicroRNA-124 Reduces Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells.
hsa-mir-124|colorectal cancer|down|MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1.
hsa-mir-124|colorectal cancer|down|miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
hsa-mir-124|colorectal cancer|down|MicroRNA-124 (MiR-124) Inhibits Cell Proliferation, Metastasis and Invasion in Colorectal Cancer by Downregulating Rho-Associated Protein Kinase 1(ROCK1).
hsa-mir-124|esophageal cancer|down|Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
hsa-mir-124|esophageal cancer|down|STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
hsa-mir-124|gastric cancer|down|miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.
hsa-mir-124|gastric cancer|down|[miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism].
hsa-mir-124|gastric cancer|down|microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.
hsa-mir-124|gastric cancer|down|miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.
hsa-mir-124|glioblastoma|down|Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L.
hsa-mir-124|glioblastoma|down|miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
hsa-mir-124|glioblastoma|down|miR-124 suppresses the migration and invasion of glioma cells in?vitro via Capn4.
hsa-mir-124|glioblastoma|down|MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma.
hsa-mir-124|glioblastoma|down|miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124|glioma|down|microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma.
hsa-mir-124|glioma|down|MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
hsa-mir-124|glioma|down|Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
hsa-mir-124|hepatocellular carcinoma|down|The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
hsa-mir-124|hepatocellular carcinoma|down|MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
hsa-mir-124|hepatocellular carcinoma|down|MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
hsa-mir-124|hepatocellular carcinoma|down|PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.
hsa-mir-124|lung adenocarcinoma|down|miR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.
hsa-mir-124|medulloblastoma|down|miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
hsa-mir-124|nasopharyngeal carcinoma|down|MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.
hsa-mir-124|neuroblastoma|down|Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.
hsa-mir-124|non-small cell lung cancer|down|miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
hsa-mir-124|non-small cell lung cancer|down|miRNA-124 modulates lung carcinoma cell migration and invasion.
hsa-mir-124|non-small cell lung cancer|down|miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
hsa-mir-124|non-small cell lung cancer|down|Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
hsa-mir-124|oral squamous cell carcinoma|down|MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.
hsa-mir-124|osteosarcoma|down|The tumor suppressor role of miR-124 in osteosarcoma.
hsa-mir-124|osteosarcoma|down|MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma.
hsa-mir-124|ovarian cancer|down|MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.
hsa-mir-124|pancreatic cancer|down|Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
hsa-mir-124|prostate cancer|down|MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells.
hsa-mir-124-3p|astrocytoma|down|Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children.
hsa-mir-124-3p|bladder cancer|down|MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.
hsa-mir-124-3p|gastric cancer|down|The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-124-5p|glioma|down|MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.
hsa-mir-1244|lung carcinoma|down|miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma.
hsa-mir-1246|cervical cancer|down|Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
hsa-mir-1246|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-1246|non-small cell lung cancer|up|Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.
hsa-mir-1246|non-small cell lung cancer|up|The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4.
hsa-mir-1247|pancreatic cancer|down|miR-1247 is Correlated with Prognosis of Pancreatic Cancer and Inhibits Cell Proliferation by Targeting Neuropilins.
hsa-mir-124a|acute lymphoblastic leukemia|down|Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
hsa-mir-124a|epithelial ovarian cancer|down|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-124a|glioblastoma|down|miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
hsa-mir-124a|glioma|down|miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and ?-catenin.
hsa-mir-124a|mantle cell lymphoma|up|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-1250|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-1258|breast cancer|down|MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
hsa-mir-1258|breast cancer|down|The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
hsa-mir-1258|hepatocellular carcinoma|down|Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
hsa-mir-1259|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-125a|breast cancer|up|MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway.
hsa-mir-125a|cervical cancer|down|MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
hsa-mir-125a|colorectal cancer|down|Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-125a|colorectal cancer|down|Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
hsa-mir-125a|glioblastoma|down|miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-125a|ovarian cancer|down|MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
hsa-mir-125a|ovarian cancer|down|MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
hsa-mir-125a-3p|gastric cancer|down|Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
hsa-mir-125a-3p|non-small cell lung cancer|down|miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
hsa-mir-125a-3p|non-small cell lung cancer|down|Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125a-5p|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-125a-5p|colon cancer|down|miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
hsa-mir-125a-5p|glioblastoma|down|MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.
hsa-mir-125a-5p|malignant melanoma|down|Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
hsa-mir-125a-5p|non-small cell lung cancer|down|Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125a-5p|non-small cell lung cancer|up|Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-125a-5p|prostate carcinoma|up|MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.
hsa-mir-125b|acute myeloid leukemia|up|[miR-125b promotes proliferation of human acute myeloid leukemia cells by targeting Bak1].
hsa-mir-125b|bladder cancer|down|MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
hsa-mir-125b|bladder cancer|down|MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
hsa-mir-125b|bladder cancer|down|microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.
hsa-mir-125b|breast cancer|down|miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
hsa-mir-125b|breast cancer|down|MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
hsa-mir-125b|breast cancer|down|Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-125b|breast cancer|down|The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
hsa-mir-125b|breast cancer|down|MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.
hsa-mir-125b|chronic lymphocytic leukemia|down|The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.
hsa-mir-125b|chronic myelogenous leukemia|up|miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1.
hsa-mir-125b|colorectal cancer|up|MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
hsa-mir-125b|colorectal cancer|down|Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
hsa-mir-125b|follicular cancer|up|MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
hsa-mir-125b|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-125b|gastric cancer|down|miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.
hsa-mir-125b|gastric cancer|up|MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis.
hsa-mir-125b|gastric cancer|up|MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.
hsa-mir-125b|glioblastoma|down|Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.
hsa-mir-125b|glioblastoma|up|miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.
hsa-mir-125b|glioma|up|MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.
hsa-mir-125b|glioma|up|miR-125b Inhibits Connexin43 and Promotes Glioma Growth.
hsa-mir-125b|glioma|down|Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
hsa-mir-125b|hepatocellular carcinoma|down|MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells.
hsa-mir-125b|hepatocellular carcinoma|down|Histone lysine methyltransferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b.
hsa-mir-125b|hepatocellular carcinoma|down|Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.
hsa-mir-125b|hepatocellular carcinoma|down|miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7.
hsa-mir-125b|hepatocellular carcinoma|down|Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
hsa-mir-125b|hepatocellular carcinoma|down|Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
hsa-mir-125b|hepatocellular carcinoma|down|MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
hsa-mir-125b|lung cancer|down|Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells.
hsa-mir-125b|malignant melanoma|down|MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
hsa-mir-125b|malignant melanoma|down|miR-125b induces cellular senescence in malignant melanoma.
hsa-mir-125b|malignant melanoma|down|MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.
hsa-mir-125b|neuroblastoma|up|MicroRNA-125b is a novel negative regulator of p53.
hsa-mir-125b|non-small cell lung cancer|up|MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.
hsa-mir-125b|oral squamous cell carcinoma|down|Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-125b|oral squamous cell carcinoma|up|[Expression and clinical significance of plasma microRNA-125b level in patients with oral squamous cell carcinoma].
hsa-mir-125b|osteosarcoma|down|miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
hsa-mir-125b|osteosarcoma|down|Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.
hsa-mir-125b|osteosarcoma|down|MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
hsa-mir-125b|ovarian cancer|down|Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-125b|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-125b|ovarian cancer|down|PPAR? inhibits ovarian cancer cells proliferation through upregulation of miR-125b.
hsa-mir-125b|ovarian cancer|down|MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
hsa-mir-125b|prostate cancer|down|Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
hsa-mir-125b|prostate cancer|up|Widespread deregulation of microRNA expression in human prostate cancer.
hsa-mir-125b|prostate cancer|up|Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
hsa-mir-125b-1-3p|mesenchymal cancer|up|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-125b-2*|colorectal cancer|up|MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-126|bladder cancer|down|MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.
hsa-mir-126|breast cancer|down|Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
hsa-mir-126|breast cancer|down|miR-126 regulated breast cancer cell invasion by targeting ADAM9.
hsa-mir-126|colon cancer|down|Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.
hsa-mir-126|colon cancer|down|[miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene].
hsa-mir-126|colon cancer|down|miR-126: A novel regulator in colon cancer.
hsa-mir-126|colon cancer|down|MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.
hsa-mir-126|colorectal cancer|down|Low expression of MicroRNA-126 is associated with poor prognosis in colorectal cancer.
hsa-mir-126|colorectal cancer|down|Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-126|colorectal cancer|down|Down-regulation of miR-126 expression in colorectal cancer and its clinical significance.
hsa-mir-126|colorectal cancer|down|Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
hsa-mir-126|colorectal cancer|down|MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.
hsa-mir-126|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-126|esophageal cancer|down|MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.
hsa-mir-126|esophageal squamous cell carcinoma|down|Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR?126 in esophageal squamous cell carcinoma.
hsa-mir-126|esophageal squamous cell carcinoma|down|MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
hsa-mir-126|gastric cancer|up|MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.
hsa-mir-126|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-126|gastric cancer|down|Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2.
hsa-mir-126|gastric cancer|down|Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
hsa-mir-126|gastric cancer|down|MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1.
hsa-mir-126|gastric cancer|down|miR-126 functions as a tumour suppressor in human gastric cancer.
hsa-mir-126|glioblastoma|down|MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.
hsa-mir-126|glioma|down|MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1).
hsa-mir-126|hepatocellular carcinoma|down|Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma.
hsa-mir-126|hepatocellular carcinoma|down|miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2.
hsa-mir-126|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-126|malignant mesothelioma|down|MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with Mitochondrial Function.
hsa-mir-126|non-small cell lung cancer|down|MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.
hsa-mir-126|non-small cell lung cancer|down|Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-126|non-small cell lung cancer|down|Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
hsa-mir-126|non-small cell lung cancer|down|Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-126|non-small cell lung cancer|down|Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
hsa-mir-126|non-small cell lung cancer|down|miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
hsa-mir-126|non-small cell lung cancer|down|miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.
hsa-mir-126|oral squamous cell carcinoma|up|Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer.
hsa-mir-126|oral squamous cell carcinoma|down|Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
hsa-mir-126|osteosarcoma|down|MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells.
hsa-mir-126|osteosarcoma|down|MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.
hsa-mir-126|osteosarcoma|down|miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.
hsa-mir-126|osteosarcoma|down|Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
hsa-mir-126|ovarian cancer|down|microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells.
hsa-mir-126|pancreatic ductal adenocarcinoma|down|MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-126|papillary thyroid carcinoma|down|miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
hsa-mir-126|renal cell carcinoma|down|Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma.
hsa-mir-126|small cell lung cancer|down|miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
hsa-mir-126*|non-small cell lung cancer|down|Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-126-3p|thyroid cancer|down|miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
hsa-mir-126-5p|acute myeloid leukemia|up|Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
hsa-mir-1260b|non-small cell lung cancer|up|Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.
hsa-mir-1260b|renal cell carcinoma|up|Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
hsa-mir-1266|gastric cancer|down|miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
hsa-mir-1269|hepatocellular carcinoma|up|Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance.
hsa-mir-1269|hepatocellular carcinoma|up|MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
hsa-mir-1269a|colorectal cancer|up|miR-1269 promotes metastasis and forms a positive feedback loop with TGF-?.
hsa-mir-127|breast cancer|down|MicroRNA-127 is Downregulated by Tudor-SN Protein and Contributes to Metastasis and Proliferation in Breast Cancer Cell Line MDA-MB-231.
hsa-mir-127|breast cancer|down|miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6.
hsa-mir-127|gastric cancer|down|The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.
hsa-mir-127|hepatocellular carcinoma|down|A Feedback Inhibition between miRNA-127 and TGF?/c-Jun Cascade in HCC Cell Migration via MMP13.
hsa-mir-127|hepatocellular carcinoma|down|MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells.
hsa-mir-127-3p|glioblastoma|down|Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-? Signaling by Targeting SKI.
hsa-mir-127-3p|glioblastoma|up|MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.
hsa-mir-127-3p|osteosarcoma|down|MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-127-3p|osteosarcoma|down|MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells.
hsa-mir-127-5p|hepatocellular carcinoma|down|MiR-127-5p targets the biliverdin reductase B/NF-?B pathway to suppress cell growth in hepatocellular carcinoma cells.
hsa-mir-1271|gastric cancer|down|miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2.
hsa-mir-1271|gastric cancer|down|MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
hsa-mir-1271|hepatocellular carcinoma|down|A functional screening identifies five miRNAs controlling glypican-3: Role of miR-1271 down-regulation in hepatocellular carcinoma.
hsa-mir-1271|non-small cell lung cancer|down|Inhibition of the growth of non-small cell lung cancer by miRNA-1271.
hsa-mir-1271|oral squamous cell carcinoma|down|miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK.
hsa-mir-1271|ovarian cancer|down|MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
hsa-mir-1271|pancreatic cancer|down|miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
hsa-mir-1274a|gastric cancer|up|The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4.
hsa-mir-128|acute lymphoblastic leukemia|up|Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128|acute myeloid leukemia|up|Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128|colorectal cancer|down|MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
hsa-mir-128|gastric cancer|down|MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-128|glioblastoma|down|Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
hsa-mir-128|glioblastoma|down|PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-128|glioblastoma|down|miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
hsa-mir-128|glioma|down|MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.
hsa-mir-128|glioma|down|Proteomic screening and identification of microRNA-128 targets in glioma cells.
hsa-mir-128|glioma|down|Serum microRNA-128 as a biomarker for diagnosis of glioma.
hsa-mir-128|glioma|down|MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.
hsa-mir-128|glioma|down|Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
hsa-mir-128|glioma|down|MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-128|head and neck squamous cell carcinoma|down|Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.
hsa-mir-128|hepatocellular carcinoma|down|miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.
hsa-mir-128|meningioma|down|Serum microRNA-128 as a biomarker for diagnosis of glioma.
hsa-mir-128|osteosarcoma|down|MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin ?2.
hsa-mir-128|osteosarcoma|up|MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.
hsa-mir-128|prostate cancer|down|MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-128|prostate cancer|down|miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.
hsa-mir-128-3p|hepatocellular carcinoma|down|miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
hsa-mir-1280|bladder cancer|down|MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer.
hsa-mir-1280|malignant melanoma|down|Anti-tumor activity of miR-1280 in melanoma by regulation of Src.
hsa-mir-1280|non-small cell lung cancer|up|Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues.
hsa-mir-1284|gastric cancer|down|miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.
hsa-mir-1285|renal cell carcinoma|down|Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma.
hsa-mir-128a|hepatocellular carcinoma|up|[miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].
hsa-mir-128a|medulloblastoma|down|MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.
hsa-mir-128b|gastric cancer|down|MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-?B axis.
hsa-mir-128b|gastric cancer|down|MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer.
hsa-mir-129|breast cancer|down|[The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility].
hsa-mir-129|colorectal cancer|down|miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
hsa-mir-129|glioblastoma|down|Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-129|glioma|down|MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.
hsa-mir-129|hepatocellular carcinoma|down|miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
hsa-mir-129|non-small cell lung cancer|down|MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer.
hsa-mir-129|prostate cancer|down|Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
hsa-mir-129-1-3p|gastric cancer|down|Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-2-3p|gastric cancer|down|Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-3p|gastric cancer|down|Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-129-3p|renal cell carcinoma|down|miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
hsa-mir-129-5p|breast cancer|down|Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
hsa-mir-129-5p|gastric cancer|down|Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-5p|gastric cancer|down|lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis.
hsa-mir-129-5p|hepatocellular carcinoma|down|MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
hsa-mir-129-5p|laryngeal squamous cell carcinoma|down|Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC.
hsa-mir-129-5p|medullary thyroid carcinoma|down|MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.
hsa-mir-129-5p|ovarian cancer|down|A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
hsa-mir-1290|colon cancer|up|Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells.
hsa-mir-1290|esophageal squamous cell carcinoma|up|MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC).
hsa-mir-1290|esophageal squamous cell carcinoma|up|MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
hsa-mir-1290|gastric cancer|up|sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells.
hsa-mir-1290|non-small cell lung cancer|up|miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.
hsa-mir-1290|non-small cell lung cancer|up|Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.
hsa-mir-1291|renal cell carcinoma|down|Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 (GLUT1) in renal cell carcinoma.
hsa-mir-1294|esophageal squamous cell carcinoma|down|Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression.
hsa-mir-1295b-3p|colorectal cancer|down|Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
hsa-mir-1296|prostate cancer|down|Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
hsa-mir-1297|lung adenocarcinoma|down|miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-1301|liver cancer|up|Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
hsa-mir-1301|prostate cancer|up|miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C.
hsa-mir-1303|gastric cancer|up|miR-1303 Targets Claudin-18 Gene to Modulate Proliferation and Invasion of Gastric Cancer Cells.
hsa-mir-1307|colorectal cancer|down|The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment.
hsa-mir-130a|breast cancer|down|MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
hsa-mir-130a|chronic myelogenous leukemia|down|Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.
hsa-mir-130a|endometrial cancer|down|Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-130a|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-130a|gastric cancer|up|Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.
hsa-mir-130a|hepatocellular carcinoma|up|Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.
hsa-mir-130a|hepatocellular carcinoma|down|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-130a|hepatocellular carcinoma|down|MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
hsa-mir-130b|colorectal cancer|up|MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer.
hsa-mir-130b|colorectal cancer|down|Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin ?1.
hsa-mir-130b|colorectal cancer|up|MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer.
hsa-mir-130b|endometrial cancer|down|Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-130b|esophageal squamous cell carcinoma|up|MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
hsa-mir-130b|glioblastoma|up|Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
hsa-mir-130b|glioma|up|MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
hsa-mir-130b|hepatocellular carcinoma|up|High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
hsa-mir-130b|hepatocellular carcinoma|up|MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1? signaling.
hsa-mir-130b|hepatocellular carcinoma|down|Repression of microRNA-130b by thyroid hormone enhances cell motility.
hsa-mir-130b|hepatocellular carcinoma|up|Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-130b|neuroblastoma|up|MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
hsa-mir-130b|osteosarcoma|up|miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
hsa-mir-130b|ovarian cancer|down|Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
hsa-mir-130b|papillary thyroid carcinoma|down|MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-130b|prostate cancer|down|MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2.
hsa-mir-130b*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-132|breast cancer|down|MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
hsa-mir-132|colorectal cancer|down|Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer.
hsa-mir-132|colorectal cancer|down|miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
hsa-mir-132|colorectal cancer|down|Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.
hsa-mir-132|gastric cancer|up|Upregulation of microRNA-132 in gastric cancer promotes cell proliferation via retinoblastoma 1 targeting.
hsa-mir-132|gastric cancer|up|miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation.
hsa-mir-132|glioma|up|Upregulation of miR-132 expression in glioma and its clinical significance.
hsa-mir-132|liver cancer|down|Effects of MicroRNA-132 Transfection on the Proliferation and Apoptosis of Human Liver Cancer Cells in vitro and in vivo.
hsa-mir-132|lung cancer|down|miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.
hsa-mir-132|osteosarcoma|down|Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma.
hsa-mir-132|osteosarcoma|down|miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.
hsa-mir-132|osteosarcoma|down|MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.
hsa-mir-132|ovarian cancer|down|miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.
hsa-mir-132|pancreatic cancer|up|miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-132|pancreatic carcinoma|down|Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
hsa-mir-133a|bladder cancer|down|The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-133a|bladder cancer|down|MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133a|breast cancer|down|microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
hsa-mir-133a|cervical cancer|down|miR-133a inhibits cervical cancer growth by targeting EGFR.
hsa-mir-133a|colorectal cancer|down|Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
hsa-mir-133a|colorectal cancer|down|MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.
hsa-mir-133a|colorectal cancer|down|Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-133a|colorectal cancer|down|Tumor suppressor functions of miR-133a in colorectal cancer.
hsa-mir-133a|colorectal cancer|down|The clinicopathological significance of miR-133a in colorectal cancer.
hsa-mir-133a|esophageal squamous cell carcinoma|down|CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
hsa-mir-133a|esophageal squamous cell carcinoma|down|miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133a|gastric cancer|down|MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-133a|gastric cancer|down|MicroRNA-133a functions as a tumor suppressor in gastric cancer.
hsa-mir-133a|gastric cancer|down|Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
hsa-mir-133a|gastric cancer|down|MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
hsa-mir-133a|glioma|down|miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
hsa-mir-133a|head and neck squamous cell carcinoma|down|Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-133a|head and neck squamous cell carcinoma|down|Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
hsa-mir-133a|hepatocellular carcinoma|down|MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
hsa-mir-133a|hepatocellular carcinoma|down|MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
hsa-mir-133a|hepatocellular carcinoma|down|MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
hsa-mir-133a|lung squamous cell carcinoma|down|Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
hsa-mir-133a|non-small cell lung cancer|down|MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance.
hsa-mir-133a|non-small cell lung cancer|down|Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer.
hsa-mir-133a|osteosarcoma|down|MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.
hsa-mir-133a|osteosarcoma|down|MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
hsa-mir-133a|ovarian cancer|down|miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor.
hsa-mir-133a|pancreatic cancer|down|miR-133a Functions as a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer.
hsa-mir-133a|renal cell carcinoma|down|The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-133a-1|hepatocellular carcinoma|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-1|lung cancer|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-1|prostate cancer|down|microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133a-2|hepatocellular carcinoma|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-2|lung cancer|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-2|prostate cancer|down|microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133a-3p|esophageal adenocarcinoma|down|Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-133b|bladder cancer|down|MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133b|cervical carcinoma|up|MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
hsa-mir-133b|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-133b|colorectal cancer|down|miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
hsa-mir-133b|colorectal cancer|down|DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.
hsa-mir-133b|esophageal squamous cell carcinoma|down|miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133b|gastric cancer|down|miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
hsa-mir-133b|gastric cancer|down|MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.
hsa-mir-133b|gastric cancer|down|MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-133b|gastric cancer|down|The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
hsa-mir-133b|gastric cancer|down|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-133b|glioblastoma|down|MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.
hsa-mir-133b|glioma|down|miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.
hsa-mir-133b|hepatocellular carcinoma|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b|lung cancer|down|Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b|lung cancer|down|MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
hsa-mir-133b|osteosarcoma|down|Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.
hsa-mir-133b|prostate cancer|down|microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133b|renal cell carcinoma|down cell line;|microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
hsa-mir-133b|renal cell carcinoma|down cell lines;|microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
hsa-mir-134|colorectal cancer|down|Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
hsa-mir-134|endometrial cancer|down|MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
hsa-mir-134|glioma|down|MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
hsa-mir-134|head and neck squamous cell carcinoma|up|miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
hsa-mir-134|hepatocellular carcinoma|down|Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin ?1 in Hepatocellular Carcinoma.
hsa-mir-134|non-small cell lung cancer|down|miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
hsa-mir-134|non-small cell lung cancer|down|Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.
hsa-mir-134|osteosarcoma|down|Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
hsa-mir-134|renal cell carcinoma|down|miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells.
hsa-mir-135a|bladder cancer|up|Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
hsa-mir-135a|breast cancer|up|miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
hsa-mir-135a|colorectal cancer|up|MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
hsa-mir-135a|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-135a|lung cancer|down|MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
hsa-mir-135a|malignant melanoma|up|MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
hsa-mir-135a|pancreatic ductal adenocarcinoma|down|MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
hsa-mir-135a|prostate cancer|down|Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
hsa-mir-135a|renal cell carcinoma|down|Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
hsa-mir-135a-1|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135a-2|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135a-5p|clear cell renal cell cancer|down|Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-135a-5p|gastric cancer|up|Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p.
hsa-mir-135b|cervical cancer|up|Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
hsa-mir-135b|colonic adenocarcinoma|down|Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-? receptor I kinase inhibitor (SD-208).
hsa-mir-135b|colorectal cancer|up|MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
hsa-mir-135b|colorectal cancer|up|Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
hsa-mir-135b|colorectal cancer|up|Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.
hsa-mir-135b|colorectal cancer|up|MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.
hsa-mir-135b|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135b|colorectal cancer|up|miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
hsa-mir-135b|colorectal cancer|up|Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-135b|colorectal cancer|up|Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-135b|gastric cancer|up|[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
hsa-mir-135b|glioblastoma|up|MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.
hsa-mir-135b|glioblastoma|down|miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
hsa-mir-135b|lung cancer|up|MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
hsa-mir-135b|prostate cancer|down|miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6.
hsa-mir-136|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-136|glioblastoma|down|Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-136|glioma|down|MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.
hsa-mir-136|non-small cell lung cancer|up|Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
hsa-mir-136|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-137|anaplastic astrocytoma|down|miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137|astrocytoma|down|miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.
hsa-mir-137|bladder cancer|up|MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.
hsa-mir-137|colorectal cancer|down|MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2.
hsa-mir-137|colorectal cancer|down|Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
hsa-mir-137|gastric cancer|down|Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.
hsa-mir-137|gastric cancer|down|miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
hsa-mir-137|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-137|glioblastoma|down|MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
hsa-mir-137|glioblastoma|down|Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells.
hsa-mir-137|glioblastoma|down|miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137|glioblastoma|down|miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
hsa-mir-137|glioblastoma|down|MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
hsa-mir-137|glioma|down|Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.
hsa-mir-137|hepatocellular carcinoma|down|FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
hsa-mir-137|hepatocellular carcinoma|down|EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
hsa-mir-137|lung cancer|down|Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
hsa-mir-137|lung cancer|down|MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.
hsa-mir-137|malignant melanoma|down|miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
hsa-mir-137|multiple myeloma|down|miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
hsa-mir-137|multiple myeloma|down|miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF.
hsa-mir-137|neuroblastoma|down|MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
hsa-mir-137|non-small cell lung cancer|down|microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
hsa-mir-137|non-small cell lung cancer|down|MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.
hsa-mir-137|osteosarcoma|down|MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
hsa-mir-137|ovarian cancer|down|miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
hsa-mir-137|ovarian cancer|down|MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
hsa-mir-137|ovarian cancer|down|MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-137|papillary thyroid carcinoma|down|miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
hsa-mir-137|squamous carcinoma|up|MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
hsa-mir-137|thyroid cancer|down|microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.
hsa-mir-137|uveal melanoma|down|Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
hsa-mir-138|anaplastic thyroid carcinoma|down|Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138|chronic lymphocytic leukemia|down|miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.
hsa-mir-138|chronic myelogenous leukemia|down|BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
hsa-mir-138|colorectal cancer|down|Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.
hsa-mir-138|esophageal squamous cell carcinoma|down|Downregulation of miR-138 Sustains NF-?B Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma.
hsa-mir-138|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-138|glioblastoma|up|MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.
hsa-mir-138|head and neck squamous cell carcinoma|down|Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.
hsa-mir-138|head and neck squamous cell carcinoma|down|Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk(1/2) signaling pathway in head and neck squamous cell carcinoma.
hsa-mir-138|head and neck squamous cell carcinoma|down|MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines.
hsa-mir-138|hepatocellular carcinoma|down|MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
hsa-mir-138|lung cancer|down|Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.
hsa-mir-138|malignant melanoma|down|MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1?.
hsa-mir-138|nasopharyngeal carcinoma|down|MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
hsa-mir-138|non-small cell lung cancer|down|MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
hsa-mir-138|non-small cell lung cancer|up|MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.
hsa-mir-138|non-small cell lung cancer|down|MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
hsa-mir-138|non-small cell lung cancer|down|MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer.
hsa-mir-138|non-small cell lung cancer|down|miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.
hsa-mir-138|non-small cell lung cancer|down|Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
hsa-mir-138|oral squamous cell carcinoma|down|Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
hsa-mir-138|oral squamous cell carcinoma|down|miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
hsa-mir-138|osteosarcoma|down|MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
hsa-mir-138|ovarian cancer|down|MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1?
hsa-mir-138|papillary thyroid carcinoma|down|Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138|papillary thyroid carcinoma|down|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-138|renal cell carcinoma|down|MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.
hsa-mir-138|renal clear cell carcinoma|down|MiR-138 suppresses expression of hypoxia-inducible factor 1? (HIF-1?) in clear cell renal cell carcinoma 786-O cells.
hsa-mir-138|small cell lung cancer|down|MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.
hsa-mir-138-5p|colorectal cancer|down|The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
hsa-mir-139|colorectal cancer|down|Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139|colorectal cancer|down|Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-139|colorectal carcinoma|down|Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139|glioma|down|MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma.
hsa-mir-139|hepatocellular carcinoma|down|The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
hsa-mir-139|hepatocellular carcinoma|down|Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
hsa-mir-139|hepatocellular carcinoma|down|miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
hsa-mir-139|non-small cell lung cancer|down|Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
hsa-mir-139-3p|colorectal cancer|up|MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-139-3p|laryngeal cancer|down|New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-139-5p|breast cancer|down|MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
hsa-mir-139-5p|colorectal cancer|down|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-139-5p|colorectal cancer|down|miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
hsa-mir-139-5p|colorectal cancer|down|MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.
hsa-mir-139-5p|glioblastoma|down|miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
hsa-mir-139-5p|glioma|down|MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.
hsa-mir-139-5p|hepatocellular carcinoma|down|miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
hsa-mir-139-5p|non-small cell lung cancer|down|MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
hsa-mir-140|breast cancer|up|Examining estrogen regulation of cancer stem cells through multicolor lineage tracing.
hsa-mir-140|esophageal cancer|down|Down-Regulation of miR-140 Induces EMT and Promotes Invasion by Targeting Slug in Esophageal Cancer.
hsa-mir-140|non-small cell lung cancer|up|Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-140|non-small cell lung cancer|down|miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor.
hsa-mir-140-3p|chordoma|up|MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-140-3p|chordoma|up|Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
hsa-mir-140-3p|lung cancer|down|MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.
hsa-mir-140-3p|non-small cell lung cancer|down|MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.
hsa-mir-140-5p|colorectal cancer|down|Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
hsa-mir-140-5p|hepatocellular carcinoma|down|MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-140-5p|hepatocellular carcinoma|down|miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.
hsa-mir-140-5p|hypopharyngeal squamous cell carcinoma|down|MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.
hsa-mir-140-5p|liver cancer|down|MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-140-5p|ovarian cancer|down|miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.
hsa-mir-141|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-141|bladder cancer|up|Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-141|breast cancer|up|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-141|colorectal cancer|down|MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-141|colorectal cancer|up|MicroRNA-141 regulates the tumour suppressor DLC-1 in colorectal cancer.
hsa-mir-141|esophageal cancer|up|miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-141|gastric cancer|down|MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
hsa-mir-141|gastric cancer|down|MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
hsa-mir-141|gastric cancer|down|Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.
hsa-mir-141|gastric cancer|down|miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.
hsa-mir-141|gastric cancer|down|The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
hsa-mir-141|hepatocellular carcinoma|down|Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
hsa-mir-141|hepatocellular carcinoma|down|miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.
hsa-mir-141|hepatocellular carcinoma|down|microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3beta in hepatocellular carcinoma cells.
hsa-mir-141|lung adenocarcinoma|down|miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-141|lung cancer|up|MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-141|malignant melanoma|up|MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-141|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-141|non-small cell lung cancer|up|High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-141|non-small cell lung cancer|up|MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2.
hsa-mir-141|non-small cell lung cancer|up|MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
hsa-mir-141|oral cancer|down|Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-141|osteosarcoma|down|Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma.
hsa-mir-141|ovarian cancer|down|A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-141|ovarian cancer|up|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-141|pancreatic cancer|down|MicroRNA-141, downregulated in pancreatic cancer, inhibited the cell proliferation and invasion by directly targeting MAP4K4.
hsa-mir-141|prostate cancer|up|Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.
hsa-mir-141|prostate cancer|up|A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-141|renal cell carcinoma|down|MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.
hsa-mir-141|renal clear cell carcinoma|down|Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-141|thyroid cancer|down|microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.
hsa-mir-142|breast cancer|up|miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
hsa-mir-142-3p|acute lymphoblastic leukemia|down|MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.
hsa-mir-142-3p|breast cancer|down|microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
hsa-mir-142-3p|colon cancer|down|MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
hsa-mir-142-3p|colorectal cancer|down|Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.
hsa-mir-142-3p|glioblastoma|down|Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
hsa-mir-142-3p|hepatocellular carcinoma|down|MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.
hsa-mir-142-3p|hepatocellular carcinoma|down|MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
hsa-mir-142-3p|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-3p|nasopharyngeal carcinoma|up|MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.
hsa-mir-142-3p|non-small cell lung cancer|down|MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
hsa-mir-142-3p|non-small cell lung cancer|up|MiR-142-3p represses TGF-?-induced growth inhibition through repression of TGF?R1 in non-small cell lung cancer.
hsa-mir-142-3p|oral squamous cell carcinoma|up|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-142-3p|osteosarcoma|down|MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1.
hsa-mir-142-3p|renal cell carcinoma|up|Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
hsa-mir-142-5p|clear cell renal cell cancer|up|Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-142-5p|colorectal cancer|down|Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.
hsa-mir-142-5p|hepatocellular carcinoma|down|MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
hsa-mir-142-5p|lung cancer|down|Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-142-5p|malt lymphoma|up|Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-142-5p|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-5p|osteosarcoma|down|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-143|bladder cancer|down|MicroRNA-143 as a tumor suppressor for bladder cancer.
hsa-mir-143|bladder cancer|down|MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-143|bladder cancer|down|Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-143|breast cancer|down|miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
hsa-mir-143|breast cancer|down|MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.
hsa-mir-143|cervical cancer|down|miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
hsa-mir-143|cervical cancer|down|A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-143|colon cancer|down|The Evi1, microRNA-143, K-Ras axis in colon cancer.
hsa-mir-143|colon cancer|down|miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-143|colon cancer|down|miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation.
hsa-mir-143|colon cancer|down|Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-143|colon cancer|down|Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-143|colon cancer|down|MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.
hsa-mir-143|colorectal cancer|down|MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.
hsa-mir-143|colorectal cancer|down|The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells.
hsa-mir-143|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-143|colorectal cancer|down|MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-143|colorectal cancer|down|Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
hsa-mir-143|colorectal cancer|down|RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-143|colorectal carcinoma|down|Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-143|colorectal carcinoma|down|[Effect of microRNA143 expression on cell proliferation in colonic carcinoma].
hsa-mir-143|colorectal carcinoma|down|MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.
hsa-mir-143|endometrial cancer|down|Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-143|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-143|esophageal cancer|up|Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-143|esophageal squamous cell carcinoma|down|MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.
hsa-mir-143|esophageal squamous cell carcinoma|down|MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-143|esophageal squamous cell carcinoma|down|miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
hsa-mir-143|gastric cancer|up|Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-143|gastric cancer|down|MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.
hsa-mir-143|gastric cancer|down|Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
hsa-mir-143|gastric cancer|down|[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-143|glioblastoma|down|miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143|glioma|down|miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143|hepatocellular carcinoma|down|[miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
hsa-mir-143|lung cancer|up|Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-143|malignant melanoma|down|MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
hsa-mir-143|nasopharyngeal carcinoma|down|MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-143|nasopharyngeal carcinoma|down|Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.
hsa-mir-143|non-small cell lung cancer|down|miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
hsa-mir-143|non-small cell lung cancer|down|miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells.
hsa-mir-143|oral squamous cell carcinoma|down|Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
hsa-mir-143|oral squamous cell carcinoma|down|Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
hsa-mir-143|oral squamous cell carcinoma|down|Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-143|osteosarcoma|down|A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-143|osteosarcoma|down|microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.
hsa-mir-143|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-143|prostate cancer|down|miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.
hsa-mir-143|prostate cancer|down|miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
hsa-mir-143|prostate cancer|down|MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.
hsa-mir-143|prostate cancer|down|The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-143|renal cell carcinoma|down|The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-144|bladder cancer|down|miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
hsa-mir-144|cholangiocarcinoma|down|MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
hsa-mir-144|cholangiocarcinoma|down|MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
hsa-mir-144|esophageal squamous cell carcinoma|down|MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
hsa-mir-144|gastric cancer|down|MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression.
hsa-mir-144|hepatocellular carcinoma|down|miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.
hsa-mir-144|lung cancer|down|MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR.
hsa-mir-144|nasopharyngeal carcinoma|up|MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
hsa-mir-144|oral squamous cell carcinoma|up|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-144|osteosarcoma|down|The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
hsa-mir-144|osteosarcoma|down|MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
hsa-mir-144|ovarian cancer|down|MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
hsa-mir-144|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-144|thyroid cancer|down|Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.
hsa-mir-144|uveal melanoma|down|MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
hsa-mir-144-3p|glioma|down|miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
hsa-mir-145|bladder cancer|down|miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.
hsa-mir-145|bladder cancer|down|miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
hsa-mir-145|bladder cancer|down|Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
hsa-mir-145|bladder cancer|down|MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-145|bladder cancer|down|Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-145|bladder cancer|down|socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells.
hsa-mir-145|bladder cancer|down|Aberrant expression of microRNAs in bladder cancer.
hsa-mir-145|breast cancer|down|miR-145 inhibits breast cancer cell growth through RTKN.
hsa-mir-145|breast cancer|down|miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
hsa-mir-145|breast cancer|down|MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
hsa-mir-145|breast cancer|down|MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
hsa-mir-145|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-145|cervical cancer|down|Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-145|cervical cancer|down|A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-145|cervical cancer|down|Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
hsa-mir-145|chondrosarcoma|down|The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma.
hsa-mir-145|colon cancer|down|Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-145|colon cancer|down|Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-145|colon cancer|down|Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.
hsa-mir-145|colon cancer|down|miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-145|colon cancer|up|miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
hsa-mir-145|colon cancer|down|Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
hsa-mir-145|colon cancer|down|MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
hsa-mir-145|colorectal cancer|down|MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.
hsa-mir-145|colorectal cancer|up|Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.
hsa-mir-145|colorectal cancer|down|Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.
hsa-mir-145|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-145|colorectal cancer|down|Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-145|colorectal cancer|down|MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-145|colorectal cancer|down|MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.
hsa-mir-145|colorectal cancer|down|Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-145|colorectal cancer|down|RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-145|colorectal carcinoma|down|Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-145|endometrial cancer|down|Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-145|endometrial cancer|up|Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
hsa-mir-145|esophageal squamous cell carcinoma|down|MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-145|esophageal squamous cell carcinoma|down|miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.
hsa-mir-145|esophageal squamous cell carcinoma|down|Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma.
hsa-mir-145|esophageal squamous cell carcinoma|down|miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-145|esophageal squamous cell carcinoma|up|Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
hsa-mir-145|gallbladder carcinoma|up|miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
hsa-mir-145|gastric cancer|down|MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-145|gastric cancer|down|[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-145|glioblastoma|down|NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145|glioblastoma|down|Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-145|glioma|down|ROCK1, a novel target of miR-145, promotes glioma cell invasion.
hsa-mir-145|glioma|down|miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2.
hsa-mir-145|glioma|down|NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145|glioma|down|MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
hsa-mir-145|hepatocellular carcinoma|down|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-145|hepatocellular carcinoma|down|MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
hsa-mir-145|hepatocellular carcinoma|down|MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
hsa-mir-145|hepatocellular carcinoma|down|miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17.
hsa-mir-145|hepatocellular carcinoma|down|MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).
hsa-mir-145|hepatocellular carcinoma|down|MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
hsa-mir-145|hepatocellular carcinoma|down|MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
hsa-mir-145|hepatocellular carcinoma|down|MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.
hsa-mir-145|intrahepatic cholangiocarcinoma|down|MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
hsa-mir-145|kidney cancer|down|MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients.
hsa-mir-145|liver cancer|down|MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
hsa-mir-145|lung adenocarcinoma|down|microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
hsa-mir-145|lung adenocarcinoma|down|[miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
hsa-mir-145|lung adenocarcinoma|down|MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.
hsa-mir-145|lung adenocarcinoma|down|Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
hsa-mir-145|lung adenocarcinoma|down|MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.
hsa-mir-145|lung cancer|down|Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-145|lung cancer|down|MicroRNA-145 inhibits lung cancer cell metastasis.
hsa-mir-145|lung cancer|down|MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer.
hsa-mir-145|lung cancer|up|Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-145|nasopharyngeal carcinoma|down|MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.
hsa-mir-145|nasopharyngeal carcinoma|down|MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-145|nasopharyngeal carcinoma|down|miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
hsa-mir-145|neuroblastoma|down|NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145|non-small cell lung cancer|down|Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
hsa-mir-145|non-small cell lung cancer|down|miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
hsa-mir-145|non-small cell lung cancer|down|MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
hsa-mir-145|non-small cell lung cancer|down|Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-145|non-small cell lung cancer|down|MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer.
hsa-mir-145|non-small cell lung cancer|down|Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.
hsa-mir-145|non-small cell lung cancer|down|MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
hsa-mir-145|non-small cell lung cancer|up|Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-145|oral squamous cell carcinoma|down|MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.
hsa-mir-145|oral squamous cell carcinoma|down|Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-145|oral squamous cell carcinoma|down|Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
hsa-mir-145|osteosarcoma|down|MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16.
hsa-mir-145|osteosarcoma|down|MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.
hsa-mir-145|osteosarcoma|down|microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.
hsa-mir-145|osteosarcoma|down|miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.
hsa-mir-145|ovarian cancer|down|miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.
hsa-mir-145|ovarian cancer|down|miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
hsa-mir-145|ovarian cancer|down|Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145.
hsa-mir-145|ovarian cancer|down|MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer.
hsa-mir-145|ovarian cancer|down|MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
hsa-mir-145|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-145|pancreatic cancer|down|MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.
hsa-mir-145|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-145|primary cns lymphomas|down|Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-145|prostate cancer|down|MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
hsa-mir-145|prostate cancer|down|The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-145|prostate cancer|down|miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
hsa-mir-145|prostate cancer|down|The functional significance of microRNA-145 in prostate cancer.
hsa-mir-145|prostate cancer|down|Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
hsa-mir-145|renal cell carcinoma|down|miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
hsa-mir-145|renal cell carcinoma|down|The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-145|retinoblastoma|down|miR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
hsa-mir-145|uveal melanoma|down|MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
hsa-mir-145-5p|colorectal cancer|down|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-145-5p|gastric cancer|down|MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.
hsa-mir-145-5p|hepatocellular carcinoma|down|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-1469|lung cancer|down|MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.
hsa-mir-146a|breast cancer|down|Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a|breast cancer|down|Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146a|breast cancer|down|MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
hsa-mir-146a|chronic myelogenous leukemia|down|ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-146a|esophageal squamous cell carcinoma|down|Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
hsa-mir-146a|gastric cancer|down|microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.
hsa-mir-146a|gastric cancer|up|microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer.
hsa-mir-146a|gastric cancer|down|MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.
hsa-mir-146a|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-146a|gastric cancer|down|Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a|glioma|down|MicroRNA-146a inhibits glioma development by targeting Notch1.
hsa-mir-146a|hepatocellular carcinoma|up|Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-146a|hepatocellular carcinoma|down|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-146a|hepatocellular carcinoma|down|Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
hsa-mir-146a|hepatocellular carcinoma|down|microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
hsa-mir-146a|lung cancer|down|Regulation of COX-2 expression by miR-146a in lung cancer cells.
hsa-mir-146a|malignant melanoma|down|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146a|non-small cell lung cancer|down|miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.
hsa-mir-146a|non-small cell lung cancer|down|MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.
hsa-mir-146a|non-small cell lung cancer|up|Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-146a|non-small cell lung cancer|down|MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.
hsa-mir-146a|oral squamous cell carcinoma|up|miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
hsa-mir-146a|pancreatic cancer|down|miR-146a suppresses invasion of pancreatic cancer cells.
hsa-mir-146a|pancreatic cancer|down|Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a|papillary thyroid carcinoma|down|MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
hsa-mir-146a|prostate cancer|down|Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a|prostate cancer|down|miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.
hsa-mir-146a|renal cell carcinoma|up|Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146a-5p|bladder cancer|up|Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
hsa-mir-146a-5p|gastric cancer|down|The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-146b|anaplastic thyroid carcinoma|up|A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-146b|breast cancer|down|Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146b|breast cancer|down|STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-?B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes.
hsa-mir-146b|esophageal cancer|up|Transcriptional regulation of miR-146b by C/EBP? LAP2 in esophageal cancer cells.
hsa-mir-146b|follicular thyroid carcinoma|up|Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-146b|glioma|down|microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
hsa-mir-146b|malignant melanoma|down|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146b|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-146b|oral squamous cell carcinoma|up|miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
hsa-mir-146b|papillary thyroid carcinoma|up|MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-146b|papillary thyroid carcinoma|up|MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-146b|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-146b|papillary thyroid carcinoma|up|Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma.
hsa-mir-146b|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-146b|primary thyroid lymphoma|up|A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-146b|prostate cancer|down|MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
hsa-mir-146b|renal cell carcinoma|up|Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146b-5p|gallbladder carcinoma|down|MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
hsa-mir-146b-5p|glioblastoma|down|MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.
hsa-mir-146b-5p|glioma|down|miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.
hsa-mir-146b-5p|osteosarcoma|up|miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
hsa-mir-146b-5p|papillary thyroid carcinoma|up|MicroRNA miR-146b-5p regulates signal transduction of TGF-? by repressing SMAD4 in thyroid cancer.
hsa-mir-146b-5p|papillary thyroid carcinoma|up|Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-146b-5p|papillary thyroid carcinoma|up|MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
hsa-mir-146b-5p|papillary thyroid carcinoma|up|In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
hsa-mir-147|breast cancer|down|Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-147|breast cancer|down|MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer.
hsa-mir-147|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-147|non-small cell lung cancer|down|Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung caner.
hsa-mir-147|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-148a|bladder cancer|down|MicroRNA-148a represents an independent prognostic marker in bladder cancer.
hsa-mir-148a|breast cancer|down|MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.
hsa-mir-148a|breast cancer|down|A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-148a|cervical squamous cell carcinoma|down|MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-148a|chordoma|up|MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-148a|colorectal cancer|down|Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
hsa-mir-148a|colorectal cancer|down|MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.
hsa-mir-148a|gastric cancer|down|MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
hsa-mir-148a|gastric cancer|down|MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
hsa-mir-148a|gastric cancer|down|microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.
hsa-mir-148a|gastric cancer|down|miR-148a downregulates the expression of transforming growth factor-?2 and SMAD2 in gastric cancer.
hsa-mir-148a|gastric cancer|down|MiR-148a is down-regulated in gastric cancer, targets MMP7 and indicates tumor invasiveness and poor prognosis.
hsa-mir-148a|gastric cancer|down|The role of miR-148a in gastric cancer.
hsa-mir-148a|gastric cancer|up|miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.
hsa-mir-148a|gastric cancer|down|[Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism].
hsa-mir-148a|gastrointestinal cancer|down|MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148a|glioblastoma|up|microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma.
hsa-mir-148a|hepatocellular carcinoma|down|MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
hsa-mir-148a|hepatocellular carcinoma|down|microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.
hsa-mir-148a|nasopharyngeal carcinoma|down|Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.
hsa-mir-148a|non-small cell lung cancer|down|MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells.
hsa-mir-148a|non-small cell lung cancer|down|Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
hsa-mir-148a|non-small cell lung cancer|down|Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-148a|non-small cell lung cancer|down|MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.
hsa-mir-148a|non-small cell lung cancer|down|MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC.
hsa-mir-148a|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-148a|ovarian cancer|down|Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-148a|ovarian cancer|down|MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1.
hsa-mir-148a|pancreatic cancer|down|MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.
hsa-mir-148a|pancreatic ductal adenocarcinoma|down|Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-148a|pancreatic ductal adenocarcinoma|down|MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
hsa-mir-148a|pancreatic ductal adenocarcinoma|down|MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-148b|colorectal cancer|down|MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
hsa-mir-148b|gastric cancer|down|MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148b|hepatocellular carcinoma|down|MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis.
hsa-mir-148b|hepatocellular carcinoma|down|MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/?-catenin pathway.
hsa-mir-148b|hepatocellular carcinoma|down|Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker.
hsa-mir-148b|hepatocellular carcinoma|down|Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.
hsa-mir-148b|liver cancer|down|microRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.
hsa-mir-148b|lung cancer|down|Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b.
hsa-mir-148b|non-small cell lung cancer|down|Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-148b|non-small cell lung cancer|down|Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
hsa-mir-148b|non-small cell lung cancer|down|MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
hsa-mir-148b|non-small cell lung cancer|down|miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).
hsa-mir-148b|ovarian cancer|up|Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b|ovarian carcinoma|up|Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b|pancreatic cancer|down|miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPK?1.
hsa-mir-148b|pancreatic cancer|down|MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
hsa-mir-148b-3p|breast cancer|down|Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
hsa-mir-149|breast cancer|down|MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis.
hsa-mir-149|colorectal cancer|down|MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1.
hsa-mir-149|gastric cancer|down|MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.
hsa-mir-149|glioblastoma|down|miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
hsa-mir-149|head and neck squamous cell carcinoma|down|The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.
hsa-mir-149|hepatocellular carcinoma|down|miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
hsa-mir-149|nasopharyngeal carcinoma|up|miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
hsa-mir-149|non-small cell lung cancer|down|miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1.
hsa-mir-150|adult t-cell leukemia|up|STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells.
hsa-mir-150|breast cancer|up|miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.
hsa-mir-150|breast cancer|up|miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
hsa-mir-150|cervical cancer|up|microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
hsa-mir-150|chronic lymphocytic leukemia|up|Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.
hsa-mir-150|chronic myelogenous leukemia|down|Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-150|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-150|esophageal squamous cell carcinoma|down|MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducers ZEB1.
hsa-mir-150|gastric cancer|up|MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
hsa-mir-150|hepatocellular carcinoma|down|microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
hsa-mir-150|hepatocellular carcinoma|down|MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
hsa-mir-150|intrahepatic cholangiocarcinoma|down|Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.
hsa-mir-150|lung adenocarcinoma|up|Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
hsa-mir-150|lung cancer|up|miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
hsa-mir-150|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-150|non-small cell lung cancer|up|Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
hsa-mir-150|non-small cell lung cancer|up|Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
hsa-mir-150|osteosarcoma|down|MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma.
hsa-mir-150|osteosarcoma|down|MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.
hsa-mir-150|pancreatic cancer|down|Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.
hsa-mir-150|pancreatic ductal adenocarcinoma|down|A Decrease in miR-150 Regulates the Malignancy of Pancreatic Cancer by Targeting c-Myb and MUC4.
hsa-mir-150|prostate cancer|up|MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1.
hsa-mir-150*|colorectal cancer|up|MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-150*|pancreatic cancer|down|Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-150-5p|colorectal cancer|down|MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4.
hsa-mir-150-5p|glioma|down|miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
hsa-mir-150-5p|hepatocellular carcinoma|down|miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
hsa-mir-150-5p|hepatocellular carcinoma|down|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-150-5p|pancreatic cancer|down|[MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
hsa-mir-151|chronic myelogenous leukemia|down|Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-151-3p|osteosarcoma|up|MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-151-5p|gastric cancer|up|Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
hsa-mir-151-5p|papillary thyroid carcinoma|up|Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-mir-152|breast cancer|down|A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-152|colorectal cancer|down|miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.
hsa-mir-152|endometrial cancer|down|miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
hsa-mir-152|endometrial cancer|down|Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.
hsa-mir-152|gastric cancer|down|miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.
hsa-mir-152|gastrointestinal cancer|down|MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-152|glioblastoma|down|MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr?ppel-like factor 4.
hsa-mir-152|glioma|down|MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-152|multiple myeloma|down|Downregulation of MicroRNA-152 Contributes to High Expression of DKK1 in Multiple Myeloma.
hsa-mir-152|non-small cell lung cancer|down|MicroRNA-152 targets ADAM17 to suppress NSCLC progression.
hsa-mir-152|non-small cell lung cancer|down|MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1.
hsa-mir-152|non-small cell lung cancer|down|Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-152|osteosarcoma|down|Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
hsa-mir-152|ovarian cancer|down|Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-152|pancreatic cancer|down|MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
hsa-mir-153|breast cancer|down|MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
hsa-mir-153|gastric cancer|down|MiR-153 regulates metastases of gastric cancer through Snail.
hsa-mir-153|glioblastoma|down|MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
hsa-mir-153|glioblastoma|down|MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation.
hsa-mir-153|hepatocellular carcinoma|up|MicroRNA-153 promotes Wnt/?-catenin activation in hepatocellular carcinoma through suppression of WWOX.
hsa-mir-153|hepatocellular carcinoma|up|MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
hsa-mir-153|laryngeal squamous cell carcinoma|down|MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5.
hsa-mir-153|lung cancer|down|Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.
hsa-mir-153|non-small cell lung cancer|down|MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.
hsa-mir-153|osteosarcoma|down|MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-?2.
hsa-mir-153|ovarian cancer|down|MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
hsa-mir-153|prostate cancer|up|Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
hsa-mir-154|colorectal cancer|down|miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.
hsa-mir-154|glioblastoma|down|MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.
hsa-mir-154|hepatocellular carcinoma|down|miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
hsa-mir-154|non-small cell lung cancer|down|miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo.
hsa-mir-154|non-small cell lung cancer|down|MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer.
hsa-mir-154|osteosarcoma|down|MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
hsa-mir-154|prostate cancer|down|miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.
hsa-mir-155|acute myeloid leukemia|up|Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
hsa-mir-155|acute myeloid leukemia|up|Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.
hsa-mir-155|anaplastic large-cell lymphoma|up|Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
hsa-mir-155|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-155|bladder cancer|up|Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
hsa-mir-155|bladder cancer|up|MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
hsa-mir-155|breast cancer|up|MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
hsa-mir-155|breast cancer|up|Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-155|breast cancer|up|[Expression and its clinical significance of miR-155 in human primary breast cancer].
hsa-mir-155|breast cancer|up|Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.
hsa-mir-155|breast cancer|up|Clinical significance of MicoRNA-155 expression in human breast cancer.
hsa-mir-155|breast cancer|up|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-155|breast cancer|up|17?-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
hsa-mir-155|breast cancer|up|MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.
hsa-mir-155|breast cancer|up|MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
hsa-mir-155|breast cancer|up|miR-155 drives telomere fragility in human breast cancer by targeting TRF1.
hsa-mir-155|cervical cancer|up|Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.
hsa-mir-155|chronic lymphocytic leukemia|up|Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia.
hsa-mir-155|chronic myelogenous leukemia|down|Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-155|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-155|clear cell renal cell cancer|up|microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.
hsa-mir-155|colon cancer|up|Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast.
hsa-mir-155|colorectal cancer|up|Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.
hsa-mir-155|cutaneous t-cell lymphoma|up|STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
hsa-mir-155|diffuse large B-cell lymphoma|up|Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.
hsa-mir-155|endometrial cancer|up|Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
hsa-mir-155|gallbladder carcinoma|up|High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
hsa-mir-155|gastric cancer|down|Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells.
hsa-mir-155|gastric cancer|down|microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
hsa-mir-155|glioma|up|MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1.
hsa-mir-155|glioma|up|Overexpression of microRNA-155 predicts poor prognosis in glioma patients.
hsa-mir-155|hepatocellular carcinoma|up|[Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
hsa-mir-155|hepatocellular carcinoma|up|Clinical significance of microRNA-155 expression in hepatocellular carcinoma.
hsa-mir-155|hepatocellular carcinoma|up|Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-155|laryngeal squamous cell carcinoma|up|The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
hsa-mir-155|liver cancer|up|TGF-?1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
hsa-mir-155|lung adenocarcinoma|up|Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
hsa-mir-155|lung cancer|up|Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.
hsa-mir-155|lung cancer|up|MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
hsa-mir-155|lung cancer|up|Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-155|malignant melanoma|down|MicroRNA-155 targets the SKI gene in human melanoma cell lines.
hsa-mir-155|malignant melanoma|down|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-155|malt lymphoma|up|Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-155|mantle cell lymphoma|up|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-155|nasopharyngeal carcinoma|up|Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
hsa-mir-155|nasopharyngeal carcinoma|up|MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration.
hsa-mir-155|nasopharyngeal carcinoma|up|Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.
hsa-mir-155|non-small cell lung cancer|up|Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.
hsa-mir-155|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-155|oral squamous cell carcinoma|up|Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.
hsa-mir-155|oral squamous cell carcinoma|up|MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
hsa-mir-155|ovarian cancer|down|MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
hsa-mir-155|papillary thyroid carcinoma|up|Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/?-Catenin Signaling.
hsa-mir-155|prostate cancer|up|A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-155|rectal cancer|up|The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-155|rectal carcinoma|up|The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer.
hsa-mir-155|renal clear cell carcinoma|up|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-155|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-155-5p|colorectal carcinoma|up|Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.
hsa-mir-155-5p|gastric cancer|down|The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-15a|breast cancer|down|MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
hsa-mir-15a|cervical carcinoma|down|MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.
hsa-mir-15a|chronic lymphocytic leukemia|down|Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
hsa-mir-15a|chronic lymphocytic leukemia|down|Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia.
hsa-mir-15a|chronic lymphocytic leukemia|down|miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-15a|chronic lymphocytic leukemia|down|Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-15a|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-15a|colorectal cancer|down|Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15a|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-15a|gastric cancer|down|Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
hsa-mir-15a|lung cancer|down|Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-15a|neuroblastoma|up|miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-15a|neuroblastoma|up|MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
hsa-mir-15a|non-small cell lung cancer|down|MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
hsa-mir-15a|osteosarcoma|down|MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
hsa-mir-15a|pancreatic cancer|down|Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a|pancreatic cancer|up|Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a|pancreatic ductal adenocarcinoma|down|miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
hsa-mir-15a|prostate cancer|down|Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-15a|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-15a|squamous carcinoma|down|miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-15a-3p|colorectal cancer|up|Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
hsa-mir-15a-5p|hepatocellular carcinoma|down|MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
hsa-mir-15b|chronic lymphocytic leukemia|down|miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-15b|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-15b|colorectal cancer|up|Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
hsa-mir-15b|colorectal cancer|down|Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15b|glioma|down|MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-15b|hepatocellular carcinoma|down|Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
hsa-mir-15b|lung cancer|down|Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-15b|malignant melanoma|up|MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-15b|neuroblastoma|up|miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-15b|pancreatic cancer|up|miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.
hsa-mir-15b|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-15b|tongue cancer|down|MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-15b-5p|non-small cell lung cancer|up|Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-16|bladder cancer|down|MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1.
hsa-mir-16|breast cancer|down|Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
hsa-mir-16|breast cancer|down|Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
hsa-mir-16|breast cancer|down|MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
hsa-mir-16|cervical carcinoma|down|MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.
hsa-mir-16|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16|chronic myelogenous leukemia|down|ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-16|colorectal cancer|down|microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway.
hsa-mir-16|colorectal cancer|down|Prognostic Significance of MicroRNA-16 Expression in Human Colorectal Cancer.
hsa-mir-16|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-16|colorectal cancer|down|Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-16|esophageal squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16|glioma|down|MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-?B1/MMP9 signaling pathway.
hsa-mir-16|glioma|down|Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1.
hsa-mir-16|head and neck squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16|hepatocellular carcinoma|down|Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-16|hepatocellular carcinoma|down|Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-mir-16|hepatocellular carcinoma|down|Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
hsa-mir-16|laryngeal carcinoma|up|MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.
hsa-mir-16|lung adenocarcinoma|down|Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
hsa-mir-16|nasopharyngeal carcinoma|down|miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
hsa-mir-16|non-small cell lung cancer|down|Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
hsa-mir-16|oral squamous cell carcinoma|down|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-16|osteosarcoma|down|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-16|osteosarcoma|down|miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
hsa-mir-16|pancreatic ductal adenocarcinoma|down|MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-16|papillary thyroid carcinoma|down|Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-16|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-16|renal cell carcinoma|up|Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
hsa-mir-16|squamous carcinoma|down|miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-16-1|chronic lymphocytic leukemia|down|miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-16-1|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16-1|lung cancer|down|Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-16-1|neuroblastoma|up|miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-16-1|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-16-1-3p|chronic lymphocytic leukemia|down|Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-16-2|chronic lymphocytic leukemia|down|miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-16-2|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16-2|lung cancer|down|Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-16-2|neuroblastoma|up|miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-16-2|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-16-5p|non-small cell lung cancer|down|Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-17|acute myeloid leukemia|down|HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-17|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17|breast cancer|up|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-17|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-17|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-17|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-17|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-17|colorectal cancer|up|Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-17|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-17|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-17|colorectal carcinoma|up|Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
hsa-mir-17|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-17|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-17|gastric cancer|up|Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification.
hsa-mir-17|gastric cancer|up|Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression.
hsa-mir-17|glioma|up|Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-17|glioma|up|Increased expression of microRNA-17 predicts poor prognosis in human glioma.
hsa-mir-17|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-17|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-17|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-17|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-17|malignant melanoma|down|MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response.
hsa-mir-17|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-17|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-17|nasopharyngeal cancer|up|Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-17|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-17|t-cell lymphoblastic lymphoma|up|Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-17-5p|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-17-5p|breast cancer|up|miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
hsa-mir-17-5p|breast cancer|down|Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
hsa-mir-17-5p|cervical cancer|down|MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
hsa-mir-17-5p|colorectal cancer|up|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-17-5p|gastric cancer|up|Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-17-5p|gastric cancer|up|miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.
hsa-mir-17-5p|gastric cancer|up|Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-17-5p|hepatocellular carcinoma|up|miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
hsa-mir-17-5p|hepatocellular carcinoma|up|miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
hsa-mir-17-5p|malignant melanoma|up|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-17-5p|malignant melanoma|up|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-17-5p|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-17-5p|ovarian cancer|up|MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.
hsa-mir-17-5p|pancreatic cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17-5p|pancreatic cancer|up|MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-17-5p|pancreatic cancer|up|miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells.
hsa-mir-17-5p|pituitary carcinoma|up|MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-181a|acute myeloid leukemia|down|MicroRNA 181a Influences the Expression of HMGB1 and CD4 in Acute Leukemias.
hsa-mir-181a|acute myeloid leukemia|up|[MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM].
hsa-mir-181a|acute promyelocytic leukemia|up|PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.
hsa-mir-181a|breast cancer|up|Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181a|breast cancer|down|Decreased serum miR-181a is a potential new tool for breast cancer screening.
hsa-mir-181a|cervical cancer|up|MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
hsa-mir-181a|chondrosarcoma|up|The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
hsa-mir-181a|chronic lymphocytic leukemia|down|Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181a|chronic lymphocytic leukemia|down|miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181a|colon cancer|up|IL-1?/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis.
hsa-mir-181a|colon cancer|up|miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway.
hsa-mir-181a|colorectal cancer|up|MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
hsa-mir-181a|gastric cancer|up|MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.
hsa-mir-181a|gastric cancer|up|Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
hsa-mir-181a|gastric cancer|down|MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer.
hsa-mir-181a|glioblastoma|down|The correlation of microRNA-181a and target genes with poor prognosis of glioblastoma patients.
hsa-mir-181a|glioma|down|hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181a|glioma|up|MiR-181a regulates blood-tumor barrier permeability by targeting Kr?ppel-like factor 6.
hsa-mir-181a|hepatocellular carcinoma|up|Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181a|hepatocellular carcinoma|up|Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.
hsa-mir-181a|oral squamous cell carcinoma|down|miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
hsa-mir-181a|osteosarcoma|up|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181a|osteosarcoma|up|MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
hsa-mir-181a|pancreatic cancer|up|LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4.
hsa-mir-181a-1|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181a-1|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181a-1|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181a-1|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181a-1|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181a-2|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181a-2|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181a-2|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181a-2|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181a-2|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181a-2*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-181a-5p|gastric cancer|up|Hsa-miR-181a-5p Expression and Effects on Cell Proliferation in Gastric Cancer.
hsa-mir-181a-5p|hepatocellular carcinoma|down|miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
hsa-mir-181a-5p|non-small cell lung cancer|down|MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.
hsa-mir-181b|acute promyelocytic leukemia|up|PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.
hsa-mir-181b|breast cancer|up|miR-181b promotes chemoresistance in breast cancer by regulating Bim expression.
hsa-mir-181b|breast cancer|up|Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181b|cervical cancer|up|miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.
hsa-mir-181b|chronic lymphocytic leukemia|down|Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181b|chronic lymphocytic leukemia|down|miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181b|gastric adenocarcinoma|down|MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.
hsa-mir-181b|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-181b|glioblastoma|down|Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.
hsa-mir-181b|glioma|down|MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells.
hsa-mir-181b|glioma|down|hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181b|glioma|down|MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.
hsa-mir-181b|hepatocellular carcinoma|up|Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181b|non-small cell lung cancer|down|Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
hsa-mir-181b|oral squamous cell carcinoma|up|Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-181b|osteosarcoma|up|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181b|ovarian cancer|up|MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
hsa-mir-181b|prostate cancer|up|MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
hsa-mir-181b|retinoblastoma|up|Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6.
hsa-mir-181b-1|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181b-1|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181b-1|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181b-1|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181b-1|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181b-2|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181b-2|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181b-2|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181b-2|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181b-2|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181b-5p|astrocytoma|down|MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
hsa-mir-181c|gastric cancer|up|Upregulation of MicroRNA 181c Expression in Gastric Cancer Tissues and Plasma.
hsa-mir-181c|glioblastoma|down|MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-? pathway.
hsa-mir-181c|glioblastoma|down|Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
hsa-mir-181c|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181c|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181c|neuroblastoma|down|MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
hsa-mir-181c|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181c|osteosarcoma|up|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181c|ovarian cancer|down|MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
hsa-mir-181c|pancreatic cancer|up|Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
hsa-mir-181c|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181c|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181d|glioma|down|MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181d|glioma|down|MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
hsa-mir-181d|hepatocellular carcinoma|up|Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181d|hepatocellular carcinoma|up|Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181d|non-small cell lung cancer|down|MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181d|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181d|prostate cancer|up|microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-182|bladder cancer|up|Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-182|breast cancer|up|Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
hsa-mir-182|breast cancer|up|Higher expression of circulating miR-182 as a novel biomarker for breast cancer.
hsa-mir-182|breast cancer|up|High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-182|breast cancer|up|Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.
hsa-mir-182|colorectal adenocarcinoma|up|Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
hsa-mir-182|colorectal cancer|up|microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.
hsa-mir-182|colorectal cancer|up|Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.
hsa-mir-182|colorectal cancer|up|SATB1 and 2 in colorectal cancer.
hsa-mir-182|colorectal cancer|up|miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
hsa-mir-182|colorectal cancer|up|Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
hsa-mir-182|colorectal carcinoma|up|Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor.
hsa-mir-182|endometrial cancer|up|MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma.
hsa-mir-182|gallbladder carcinoma|up|TGF-? upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1.
hsa-mir-182|gastric adenocarcinoma|down|MicroRNA-182 targets cAMP-responsive element-binding protein?1 and suppresses cell growth in human gastric adenocarcinoma.
hsa-mir-182|gastric cancer|down|MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.
hsa-mir-182|glioma|up|miR-182 as a prognostic marker for glioma progression and patient survival.
hsa-mir-182|glioma|up|The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-182|hepatocellular carcinoma|up|Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
hsa-mir-182|hepatocellular carcinoma|up|Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.
hsa-mir-182|hepatocellular carcinoma|up|MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
hsa-mir-182|hepatocellular carcinoma|up|MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.
hsa-mir-182|hepatocellular carcinoma|up|OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
hsa-mir-182|hepatocellular carcinoma|up|Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-182|lung cancer|up|Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells.
hsa-mir-182|lung cancer|down|[Methylation Status of miR-182 Promoter in Lung Cancer Cell Lines].
hsa-mir-182|lung cancer|up|Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-182|malignant melanoma|up|Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
hsa-mir-182|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-182|mesenchymal cancer|up|MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.
hsa-mir-182|non-small cell lung cancer|up|Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-182|osteosarcoma|down|The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.
hsa-mir-182|ovarian cancer|up|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-182|ovarian cancer|up|Anti-MiR-182 reduces ovarian cancer burden, invasion and metastasis: An in vivo study in orthotopic xenografts of nude mice.
hsa-mir-182|ovarian cancer|up|The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-182|ovarian carcinoma|up|MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
hsa-mir-182|papillary thyroid carcinoma|up|miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
hsa-mir-182|prostate cancer|up|Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer.
hsa-mir-182|prostate cancer|up|miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-182|prostate cancer|up|Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).
hsa-mir-182|uveal melanoma|down|Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
hsa-mir-182-5p|bladder cancer|up|Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
hsa-mir-182-5p|prostate cancer|up|MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.
hsa-mir-182-5p|renal cell carcinoma|down|Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
hsa-mir-1826|breast cancer|down|MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
hsa-mir-1826|kidney cancer|down|MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
hsa-mir-1827|colorectal cancer|down|microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
hsa-mir-183|astrocytoma|up|Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
hsa-mir-183|bladder cancer|up|MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-183|bladder cancer|up|Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-183|breast cancer|down|Dysregulated miR-183 inhibits migration in breast cancer cells.
hsa-mir-183|breast cancer|up|High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-183|cervical cancer|down|MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
hsa-mir-183|colon cancer|up|miR-183 functions as an oncogene by targeting ABCA1 in colon cancer.
hsa-mir-183|colorectal cancer|up|Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
hsa-mir-183|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-183|colorectal cancer|up|Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
hsa-mir-183|colorectal cancer|up|miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG.
hsa-mir-183|esophageal cancer|up|miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4.
hsa-mir-183|esophageal squamous cell carcinoma|up|MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.
hsa-mir-183|follicular thyroid carcinoma|up|Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-183|gastric cancer|up|MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.
hsa-mir-183|gastric cancer|up|MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer.
hsa-mir-183|gastric cancer|down|MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1.
hsa-mir-183|gastric cancer|down|miR-183 inhibits invasion of gastric cancer by targeting Ezrin.
hsa-mir-183|glioblastoma|up|Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
hsa-mir-183|glioma|up|Upregulation of miR-183 expression and its clinical significance in human brain glioma.
hsa-mir-183|glioma|up|The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-183|hepatocellular carcinoma|up|miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.
hsa-mir-183|hepatocellular carcinoma|up|MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
hsa-mir-183|hepatocellular carcinoma|up|Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma.
hsa-mir-183|hepatocellular carcinoma|up|Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-183|kidney cancer|up|microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells.
hsa-mir-183|medullary thyroid carcinoma|up|MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
hsa-mir-183|non-small cell lung cancer|up|Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-183|osteosarcoma|down|Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
hsa-mir-183|papillary thyroid carcinoma|up|miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
hsa-mir-183|prostate cancer|up|miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-183|prostate cancer|up|microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.
hsa-mir-183|renal cell carcinoma|up|High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells.
hsa-mir-183|retinoblastoma|down|MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.
hsa-mir-183-3p|lung cancer|up|Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
hsa-mir-183-5p|colorectal cancer|up|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-184|glioma|down|Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-184|glioma|down|MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-184|head and neck squamous cell carcinoma|up|Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-184|hepatocellular carcinoma|up|MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-184|hepatocellular carcinoma|up|Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma.
hsa-mir-184|malignant melanoma|down|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-184|neuroblastoma|down|MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
hsa-mir-184|neuroblastoma|down|MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.
hsa-mir-184|non-small cell lung cancer|down|MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
hsa-mir-184|squamous carcinoma|up|MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-185|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-185|breast cancer|down|MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.
hsa-mir-185|breast cancer|down|MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.
hsa-mir-185|chondrosarcoma|down|Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.
hsa-mir-185|esophageal squamous cell carcinoma|down|[Molecular mechanism and effect of microRNA185 on proliferation, migration and invasion of esophageal squamous cell carcinoma].
hsa-mir-185|esophageal squamous cell carcinoma|down|Plasma miR-185 is decreased in esophageal squamous cell carcinoma patients and might suppress tumor migration and invasion by targeting RAGE.
hsa-mir-185|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-185|gastric cancer|down|miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer.
hsa-mir-185|glioma|down|LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.
hsa-mir-185|hepatocellular carcinoma|down|MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.
hsa-mir-185|hepatocellular carcinoma|down|miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
hsa-mir-185|malignant melanoma|down|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-185|non-small cell lung cancer|down|miR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.
hsa-mir-186|bladder cancer|down|MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
hsa-mir-186|colon carcinoma|down|[Expression of hsa-miR-186 and its role in human colon carcinoma cells].
hsa-mir-186|esophageal squamous cell carcinoma|down|microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.
hsa-mir-186|gastric cancer|down|MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1? regulation.
hsa-mir-186|multiple myeloma|down|miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.
hsa-mir-186|non-small cell lung cancer|down|miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.
hsa-mir-186|non-small cell lung cancer|down|MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.
hsa-mir-186|pancreatic ductal adenocarcinoma|up|miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells.
hsa-mir-187|colorectal cancer|down|MicroRNA-187, a downstream effector of TGF? pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-187|prostate cancer|down|MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.
hsa-mir-188|nasopharyngeal carcinoma|down|MicroRNA-188 suppresses G 1 /S transition by targeting multiple cyclin/CDK complexes.
hsa-mir-188|oral squamous cell carcinoma|down|microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
hsa-mir-188-5p|hepatocellular carcinoma|down|MicroRNA-188-5p Suppresses Tumor Cell Proliferation and Metastasis by Directly Targeting FGF5 in Hepatocellular Carcinoma.
hsa-mir-188-5p|prostate cancer|down|miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
hsa-mir-18a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-18a|bladder cancer|down|microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
hsa-mir-18a|breast cancer|up|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-18a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-18a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-18a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-18a|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-18a|colon cancer|up|MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer.
hsa-mir-18a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-18a|colorectal cancer|up|microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-18a|colorectal cancer|up|Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
hsa-mir-18a|colorectal cancer|down|miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells.
hsa-mir-18a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-18a|esophageal squamous cell carcinoma|up|Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-18a|gastric cancer|up|MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
hsa-mir-18a|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-18a|gastric cancer|up|Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
hsa-mir-18a|glioblastoma|up|MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.
hsa-mir-18a|hepatocellular carcinoma|up|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-18a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-18a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-18a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-18a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-18a|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-18a|malignant melanoma|up|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-18a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-18a|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-18a|nasopharyngeal carcinoma|up|miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
hsa-mir-18a|neuroblastoma|up|MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
hsa-mir-18a|non-small cell lung cancer|up|Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-18a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-18a|pancreatic cancer|up|Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
hsa-mir-18a|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-18a|prostate cancer|up|MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo.
hsa-mir-18b|breast cancer|up|microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.
hsa-mir-18b|malignant melanoma|down|The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.
hsa-mir-1908|glioblastoma|up|MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
hsa-mir-1908|non-small cell lung cancer|down|miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells.
hsa-mir-1908|osteosarcoma|up|MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
hsa-mir-190b|hepatocellular carcinoma|up|Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma.
hsa-mir-191|breast cancer|up|Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-191|breast cancer|down|Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-191|breast cancer|up|HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGF?-signaling in hypoxic microenvironment.
hsa-mir-191|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-191|colorectal cancer|up|miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBP?.
hsa-mir-191|colorectal carcinoma|up|MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3.
hsa-mir-191|colorectal carcinoma|up|MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3.
hsa-mir-191|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-191|hepatocellular carcinoma|up|Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.
hsa-mir-191|osteosarcoma|up|MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-191|osteosarcoma|up|MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2.
hsa-mir-191|osteosarcoma|up|Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
hsa-mir-191|pancreatic cancer|up|MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.
hsa-mir-192|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-192|bladder cancer|down|Regulation of growth of human bladder cancer by miR-192.
hsa-mir-192|colon cancer|down|Prognostic significance of miR-215 in colon cancer.
hsa-mir-192|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-192|colorectal cancer|down|microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-192|epithelial ovarian cancer|down|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-192|esophageal squamous cell carcinoma|up|Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.
hsa-mir-192|gastric cancer|up|MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-192|gastric cancer|up|Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
hsa-mir-192|gastric cancer|up|MiR-215/192 participates in gastric cancer progression.
hsa-mir-192|hepatocellular carcinoma|down|miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
hsa-mir-192|lung cancer|down|MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.
hsa-mir-192|pancreatic ductal adenocarcinoma|up|Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
hsa-mir-193a|epithelial ovarian cancer|down|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-193a-3p|breast cancer|down|Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-193a-3p|lung cancer|down|miR-193a-3p functions as a tumor suppressor in lung cancer by downregulating ERBB4.
hsa-mir-193a-3p|non-small cell lung cancer|down|Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues.
hsa-mir-193a-3p|renal cell carcinoma|up|A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-193a-5p|colorectal cancer|down|Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-193b|breast cancer|down|Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
hsa-mir-193b|breast cancer|cell line:MDA-MB-231,MCF-7;|Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
hsa-mir-193b|breast cancer|cell lines:MDA-MB-231,MCF-7;|Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
hsa-mir-193b|cervical cancer|up|Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-193b|glioma|up|miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
hsa-mir-193b|hepatocellular carcinoma|down|miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
hsa-mir-193b|malignant melanoma|up|miR-193b Regulates Mcl-1 in Melanoma.
hsa-mir-193b|malignant melanoma|down|Stathmin 1 is a potential novel oncogene in melanoma.
hsa-mir-193b|non-small cell lung cancer|down|MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
hsa-mir-193b|ovarian cancer|down|Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer.
hsa-mir-193b|primary cns lymphomas|down|Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-194|bladder cancer|down|MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.
hsa-mir-194|colorectal cancer|down|MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
hsa-mir-194|colorectal cancer|down|microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-194|gastric cancer|down|miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.
hsa-mir-194|gastric cancer|down|MicroRNA-194 Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1.
hsa-mir-194|hepatocellular carcinoma|down|NF-?B signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1?.
hsa-mir-194|hepatocellular carcinoma|down|MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
hsa-mir-194|lung cancer|down|miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1.)
hsa-mir-194|non-small cell lung cancer|down|MiR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
hsa-mir-194|osteosarcoma|down|microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.
hsa-mir-194|pancreatic ductal adenocarcinoma|up|Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
hsa-mir-194-5p|bladder cancer|down|Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
hsa-mir-195|adrenal cortical carcinoma|down|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-195|adrenal cortical carcinoma|down|miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-195|bladder cancer|down|microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.
hsa-mir-195|bladder cancer|down|Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
hsa-mir-195|breast cancer|down|Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-195|breast cancer|down|MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.
hsa-mir-195|breast cancer|down|Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
hsa-mir-195|breast cancer|down|Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
hsa-mir-195|cervical cancer|down|microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression.
hsa-mir-195|cervical cancer|down|MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
hsa-mir-195|chronic lymphocytic leukemia|down|miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-195|chronic lymphocytic leukemia|down|Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-195|colorectal cancer|down|Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.
hsa-mir-195|colorectal cancer|down|microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
hsa-mir-195|colorectal cancer|down|Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-195|colorectal cancer|down|MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3.
hsa-mir-195|esophageal squamous cell carcinoma|down|Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42.
hsa-mir-195|gastric cancer|down|MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-195|glioblastoma|down|MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.
hsa-mir-195|glioma|down|MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1.
hsa-mir-195|hepatocellular carcinoma|down|miR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
hsa-mir-195|hepatocellular carcinoma|down|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-195|hepatocellular carcinoma|down|Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells.
hsa-mir-195|hepatocellular carcinoma|down|MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42.
hsa-mir-195|hepatocellular carcinoma|down|MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
hsa-mir-195|hepatocellular carcinoma|down|microRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.
hsa-mir-195|lung cancer|down|Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-195|lung cancer|down|MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
hsa-mir-195|neuroblastoma|up|miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-195|non-small cell lung cancer|down|MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.
hsa-mir-195|non-small cell lung cancer|down|miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.
hsa-mir-195|non-small cell lung cancer|down|MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
hsa-mir-195|osteosarcoma|down|MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
hsa-mir-195|osteosarcoma|down|microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.
hsa-mir-195|papillary thyroid carcinoma|down|microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
hsa-mir-195|prostate cancer|down|A microRNA code for prostate cancer metastasis.
hsa-mir-195|prostate cancer|down|miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
hsa-mir-195|prostate cancer|down|miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
hsa-mir-195|prostate carcinoma|down|MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.
hsa-mir-195-5p|hepatocellular carcinoma|down|MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma.
hsa-mir-195-5p|hepatocellular carcinoma|down|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-195-5p|osteosarcoma|up|Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-196a|breast cancer|up|MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
hsa-mir-196a|cervical cancer|up|MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27(Kip1.).
hsa-mir-196a|cervical cancer|up|Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
hsa-mir-196a|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-196a|colorectal cancer|up|Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.
hsa-mir-196a|esophageal adenocarcinoma|up|MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-196a|gastric cancer|up|MiR-196a Is Up-regulated in Gastric cancer and Promotes Cell proliferation by Down-regulating p27kip1.
hsa-mir-196a|gastrointestinal stromal tumor|up|Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors.
hsa-mir-196a|glioblastoma|up|MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of I?B? both in vitro and in vivo.
hsa-mir-196a|head and neck squamous cell carcinoma|up|MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
hsa-mir-196a|non-small cell lung cancer|up|MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
hsa-mir-196a|ovarian carcinoma|up|Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
hsa-mir-196a|pancreatic cancer|up|MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha.
hsa-mir-196a|pancreatic ductal adenocarcinoma|up|MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-196a|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-196a*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-196a-1|glioblastoma|up|MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196a-1|oral cancer|up|OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196a-1|oral squamous cell carcinoma|up|miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-196a-2|glioblastoma|up|MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196a-2|oral cancer|up|OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196a-2|oral squamous cell carcinoma|up|miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-196a-5p|gastric cancer|up|Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
hsa-mir-196b|colorectal cancer|up|Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.
hsa-mir-196b|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-196b|gastric cancer|up|Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.
hsa-mir-196b|gastric cancer|up|Epigenetic regulation of miR-196b expression in gastric cancer.
hsa-mir-196b|glioblastoma|up|MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196b|glioblastoma|up|Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.
hsa-mir-196b|oral cancer|up|OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196b|oral squamous cell carcinoma|up|miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-197|breast cancer|up|Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-197|esophageal cancer|down|Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis.
hsa-mir-197|follicular thyroid carcinoma|up|A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-197|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-197|hepatocellular carcinoma|down|Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma.
hsa-mir-197|hepatocellular carcinoma|down|Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
hsa-mir-197|lung cancer|up|Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-197|multiple myeloma|down|miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
hsa-mir-197|uterine leiomyoma|down|Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.
hsa-mir-1974|adrenal cortical carcinoma|down|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-198|colorectal cancer|down|MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.
hsa-mir-198|hepatocellular carcinoma|down|miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
hsa-mir-198|lung cancer|down|MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1.
hsa-mir-198|osteosarcoma|down|MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1.
hsa-mir-198|pancreatic cancer|down|A Tumorigenic Factor Interactome Connected Through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer.
hsa-mir-198|pancreatic ductal adenocarcinoma|up|MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-199a|chondrosarcoma|down|CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
hsa-mir-199a|gastric cancer|up|miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer.
hsa-mir-199a|hepatocellular carcinoma|down|Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
hsa-mir-199a|hepatocellular carcinoma|down|MiR-199a regulates cell proliferation and survival by targeting FZD7.
hsa-mir-199a|hepatocellular carcinoma|down|[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199a|hepatocellular carcinoma|down|Suppression of miR-199a maturation by HuR is?crucial for hypoxia-induced glycolytic switch in?hepatocellular carcinoma.
hsa-mir-199a|hepatocellular carcinoma|down|Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-199a|kidney cancer|down|Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3?.
hsa-mir-199a|non-small cell lung cancer|down|MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1?
hsa-mir-199a|ovarian cancer|down|Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-199a|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-199a|primary cns lymphomas|down|Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-199a-3p|esophageal adenocarcinoma|up|MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-3p|gastric cancer|down|MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation.
hsa-mir-199a-3p|gastric cancer|up|MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
hsa-mir-199a-3p|glioma|down|MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway.
hsa-mir-199a-3p|hepatocellular carcinoma|down|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-199a-3p|kidney cancer|down|miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
hsa-mir-199a-3p|osteosarcoma|down|CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
hsa-mir-199a-3p|osteosarcoma|down|MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-199a-3p|osteosarcoma|down|A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-199a-3p|osteosarcoma|up|Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-199a-3p|osteosarcoma|down|Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells.
hsa-mir-199a-3p|papillary thyroid carcinoma|down|miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
hsa-mir-199a-3p|renal cell carcinoma|down|miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
hsa-mir-199a-5p|colorectal cancer|down|The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
hsa-mir-199a-5p|esophageal adenocarcinoma|up|MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-5p|esophageal cancer|down|Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).
hsa-mir-199a-5p|gastric cancer|up|Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho.
hsa-mir-199a-5p|hepatocellular carcinoma|down|Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
hsa-mir-199a-5p|hepatocellular carcinoma|down|Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-199a-5p|hepatocellular carcinoma|down|Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.
hsa-mir-199b|acute myeloid leukemia|down|miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.
hsa-mir-199b|choriocarcinoma|down|Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.
hsa-mir-199b|colorectal cancer|down|Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
hsa-mir-199b|follicular thyroid carcinoma|down|Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-199b|hepatocellular carcinoma|down|[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199b|hepatocellular carcinoma|down|Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1? in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
hsa-mir-199b|prostate cancer|down|MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells.
hsa-mir-199b-3p|esophageal adenocarcinoma|up|MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199b-5p|breast cancer|down|MiR-199b-5p targets HER2 in breast cancer cells.
hsa-mir-199b-5p|hepatocellular carcinoma|down|Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-199b-5p|medulloblastoma|down|The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
hsa-mir-199b-5p|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-199b-5p|osteosarcoma|up|Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
hsa-mir-199b-5p|papillary thyroid carcinoma|up|Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
hsa-mir-19a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a|bladder cancer|up|miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer.
hsa-mir-19a|breast cancer|up|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-19a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-19a|cervical cancer|up|MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-19a|colorectal cancer|up|Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-19a|colorectal cancer|up|Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-? induced epithelial-to-mesenchymal transition in colorectal cancer.
hsa-mir-19a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-19a|gastric cancer|up|MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19a|gastric cancer|up|miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer.
hsa-mir-19a|gastric cancer|up|MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
hsa-mir-19a|gastric cancer|up|MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a|gastric cancer|up|MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a|glioma|up|miR-19a and miR-19b Overexpression in Gliomas.
hsa-mir-19a|glioma|up|MicroRNA-19a promotes glioma cell growth by repressing LRIG1.
hsa-mir-19a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-19a|laryngeal squamous cell carcinoma|up|MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.
hsa-mir-19a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-19a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-19a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-19a|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19a|neuroblastoma|up|MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
hsa-mir-19a|non-small cell lung cancer|up|Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
hsa-mir-19a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-19a|t-cell lymphoblastic lymphoma|up|Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19a-3p|breast cancer|down|MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
hsa-mir-19b|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19b|breast cancer|up|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-19b|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-19b|cervical cancer|up|MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19b|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19b|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19b|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-19b|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-19b|gastric cancer|up|MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
hsa-mir-19b|gastric cancer|up|MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19b|glioma|up|miR-19a and miR-19b Overexpression in Gliomas.
hsa-mir-19b|hepatocellular carcinoma|up|Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
hsa-mir-19b|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-19b|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-19b|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19b|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-19b|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-19b|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19b|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-19b-1|t-cell lymphoblastic lymphoma|up|Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19b-2|t-cell lymphoblastic lymphoma|up|Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-200a|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200a|breast cancer|up|MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer.
hsa-mir-200a|breast cancer|down|microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer.
hsa-mir-200a|breast cancer|up|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200a|colorectal cancer|down|MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200a|esophageal adenocarcinoma|up|Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a|esophageal cancer|up|miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-200a|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-200a|gastric adenocarcinoma|down|Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/?-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
hsa-mir-200a|gastric adenocarcinoma|down|Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a|glioma|down|MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
hsa-mir-200a|hepatocellular carcinoma|down|The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
hsa-mir-200a|hepatocellular carcinoma|down|miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.
hsa-mir-200a|hepatocellular carcinoma|down|MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2.
hsa-mir-200a|hepatocellular carcinoma|down|MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.
hsa-mir-200a|hepatocellular carcinoma|down|The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
hsa-mir-200a|lung adenocarcinoma|down|miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200a|lung cancer|up|MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200a|malignant melanoma|up|MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200a|meningioma|down|Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
hsa-mir-200a|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200a|nasopharyngeal carcinoma|up|MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-?B.
hsa-mir-200a|neuroblastoma|down|miR-200a inhibits tumor proliferation by targeting AP-2? in neuroblastoma cells.
hsa-mir-200a|non-small cell lung cancer|up|MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1.
hsa-mir-200a|non-small cell lung cancer|down|MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.
hsa-mir-200a|oral cancer|down|Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200a|ovarian cancer|down|A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200a|ovarian cancer|up|Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer.
hsa-mir-200a|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200a|pancreatic ductal adenocarcinoma|down|MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene.
hsa-mir-200a|renal cell carcinoma|down|Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
hsa-mir-200a-3p|gastric cancer|up|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-200a-3p|renal cell carcinoma|down|MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
hsa-mir-200b|astrocytoma|down|Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.
hsa-mir-200b|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200b|breast cancer|up|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200b|breast cancer|down|Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis.
hsa-mir-200b|breast cancer|down|miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.
hsa-mir-200b|cervical carcinoma|down|MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma.
hsa-mir-200b|cholangiocarcinoma|down|Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200b|cholangiocarcinoma|down|Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200b|colorectal cancer|up|microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
hsa-mir-200b|colorectal cancer|down|MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200b|endometrial cancer|up|MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.
hsa-mir-200b|esophageal squamous cell carcinoma|down|miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.
hsa-mir-200b|esophageal squamous cell carcinoma|down|Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin ?1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
hsa-mir-200b|gastric cancer|up|MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma.
hsa-mir-200b|gastric cancer|down|miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
hsa-mir-200b|glioma|down|miR-200b as a prognostic factor targets multiple members of RAB family in glioma.
hsa-mir-200b|glioma|down|Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
hsa-mir-200b|glioma|down|[miR-200b suppresses glioma cell invasion by targeting PROM1].
hsa-mir-200b|hepatocellular carcinoma|down|Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
hsa-mir-200b|hepatocellular carcinoma|down|The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
hsa-mir-200b|lung adenocarcinoma|down|miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200b|lung cancer|up|MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200b|malignant melanoma|up|MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200b|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200b|mucinous cystadenocarcinoma|up|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-200b|nasopharyngeal carcinoma|down|miR-200b Suppresses Cell Growth, Migration and Invasion by Targeting Notch1 in Nasopharyngeal Carcinoma.
hsa-mir-200b|oral cancer|down|Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200b|ovarian cancer|down|A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200b|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200b|prostate cancer|down|miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.
hsa-mir-200b|prostate cancer|down|miR-200b inhibits prostate cancer EMT, growth and metastasis.
hsa-mir-200b|tongue cancer|down|MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-200c|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200c|bladder cancer|down|miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
hsa-mir-200c|breast cancer|up|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200c|breast cancer|down|MiR-200c suppresses TGF-? signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
hsa-mir-200c|breast cancer|down|miR-200c inhibits breast cancer proliferation by targeting KRAS.
hsa-mir-200c|cholangiocarcinoma|down|Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200c|cholangiocarcinoma|down|Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200c|colon cancer|down|miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c|colon cancer|up|The roles of miR-200c in colon cancer and associated molecular mechanisms.
hsa-mir-200c|colorectal cancer|up|Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
hsa-mir-200c|colorectal cancer|up|microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
hsa-mir-200c|colorectal cancer|down|MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200c|colorectal cancer|down|miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c|colorectal cancer|up|MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
hsa-mir-200c|endometrial cancer|up|The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
hsa-mir-200c|gastric cancer|down|The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
hsa-mir-200c|gastric cancer|down|miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
hsa-mir-200c|head and neck squamous cell carcinoma|down|MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
hsa-mir-200c|hepatocellular carcinoma|down|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-200c|hepatocellular carcinoma|down|Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
hsa-mir-200c|laryngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c|lung adenocarcinoma|down|miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200c|lung cancer|up|MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200c|malignant melanoma|up|MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200c|malignant melanoma|down|Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-200c|malignant melanoma|down|miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1.
hsa-mir-200c|malignant melanoma|down|miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
hsa-mir-200c|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200c|mucinous cystadenocarcinoma|up|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-200c|non-small cell lung cancer|up|High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-200c|non-small cell lung cancer|up|Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
hsa-mir-200c|oral cancer|down|Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200c|oropharyngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c|ovarian cancer|down|A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200c|ovarian cancer|down|Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
hsa-mir-200c|ovarian cancer|up|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-200c|ovarian cancer|up|miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
hsa-mir-200c|pancreatic ductal adenocarcinoma|down|XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200c|rectal cancer|up|The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-200c|renal clear cell carcinoma|down|Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-200c|renal clear cell carcinoma|down|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-202|follicular lymphoma|down|Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.
hsa-mir-202|hepatocellular carcinoma|down|miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
hsa-mir-202|osteosarcoma|up|TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
hsa-mir-202-3p|colorectal carcinoma|down|MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma.
hsa-mir-202-3p|gastric cancer|down|Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer.
hsa-mir-203|basal cell carcinoma|down|MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma.
hsa-mir-203|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-203|bladder cancer|down|microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
hsa-mir-203|bladder cancer|down|Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.
hsa-mir-203|breast cancer|up|Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.
hsa-mir-203|cervical cancer|down|Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.
hsa-mir-203|cervical cancer|down|miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer.
hsa-mir-203|cervical cancer|down|BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer.
hsa-mir-203|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-203|colorectal cancer|down|MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.
hsa-mir-203|esophageal adenocarcinoma|down|Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma.
hsa-mir-203|esophageal cancer|down|MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
hsa-mir-203|esophageal cancer|down|miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.
hsa-mir-203|esophageal cancer|up|Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-203|esophageal squamous cell carcinoma|down|MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma.
hsa-mir-203|esophageal squamous cell carcinoma|down|miR-203 is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells.
hsa-mir-203|gastric cancer|down|MiRNA-203 suppresses tumor cell proliferation, migration and invasion by targeting Slug in gastric cancer.
hsa-mir-203|gastric cancer|down|Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
hsa-mir-203|gastric cancer|down|MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.
hsa-mir-203|glioma|down|MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.
hsa-mir-203|head and neck squamous cell carcinoma|down|microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
hsa-mir-203|hepatocellular carcinoma|down|Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
hsa-mir-203|hepatocellular carcinoma|down|miR-203 inhibits proliferation of HCC cells by targeting survivin.
hsa-mir-203|hepatocellular carcinoma|down|Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.
hsa-mir-203|hepatocellular carcinoma|down|miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.
hsa-mir-203|hypopharyngeal cancer|up|Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma.
hsa-mir-203|kidney cancer|down|miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
hsa-mir-203|laryngeal squamous cell carcinoma|down|MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.
hsa-mir-203|lung cancer|down|miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC.
hsa-mir-203|lung cancer|down|The expression and function of microRNA-203 in lung cancer.
hsa-mir-203|lung carcinoma|down|miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.
hsa-mir-203|malignant melanoma|down|Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.
hsa-mir-203|malignant melanoma|down|MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.
hsa-mir-203|malignant melanoma|down|DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
hsa-mir-203|malignant melanoma|down|Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
hsa-mir-203|malignant melanoma|down|Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells.
hsa-mir-203|malignant melanoma|down|MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican.
hsa-mir-203|non-small cell lung cancer|down|MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.
hsa-mir-203|non-small cell lung cancer|down|MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
hsa-mir-203|non-small cell lung cancer|down|MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
hsa-mir-203|oral squamous cell carcinoma|up|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-203|osteosarcoma|down|miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.
hsa-mir-203|osteosarcoma|down|MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.
hsa-mir-203|ovarian cancer|down|miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.
hsa-mir-203|pancreatic adenocarcinoma|up|MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
hsa-mir-203|pancreatic cancer|up|miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer.
hsa-mir-203|pancreatic cancer|down|miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells.
hsa-mir-203|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-203|prostate cancer|down|Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
hsa-mir-203|prostate cancer|down|MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
hsa-mir-203|rhabdomyosarcoma|down|miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in Rhabdomyosarcoma.
hsa-mir-203|squamous carcinoma|down|MicroRNA expression profiles of esophageal cancer.
hsa-mir-203|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-203a|esophageal cancer|down|Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
hsa-mir-203a|hepatocellular carcinoma|down|EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
hsa-mir-203a|renal cell carcinoma|up|miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3? in human renal cell carcinoma.
hsa-mir-204|breast cancer|down|MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
hsa-mir-204|colon cancer|down|[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-204|esophageal cancer|down|miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
hsa-mir-204|gastric cancer|down|miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.
hsa-mir-204|gastric cancer|down|Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.
hsa-mir-204|gastric cancer|down|MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
hsa-mir-204|glioma|down|Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.
hsa-mir-204|intrahepatic cholangiocarcinoma|down|miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
hsa-mir-204|malignant melanoma|down|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-204|nasopharyngeal carcinoma|down|Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
hsa-mir-204|non-small cell lung cancer|down|miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.
hsa-mir-204|non-small cell lung cancer|down|miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC.
hsa-mir-204|non-small cell lung cancer|down|MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
hsa-mir-204|non-small cell lung cancer|down|Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
hsa-mir-204|osteosarcoma|down|MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
hsa-mir-204|prostate cancer|up|Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
hsa-mir-204|renal cell carcinoma|down|miR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
hsa-mir-204|renal cell carcinoma|down|Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.
hsa-mir-204|renal clear cell carcinoma|down|VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.
hsa-mir-204|retinoblastoma|down|MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.
hsa-mir-204|thyroid cancer|down|MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
hsa-mir-204-3p|hepatocellular carcinoma|down|Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
hsa-mir-204-5p|breast cancer|down|MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
hsa-mir-204-5p|colorectal cancer|down|miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.
hsa-mir-204-5p|colorectal cancer|up|miR-204-5p expression in colorectal cancer: an autophagy-associated gene.
hsa-mir-204-5p|gastric cancer|down|MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.
hsa-mir-204-5p|papillary thyroid carcinoma|down|miR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
hsa-mir-205|adrenal cortical carcinoma|down|MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13?cells via targeting Bcl-2.
hsa-mir-205|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-205|bladder cancer|up|Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
hsa-mir-205|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-205|bladder cancer|down|Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.
hsa-mir-205|breast cancer|down|miRNA-205 affects infiltration and metastasis of breast cancer.
hsa-mir-205|breast cancer|up|Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-205|breast cancer|down|MicroRNA-205 increases the sensitivity of docetaxel in breast cancer.
hsa-mir-205|breast cancer|down|MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
hsa-mir-205|breast cancer|down|Suppression of cell growth and invasion by miR-205 in breast cancer.
hsa-mir-205|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-205|cervical cancer|up|Serum microRNA-205 as a novel biomarker for cervical cancer patients.
hsa-mir-205|cervical cancer|up|miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells.
hsa-mir-205|cervical squamous cell carcinoma|up|miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
hsa-mir-205|chronic myelogenous leukemia|down|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-205|colorectal cancer|down|MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).
hsa-mir-205|colorectal cancer|down|Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
hsa-mir-205|endometrial cancer|up|miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.
hsa-mir-205|endometrial cancer|up|miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
hsa-mir-205|endometrial cancer|down|MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
hsa-mir-205|esophageal cancer|up|miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-205|esophageal cancer|up|Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-205|esophageal squamous cell carcinoma|down|Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
hsa-mir-205|gastric cancer|down|Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation.
hsa-mir-205|glioma|down|MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A.
hsa-mir-205|glioma|down|Identification of microRNA-205 as a potential prognostic indicator for human glioma.
hsa-mir-205|glioma|down|Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
hsa-mir-205|head and neck squamous cell carcinoma|down|Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-205|hepatocellular carcinoma|down|Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
hsa-mir-205|hepatocellular carcinoma|down|MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
hsa-mir-205|kidney cancer|down|MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
hsa-mir-205|laryngeal carcinoma|up|[Effect of microRNA-205 on proliferation of laryngeal carcinoma cell line Hep-2].
hsa-mir-205|laryngeal squamous cell carcinoma|up|miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
hsa-mir-205|laryngeal squamous cell carcinoma|down|MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
hsa-mir-205|lung cancer|up|Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-205|lung cancer|up|miR-205 regulates A549 cells proliferation by targeting PTEN.
hsa-mir-205|malignant melanoma|down|Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo.
hsa-mir-205|malignant melanoma|down|miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
hsa-mir-205|malignant melanoma|down|Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-205|non-small cell lung cancer|up|Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
hsa-mir-205|non-small cell lung cancer|up|miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
hsa-mir-205|osteosarcoma|down|MiR-205 functions as a tumor suppressor via targeting TGF-? in osteosarcoma.
hsa-mir-205|ovarian cancer|up|The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion.
hsa-mir-205|prostate cancer|down|miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.
hsa-mir-205|prostate cancer|down|Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
hsa-mir-205|prostate cancer|down|MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
hsa-mir-205|prostate cancer|down|Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.
hsa-mir-205|prostate cancer|down|Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
hsa-mir-205|prostate cancer|down|Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
hsa-mir-205|prostate cancer|down|MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
hsa-mir-205|renal cell carcinoma|down|miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma.
hsa-mir-205|squamous carcinoma|down|MicroRNA expression profiles of esophageal cancer.
hsa-mir-205|thyroid cancer|down|Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
hsa-mir-205-3p|non-small cell lung cancer|up|Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
hsa-mir-205-5p|non-small cell lung cancer|up|Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
hsa-mir-206|breast cancer|down|miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
hsa-mir-206|breast cancer|down|Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
hsa-mir-206|cervical cancer|down|Decreased microRNA-206 and its function in cervical cancer.
hsa-mir-206|clear cell renal cell cancer|down|Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-206|colorectal cancer|down|miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
hsa-mir-206|colorectal cancer|down|microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
hsa-mir-206|colorectal cancer|down|MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.
hsa-mir-206|gastric cancer|down|MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2.
hsa-mir-206|gastric cancer|down|Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
hsa-mir-206|gastric cancer|down|MicroRNA-206 suppresses gastric cancer cell growth and metastasis.
hsa-mir-206|gastric cancer|down|Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
hsa-mir-206|gastric cancer|down|MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
hsa-mir-206|head and neck squamous cell carcinoma|down|Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
hsa-mir-206|hepatocellular carcinoma|down|MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206|hepatocellular carcinoma|down|MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206|laryngeal squamous cell carcinoma|down|miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2.
hsa-mir-206|laryngeal squamous cell carcinoma|down|Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
hsa-mir-206|lung cancer|down|MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway.
hsa-mir-206|lung cancer|down|Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
hsa-mir-206|lung cancer|down|Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
hsa-mir-206|malignant melanoma|down|MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
hsa-mir-206|medulloblastoma|down|MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
hsa-mir-206|non-small cell lung cancer|down|miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9.
hsa-mir-206|oral squamous cell carcinoma|down|MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma.
hsa-mir-208|esophageal squamous cell carcinoma|up|Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma.
hsa-mir-208a|lung cancer|up|Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.
hsa-mir-20a|acute myeloid leukemia|down|HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-20a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-20a|breast cancer|up|MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
hsa-mir-20a|breast cancer|up|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-20a|breast cancer|up|Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-20a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-20a|cervical cancer|up|Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.
hsa-mir-20a|cervical cancer|up|miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.
hsa-mir-20a|cervical cancer|up|Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer.
hsa-mir-20a|cervical cancer|up|MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo.
hsa-mir-20a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-20a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-20a|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-20a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-20a|colorectal cancer|up|MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-20a|colorectal cancer|up|microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases.
hsa-mir-20a|colorectal cancer|up|Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-20a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-20a|esophageal squamous cell carcinoma|up|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-mir-20a|gastric cancer|up|miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
hsa-mir-20a|gastric cancer|up|Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2).
hsa-mir-20a|glioma|up|[Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro].
hsa-mir-20a|glioma|up|DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
hsa-mir-20a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-20a|hepatocellular carcinoma|down|Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
hsa-mir-20a|hepatocellular carcinoma|up|MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
hsa-mir-20a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-20a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-20a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-20a|malignant melanoma|up|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-20a|malignant melanoma|down|Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex.
hsa-mir-20a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-20a|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-20a|nasopharyngeal cancer|up|Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-20a|oral squamous cell carcinoma|up|HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.
hsa-mir-20a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-20a|ovarian cancer|up|miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.
hsa-mir-20a|ovarian cancer|up|Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.
hsa-mir-20a|pituitary carcinoma|up|MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-20a|prostate cancer|up|miR-20a promotes Prostate cancer invasion and migration through targeting ABL2.
hsa-mir-20a-5p|colorectal cancer|up|MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
hsa-mir-20a-5p|colorectal cancer|up|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-20a-5p|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-20a-5p|non-small cell lung cancer|down|Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-20b|bladder cancer|down|MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
hsa-mir-20b|breast cancer|up|MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
hsa-mir-20b|breast cancer|up|MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN).
hsa-mir-20b|gastric cancer|up|miR-20b overexpression is predictive of poor prognosis in gastric cancer.
hsa-mir-20b|hepatocellular carcinoma|up|Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer.
hsa-mir-20b-5p|renal cell carcinoma|down|MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
hsa-mir-21|adrenal cortical carcinoma|up|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-21|b-cell lymphoma|up|miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
hsa-mir-21|b-cell lymphoma|up|Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-21|breast cancer|up|Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-21|breast cancer|up|Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.
hsa-mir-21|breast cancer|up|Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-21|breast cancer|up|BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
hsa-mir-21|breast cancer|up|Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-21|breast cancer|up|miR-21: A gene of dual regulation in breast cancer.
hsa-mir-21|breast cancer|up|Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.
hsa-mir-21|breast cancer|up|The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-21|breast cancer|up|Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
hsa-mir-21|breast cancer|up|Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
hsa-mir-21|breast cancer|up|MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.
hsa-mir-21|breast cancer|up|Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.
hsa-mir-21|breast cancer|up|MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-? pathways.
hsa-mir-21|breast cancer|up|Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-21|breast cancer|up|Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females.
hsa-mir-21|cervical cancer|up|Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.
hsa-mir-21|cervical carcinoma|up|MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
hsa-mir-21|cholangiocarcinoma|up|MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
hsa-mir-21|cholangiocarcinoma|up|MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
hsa-mir-21|cholangiocarcinoma|up|PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
hsa-mir-21|cholangiocarcinoma|up|PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
hsa-mir-21|cholangiocarcinoma|up|miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth.
hsa-mir-21|cholangiocarcinoma|up|miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth.
hsa-mir-21|cholangiocarcinoma|up|miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
hsa-mir-21|cholangiocarcinoma|up|miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
hsa-mir-21|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-21|colon cancer|down|miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
hsa-mir-21|colon cancer|up|Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker.
hsa-mir-21|colorectal cancer|up|Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-21|colorectal cancer|up|Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages.
hsa-mir-21|colorectal cancer|up|Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer.
hsa-mir-21|colorectal cancer|up|MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation.
hsa-mir-21|colorectal cancer|up|Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.
hsa-mir-21|colorectal cancer|up|Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-21|colorectal cancer|down|Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-21|colorectal cancer|up|MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
hsa-mir-21|colorectal cancer|up|Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
hsa-mir-21|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-21|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-21|colorectal carcinoma|up|Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-21|colorectal carcinoma|up|MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
hsa-mir-21|diffuse large B-cell lymphoma|up|Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma.
hsa-mir-21|endometrial cancer|up|Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
hsa-mir-21|esophageal cancer|up|The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
hsa-mir-21|esophageal cancer|up|[Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer].
hsa-mir-21|esophageal cancer|up|Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-21|esophageal cancer|up|MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
hsa-mir-21|esophageal squamous cell carcinoma|up|Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer.
hsa-mir-21|esophageal squamous cell carcinoma|down|Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma.
hsa-mir-21|esophageal squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21|esophageal squamous cell carcinoma|up|MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
hsa-mir-21|gastric cancer|up|Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-21|gastric cancer|up|MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.
hsa-mir-21|gastric cancer|up|MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
hsa-mir-21|gastric cancer|up|miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.
hsa-mir-21|gastric cancer|up|Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer.
hsa-mir-21|gastric cancer|up|miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.
hsa-mir-21|gastric cancer|up|Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-21|gastric cancer|up|Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-21|gastric cancer|up|Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-21|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-21|gastric cancer|up|miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells.
hsa-mir-21|gastric cancer|up|Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21.
hsa-mir-21|gastric cancer|up|microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
hsa-mir-21|glioblastoma|up|Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy.
hsa-mir-21|glioblastoma|up|MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.
hsa-mir-21|glioblastoma|up|Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4.
hsa-mir-21|glioblastoma|up|Sulforaphane enhances temozolomide-induced apoptosis due to downregulation of miR-21 via Wnt/?-catenin signaling in glioblastoma.
hsa-mir-21|glioblastoma|up|MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
hsa-mir-21|glioblastoma|up|PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-21|glioblastoma|up|Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
hsa-mir-21|glioblastoma|up|Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
hsa-mir-21|glioblastoma|up|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-21|glioblastoma|up|Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.
hsa-mir-21|glioblastoma|up|MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3).
hsa-mir-21|glioblastoma|up|Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
hsa-mir-21|glioblastoma|up|MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.
hsa-mir-21|glioblastoma|up|MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.
hsa-mir-21|glioblastoma|down|MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.
hsa-mir-21|glioma|up|miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.
hsa-mir-21|head and neck cancer|up|MicroRNA alterations in head and neck squamous cell carcinoma.
hsa-mir-21|head and neck cancer|up|[Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
hsa-mir-21|head and neck squamous cell carcinoma|up|Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-21|head and neck squamous cell carcinoma|up|Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-21|head and neck squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21|head and neck squamous cell carcinoma|up|Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma.
hsa-mir-21|hepatocellular carcinoma|up|MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3.
hsa-mir-21|hepatocellular carcinoma|up|Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
hsa-mir-21|hepatocellular carcinoma|up|miR-21 expression predicts prognosis in hepatocellular carcinoma.
hsa-mir-21|hepatocellular carcinoma|up|Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-21|hepatocellular carcinoma|up|MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
hsa-mir-21|hepatocellular carcinoma|up|Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-21|hepatocellular carcinoma|up|Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.
hsa-mir-21|hepatocellular carcinoma|up|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-21|hepatocellular carcinoma|up|Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-21|hepatocellular carcinoma|up|Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-21|hepatocellular carcinoma|up|MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.
hsa-mir-21|hepatocellular carcinoma|up|MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
hsa-mir-21|hepatocellular carcinoma|up|Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-21|hepatocellular carcinoma|down|Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-mir-21|hepatocellular carcinoma|up|MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
hsa-mir-21|hepatocellular carcinoma|up|Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.
hsa-mir-21|hepatocellular carcinoma|up|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-21|hepatocellular carcinoma|up|Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor ? and androgen receptor.
hsa-mir-21|hepatocellular carcinoma|up|miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
hsa-mir-21|hepatocellular carcinoma|up|miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
hsa-mir-21|hepatocellular carcinoma|up|Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.
hsa-mir-21|hypopharyngeal squamous cell carcinoma|up|Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21|kidney cancer|up|miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21|laryngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-21|laryngeal carcinoma|up|Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
hsa-mir-21|laryngeal squamous cell carcinoma|up|Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma.
hsa-mir-21|laryngeal squamous cell carcinoma|up|Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21|liver cancer|up|microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
hsa-mir-21|lung cancer|up|Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-21|lung cancer|up|Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-21|lung cancer|up|Expression and significance of miRNA-21 and BTG2 in lung cancer.
hsa-mir-21|malignant melanoma|up|MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
hsa-mir-21|malignant melanoma|up|Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
hsa-mir-21|malignant melanoma|up|microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells.
hsa-mir-21|mucinous cystadenocarcinoma|up|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-21|multiple myeloma|up|Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
hsa-mir-21|multiple myeloma|up|Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
hsa-mir-21|nasopharyngeal carcinoma|up|Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene.
hsa-mir-21|nasopharyngeal carcinoma|up|Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma.
hsa-mir-21|non-small cell lung cancer|up|Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features.
hsa-mir-21|non-small cell lung cancer|up|Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
hsa-mir-21|non-small cell lung cancer|up|[Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
hsa-mir-21|non-small cell lung cancer|up|MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells.
hsa-mir-21|non-small cell lung cancer|up|Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-21|non-small cell lung cancer|up|Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.
hsa-mir-21|non-small cell lung cancer|up|Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
hsa-mir-21|non-small cell lung cancer|up|Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer.
hsa-mir-21|non-small cell lung cancer|up|MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19.
hsa-mir-21|non-small cell lung cancer|up|MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.
hsa-mir-21|non-small cell lung cancer|up|High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-21|non-small cell lung cancer|up|Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-21|non-small cell lung cancer|up|Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
hsa-mir-21|non-small cell lung cancer|up|Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.
hsa-mir-21|non-small cell lung cancer|up|Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer.
hsa-mir-21|non-small cell lung cancer|up|Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
hsa-mir-21|oral cancer|up|MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/?-Catenin Pathway by Targeting DKK2.
hsa-mir-21|oral squamous cell carcinoma|up|Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-21|oral squamous cell carcinoma|up|Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
hsa-mir-21|oropharyngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-21|osteosarcoma|up|MicroRNA-21 is involved in osteosarcoma cell invasion and migration.
hsa-mir-21|osteosarcoma|up|A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-21|osteosarcoma|up|Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma.
hsa-mir-21|osteosarcoma|up|MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.
hsa-mir-21|ovarian cancer|up|The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.
hsa-mir-21|pancreatic adenocarcinoma|up|Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
hsa-mir-21|pancreatic cancer|up|MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.
hsa-mir-21|pancreatic cancer|up|MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma.
hsa-mir-21|pancreatic ductal adenocarcinoma|up|Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-21|papillary thyroid carcinoma|up|MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.
hsa-mir-21|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-21|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-21|papillary thyroid carcinoma|up|MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.
hsa-mir-21|papillary thyroid carcinoma|up|In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
hsa-mir-21|prostate cancer|up|A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-21|prostate cancer|up|A microRNA code for prostate cancer metastasis.
hsa-mir-21|prostate cancer|up|MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
hsa-mir-21|renal cell carcinoma|up|The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
hsa-mir-21|renal cell carcinoma|up|miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21|renal cell carcinoma|up|MicroRNA-21 is overexpressed in renal cell carcinoma.
hsa-mir-21|renal cell carcinoma|up|MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
hsa-mir-21|renal cell carcinoma|up|MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
hsa-mir-21|retinoblastoma|up|Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
hsa-mir-21|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-21-3p|hepatocellular carcinoma|down|MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
hsa-mir-21-3p|laryngeal cancer|up|New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-21-5p|clear cell renal cell cancer|up|Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-21-5p|colorectal cancer|up|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-21-5p|hepatocellular carcinoma|up|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-21-5p|rectal cancer|up|Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
hsa-mir-210|adrenal cortical carcinoma|up|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-210|bladder cancer|up|Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-210|colorectal cancer|up|Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.
hsa-mir-210|colorectal cancer|up|Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer.
hsa-mir-210|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-210|esophageal squamous cell carcinoma|down|MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
hsa-mir-210|esophageal squamous cell carcinoma|down|The Role of MicroRNA-210 in Esophageal Squamous Cell Carcinoma.
hsa-mir-210|esophageal squamous cell carcinoma|down|MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.
hsa-mir-210|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-210|glioblastoma|up|Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.
hsa-mir-210|glioblastoma|up|MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
hsa-mir-210|glioma|up|MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
hsa-mir-210|glioma|up|MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
hsa-mir-210|hepatocellular carcinoma|up|Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice.
hsa-mir-210|hepatocellular carcinoma|up|Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.
hsa-mir-210|kidney cancer|up|miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
hsa-mir-210|lung cancer|up|MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
hsa-mir-210|malignant melanoma|up|MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-210|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-210|malignant melanoma|up|A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
hsa-mir-210|medulloblastoma|up|Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma.
hsa-mir-210|non-small cell lung cancer|up|Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-210|osteosarcoma|up|Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.
hsa-mir-210|osteosarcoma|up|Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo.
hsa-mir-210|ovarian cancer|up|miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell.
hsa-mir-210|renal cell carcinoma|up|Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion.
hsa-mir-210|renal cell carcinoma|up|MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
hsa-mir-210|renal clear cell carcinoma|up|Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
hsa-mir-210|renal clear cell carcinoma|up|Overexpression of miR-210, a downstream target of HIF1?, causes centrosome amplification in renal carcinoma cells.
hsa-mir-210|renal clear cell carcinoma|up|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-210-3p|glioblastoma|up|Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
hsa-mir-211|breast cancer|down|MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
hsa-mir-211|colon cancer|down|[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-211|colorectal cancer|up|MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
hsa-mir-211|gastric cancer|down|MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.
hsa-mir-211|hepatocellular carcinoma|down|MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma.
hsa-mir-211|hepatocellular carcinoma|down|miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
hsa-mir-211|hepatocellular carcinoma|up|[MiR-211 promotes invasion of hepatoma cells by targeting estrogen receptor alpha].
hsa-mir-211|malignant melanoma|down|Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.
hsa-mir-211|malignant melanoma|down|Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
hsa-mir-211|malignant melanoma|down|microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
hsa-mir-211|malignant melanoma|down|Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-211|malignant melanoma|down|The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
hsa-mir-211|non-small cell lung cancer|up|miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.
hsa-mir-212|colorectal cancer|down|Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD.
hsa-mir-212|gastric cancer|down|miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
hsa-mir-212|gastric cancer|down|Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.
hsa-mir-212|hepatocellular carcinoma|down|Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212.
hsa-mir-212|hepatocellular carcinoma|down|MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1.
hsa-mir-212|non-small cell lung cancer|down|miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
hsa-mir-212|non-small cell lung cancer|up|MiR-212 displays Tumor Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1.
hsa-mir-212|non-small cell lung cancer|up|Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
hsa-mir-212|osteosarcoma|down|MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.
hsa-mir-212|ovarian cancer|down|MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF.
hsa-mir-212|pancreatic cancer|up|miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-212|pancreatic ductal adenocarcinoma|up|miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1.
hsa-mir-212|prostate cancer|down|A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer.
hsa-mir-212|prostate cancer|down|MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.
hsa-mir-212-3p|glioblastoma|down|MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.
hsa-mir-214|bladder cancer|down|MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
hsa-mir-214|cervical cancer|down|MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.
hsa-mir-214|cervical cancer|down|MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells.
hsa-mir-214|cervical squamous cell carcinoma|down|Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-214|colon cancer|down|microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.
hsa-mir-214|colon cancer|down|[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-214|esophageal cancer|down|Regulation of ?-catenin-mediated esophageal cancer growth and invasion by miR-214.
hsa-mir-214|esophageal squamous cell carcinoma|down|MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-214|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-214|gastric cancer|up|Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein.
hsa-mir-214|gastric cancer|up|Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-214|gastric cancer|up|Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.
hsa-mir-214|glioma|up|Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma.
hsa-mir-214|hepatocellular carcinoma|down|Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-214|hepatocellular carcinoma|down|miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
hsa-mir-214|hepatocellular carcinoma|up|MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
hsa-mir-214|hepatocellular carcinoma|down|MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.
hsa-mir-214|hepatocellular carcinoma|down|MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin.
hsa-mir-214|hepatocellular carcinoma|down|Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma.
hsa-mir-214|hepatocellular carcinoma|down|Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
hsa-mir-214|lung adenocarcinoma|up|microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).
hsa-mir-214|malignant melanoma|up|Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-214|multiple myeloma|down|Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication.
hsa-mir-214|nasopharyngeal carcinoma|up|miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
hsa-mir-214|nasopharyngeal carcinoma|up|Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma.
hsa-mir-214|osteosarcoma|up|Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
hsa-mir-214|ovarian cancer|down|MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.
hsa-mir-214|ovarian cancer|up|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-214|pancreatic cancer|down|Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214|pancreatic cancer|up|Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214|primary cns lymphomas|down|Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-214|renal cell carcinoma|down|microRNA-214 Reduces IGF-1 Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.
hsa-mir-214-3p|esophageal cancer|down|Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
hsa-mir-214-3p|hepatocellular carcinoma|down|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-215|cervical cancer|up|MicroRNA-215 is a potential prognostic marker for cervical cancer.
hsa-mir-215|colon cancer|down|Prognostic significance of miR-215 in colon cancer.
hsa-mir-215|colorectal cancer|down|Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-215|colorectal cancer|down|microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-215|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-215|gastric cancer|up|MiR-215/192 participates in gastric cancer progression.
hsa-mir-215|gastric cancer|up|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-215|gastric cancer|up|MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-215|gastric cancer|up|MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
hsa-mir-215|glioma|up|MiR-215, an activator of the CTNNBIP1/?-catenin pathway, is a marker of poor prognosis in human glioma.
hsa-mir-215|hepatocellular carcinoma|up|Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-215|non-small cell lung cancer|down|miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.
hsa-mir-215|pancreatic cancer|down|MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
hsa-mir-216a|esophageal squamous cell carcinoma|down|Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
hsa-mir-216a|hepatocellular carcinoma|up|Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-216a|hepatocellular carcinoma|up|MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-216a|oral squamous cell carcinoma|down|MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
hsa-mir-216a|pancreatic cancer|down|MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
hsa-mir-216a|pancreatic cancer|down|miR-216a may inhibit pancreatic tumor growth by targeting JAK2.
hsa-mir-216a|pancreatic cancer|down|[Expression of miR-216a in pancreatic cancer and its clinical significance].
hsa-mir-216b|breast cancer|down|Regulation of the P2X7R by microRNA-216b in human breast cancer.
hsa-mir-216b|esophageal squamous cell carcinoma|down|Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
hsa-mir-216b|gastric adenocarcinoma|down|MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
hsa-mir-216b|gastric cancer|down|MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
hsa-mir-216b|nasopharyngeal carcinoma|down|miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
hsa-mir-216b|nasopharyngeal carcinoma|down|[miR-216b suppresses cell proliferation and invasion by targeting PKC? in nasopharyngeal carcinoma cells].
hsa-mir-217|breast cancer|up|MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.
hsa-mir-217|gastric cancer|down|microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
hsa-mir-217|gastric cancer|down|The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
hsa-mir-217|glioma|down|MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.
hsa-mir-217|hepatocellular carcinoma|down|miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.
hsa-mir-217|hepatocellular carcinoma|up|MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-217|lung cancer|down|MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.
hsa-mir-217|osteosarcoma|down|MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.
hsa-mir-217|osteosarcoma|down|The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
hsa-mir-217|pancreatic ductal adenocarcinoma|down|The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
hsa-mir-217|pancreatic ductal adenocarcinoma|down|MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-217|pancreatic ductal adenocarcinoma|down|MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-218|bladder cancer|down|MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
hsa-mir-218|breast cancer|down|Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway.
hsa-mir-218|cervical cancer|down|Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.
hsa-mir-218|cervical cancer|down|MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
hsa-mir-218|cervical cancer|down|MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.
hsa-mir-218|cervical cancer|down|Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-218|cervical squamous cell carcinoma|down|Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
hsa-mir-218|chondrosarcoma|up|Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.
hsa-mir-218|choriocarcinoma|down|MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8.
hsa-mir-218|colorectal cancer|down|MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene.
hsa-mir-218|colorectal cancer|down|Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
hsa-mir-218|colorectal cancer|down|MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
hsa-mir-218|esophageal cancer|down|Serum microRNA-218 is a potential biomarker for esophageal cancer.
hsa-mir-218|esophageal squamous cell carcinoma|up|miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
hsa-mir-218|esophageal squamous cell carcinoma|down|MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.
hsa-mir-218|gastric cancer|down|Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-218|gastric cancer|down|Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis.
hsa-mir-218|gastric cancer|down|MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin.
hsa-mir-218|gastric cancer|down|Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin.
hsa-mir-218|gastric cancer|down|Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
hsa-mir-218|gastric cancer|down|[Reduced expression of miR-218 and its significance in gastric cancer].
hsa-mir-218|gastrointestinal stromal tumor|down|MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.
hsa-mir-218|glioma|down|miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway.
hsa-mir-218|glioma|down|miR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1.
hsa-mir-218|glioma|down|MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation and Cancer Stem-like Cell Self-renewal by Targeting the Polycomb Group Gene Bmi1.
hsa-mir-218|glioma|down|Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
hsa-mir-218|head and neck squamous cell carcinoma|down|Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
hsa-mir-218|hepatocellular carcinoma|down|miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
hsa-mir-218|hepatocellular carcinoma|down|Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET
hsa-mir-218|hepatocellular carcinoma|down|MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.
hsa-mir-218|lung cancer|down|MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218|lung cancer|down|ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.
hsa-mir-218|lung cancer|down|MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.
hsa-mir-218|lung squamous cell carcinoma|down|MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218|malignant melanoma|down|Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma.
hsa-mir-218|nasopharyngeal cancer|down|MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
hsa-mir-218|oral cancer|down|The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
hsa-mir-218|osteosarcoma|down|miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9.
hsa-mir-218|pancreatic ductal adenocarcinoma|down|Enhancer of Zeste Homolog 2 Silences miR-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin.
hsa-mir-218|prostate cancer|down|Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
hsa-mir-218|prostate cancer|down|microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
hsa-mir-218|renal cell carcinoma|down|MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma Through Targeting Caveolin-2 Involved in Focal Adhesion Pathway.
hsa-mir-218|renal clear cell carcinoma|down|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-218-5p|glioma|down|miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells.
hsa-mir-219-5p|colorectal cancer|down|MicroRNA-219-5p functions as a?tumor suppressor partially by targeting platelet-derived growth factor receptor alpha in colorectal cancer.
hsa-mir-219-5p|glioblastoma|down|miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p|glioma|down|miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p|hepatocellular carcinoma|down|MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
hsa-mir-219-5p|papillary thyroid carcinoma|down|miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor ?
hsa-mir-22|breast cancer|down|A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
hsa-mir-22|breast cancer|down|miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
hsa-mir-22|colon cancer|down|MicroRNA-22 regulates hypoxia signaling in colon cancer cells.
hsa-mir-22|colon cancer|down|MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
hsa-mir-22|colon cancer|down|miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-22|colorectal cancer|down|Clinical significance of miR-22 expression in patients with colorectal cancer.
hsa-mir-22|esophageal squamous cell carcinoma|down|Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation.
hsa-mir-22|esophageal squamous cell carcinoma|down|miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion.
hsa-mir-22|gastric cancer|down|MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
hsa-mir-22|gastric cancer|down|miR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.
hsa-mir-22|gastric cancer|down|microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.
hsa-mir-22|gastric cancer|down|miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.
hsa-mir-22|gastric cancer|down|Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.
hsa-mir-22|glioblastoma|down|miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.
hsa-mir-22|hepatocellular carcinoma|down|MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
hsa-mir-22|hepatocellular carcinoma|down|microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
hsa-mir-22|kidney cancer|down|MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
hsa-mir-22|liver cancer|down|microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.
hsa-mir-22|lung cancer|down|Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
hsa-mir-22|medulloblastoma|down|MiR-22 is Frequently Down-regulated in Medulloblastomas, and Inhibits Cell Proliferation via the Novel Target PAPST1.
hsa-mir-22|non-small cell lung cancer|up|Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-22|osteosarcoma|down|miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy.
hsa-mir-22|osteosarcoma|down|Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
hsa-mir-22|prostate cancer|up|Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
hsa-mir-22|t-cell lymphoma|down|miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-220a|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-221|anaplastic thyroid carcinoma|up|A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-221|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-221|bladder cancer|up|MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.
hsa-mir-221|breast cancer|up|Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
hsa-mir-221|breast cancer|down|Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
hsa-mir-221|breast cancer|up|TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-221|breast cancer|up|From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review).
hsa-mir-221|breast cancer|up|Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
hsa-mir-221|breast cancer|up|miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.
hsa-mir-221|cervical cancer|up|MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.
hsa-mir-221|colon carcinoma|up|[MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
hsa-mir-221|colorectal cancer|up|[MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
hsa-mir-221|colorectal cancer|up|MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
hsa-mir-221|colorectal cancer|up|MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
hsa-mir-221|esophageal cancer|up|Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-221|extrahepatic cholangiocarcinoma|up|miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with ?-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
hsa-mir-221|follicular thyroid carcinoma|up|Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-221|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-221|gastric cancer|up|Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
hsa-mir-221|gastric cancer|up|Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-221|gastrointestinal stromal tumor|down|Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-221|gastrointestinal stromal tumor|down|Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
hsa-mir-221|glioma|up|MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma.
hsa-mir-221|glioma|up|MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.
hsa-mir-221|glioma|up|Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
hsa-mir-221|glioma|up|MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-221|glioma|down|Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.
hsa-mir-221|glioma|up|Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.
hsa-mir-221|hepatocellular carcinoma|up|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-221|hepatocellular carcinoma|up|Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
hsa-mir-221|hepatocellular carcinoma|up|MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
hsa-mir-221|hepatocellular carcinoma|up|Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-221|hepatocellular carcinoma|up|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-221|hepatocellular carcinoma|up|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221|hepatocellular carcinoma|up|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-221|hepatocellular carcinoma|up|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-221|liver cancer|up|Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
hsa-mir-221|malignant melanoma|up|The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
hsa-mir-221|non-small cell lung cancer|up|MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.
hsa-mir-221|non-small cell lung cancer|up|Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.
hsa-mir-221|non-small cell lung cancer|up|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-221|oral squamous cell carcinoma|up|Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.
hsa-mir-221|oral squamous cell carcinoma|up|miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-221|osteosarcoma|up|miR-221 increases osteosarcoma?cell?proliferation, invasion and migration partly through?the downregulation of PTEN.
hsa-mir-221|osteosarcoma|up|MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma.
hsa-mir-221|ovarian cancer|up|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-221|pancreatic adenocarcinoma|up|Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
hsa-mir-221|pancreatic cancer|up|Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.
hsa-mir-221|pancreatic cancer|up|miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
hsa-mir-221|pancreatic cancer|up|Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
hsa-mir-221|papillary thyroid carcinoma|up|MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-221|papillary thyroid carcinoma|up|In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.
hsa-mir-221|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-221|papillary thyroid carcinoma|up|In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.
hsa-mir-221|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-221|papillary thyroid carcinoma|up|Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-221|prostate cancer|down|Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-221|prostate cancer|up|Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
hsa-mir-221|prostate cancer|down|MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
hsa-mir-221|prostate cancer|up|MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
hsa-mir-221|renal cell carcinoma|up|miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
hsa-mir-221|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-221|thyroid carcinoma|up|MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-221*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-221-3p|hepatocellular carcinoma|up|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-222|anaplastic thyroid carcinoma|up|A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-222|bladder cancer|up|Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
hsa-mir-222|bladder cancer|up|miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
hsa-mir-222|breast cancer|up|Analysis of serum genome-wide microRNAs for breast cancer detection.
hsa-mir-222|breast cancer|up|miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.
hsa-mir-222|breast cancer|up|TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-222|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-222|chordoma|down|MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-222|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-222|gastric cancer|up|Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.
hsa-mir-222|gastric cancer|up|Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-222|gastric cancer|up|Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.
hsa-mir-222|gastric cancer|up|miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.
hsa-mir-222|gastrointestinal stromal tumor|down|Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-222|gastrointestinal stromal tumor|down|Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
hsa-mir-222|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-222|glioma|up|Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
hsa-mir-222|glioma|up|MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-222|glioma|up|MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.
hsa-mir-222|hepatocellular carcinoma|up|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-222|hepatocellular carcinoma|up|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-222|hepatocellular carcinoma|up|[Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].
hsa-mir-222|hepatocellular carcinoma|up|GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma.
hsa-mir-222|hepatocellular carcinoma|up|Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-222|hepatocellular carcinoma|up|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222|hepatocellular carcinoma|up|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-222|malignant melanoma|up|The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
hsa-mir-222|non-small cell lung cancer|up|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222|non-small cell lung cancer|up|Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-222|non-small cell lung cancer|up|MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27.
hsa-mir-222|oral squamous cell carcinoma|up|miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-222|pancreatic cancer|up|miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
hsa-mir-222|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-222|papillary thyroid carcinoma|up|MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-222|papillary thyroid carcinoma|up|Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-mir-222|papillary thyroid carcinoma|up|Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-222|papillary thyroid carcinoma|up|Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-222|papillary thyroid carcinoma|up|MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-222|prostate cancer|up|Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
hsa-mir-222|prostate cancer|down|MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
hsa-mir-222|thyroid carcinoma|up|MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-222-3p|endometrial cancer|up|Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ER?.
hsa-mir-223|acute myeloid leukemia|down|Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
hsa-mir-223|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-223|breast cancer|down|Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.
hsa-mir-223|cervical cancer|down|MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
hsa-mir-223|chronic lymphocytic leukemia|down|MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223|chronic lymphocytic leukemia|down|[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223|colorectal cancer|up|Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-223|colorectal cancer|up|C/EBP-?-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
hsa-mir-223|colorectal cancer|up|Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-223|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-223|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-223|colorectal cancer|up|MicroRNA-223 functions as an oncogene in human colorectal cancer cells.
hsa-mir-223|endometrial cancer|down|MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R.
hsa-mir-223|esophageal adenocarcinoma|up|MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-223|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-223|esophageal squamous cell carcinoma|up|Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-223|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-223|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-223|gastric cancer|up|MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
hsa-mir-223|gastric cancer|up|Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-223|gastric cancer|down|miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.
hsa-mir-223|glioblastoma|up|microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.
hsa-mir-223|hepatocellular carcinoma|down|Sulfatide Epigenetically Regulates miR-223 and Promotes the Migration of Human Hepatocellular Carcinoma Cells.
hsa-mir-223|hepatocellular carcinoma|down|Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
hsa-mir-223|hepatocellular carcinoma|up|Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-223|hepatocellular carcinoma|down|[Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis.]
hsa-mir-223|hepatocellular carcinoma|down|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-223|kidney cancer|up|[Expression of miR-223 in clear cell renal cell carcinoma and its significance].
hsa-mir-223|lung cancer|down|miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2.
hsa-mir-223|mantle cell lymphoma|down|MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223|mantle cell lymphoma|down|[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223|mucinous cystadenocarcinoma|up|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-223|nasopharyngeal cancer|down|Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-223|nasopharyngeal carcinoma|down|MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
hsa-mir-223|oral squamous cell carcinoma|up|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-223|prostate cancer|down|Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
hsa-mir-223|prostate cancer|down|Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.
hsa-mir-223|splenic marginal zone lymphoma|down|MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223|splenic marginal zone lymphoma|down|[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223-3p|prostate cancer|up|MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.
hsa-mir-224|breast cancer|up|MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
hsa-mir-224|cervical cancer|up|Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-224|colorectal cancer|up|The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
hsa-mir-224|colorectal cancer|up|microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2.
hsa-mir-224|colorectal cancer|up|Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer.
hsa-mir-224|colorectal cancer|up|Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
hsa-mir-224|colorectal cancer|down|MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.
hsa-mir-224|esophageal squamous cell carcinoma|tissue;|Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.
hsa-mir-224|gastric cancer|up|[Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis].
hsa-mir-224|glioma|up|Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
hsa-mir-224|hepatocellular carcinoma|up|MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-224|hepatocellular carcinoma|up|Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-224|hepatocellular carcinoma|up|Transcriptional regulation of miR-224 upregulated in human HCCs by NF?B inflammatory pathways.
hsa-mir-224|hepatocellular carcinoma|up|Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-224|hepatocellular carcinoma|up|Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-224|hepatocellular carcinoma|up|MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.
hsa-mir-224|hepatocellular carcinoma|up|miR-224 promotes cell migration and invasion by modulating p-PAK4 and MMP-9 via targeting HOXD10 in human hepatocellular carcinoma.
hsa-mir-224|meningioma|up|MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
hsa-mir-224|non-small cell lung cancer|down|Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
hsa-mir-224|non-small cell lung cancer|up|MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.
hsa-mir-224|osteosarcoma|down|MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.
hsa-mir-224|prostate cancer|down|MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
hsa-mir-224|prostate cancer|down|Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
hsa-mir-224|prostate cancer|down|MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
hsa-mir-224-5p|hepatocellular carcinoma|up|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-224-5p|ovarian cancer|up|Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma.
hsa-mir-2278|chronic myelogenous leukemia|down|Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeti
hsa-mir-23a|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23a|breast cancer|up|c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-23a|colon carcinoma|up|[Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
hsa-mir-23a|colorectal cancer|up|Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-23a|gastric adenocarcinoma|up|MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor.
hsa-mir-23a|gastric adenocarcinoma|up|miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.
hsa-mir-23a|gastric cancer|up|MiR-23a in Amplified 19p13.13 Loci Targets Metallothionein 2A and Promotes Growth in Gastric Cancer Cells.
hsa-mir-23a|gastric cancer|up|Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
hsa-mir-23a|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23a|glioma|up|Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10.
hsa-mir-23a|hepatocellular carcinoma|up|Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?
hsa-mir-23a|hepatocellular carcinoma|up|MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
hsa-mir-23a|laryngeal cancer|up|High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
hsa-mir-23a|laryngeal carcinoma|up|Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma.
hsa-mir-23a|neuroblastoma|up|MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1.
hsa-mir-23a|non-small cell lung cancer|up|Clinical value of microRNA-23a upregulation in non-small cell lung cancer.
hsa-mir-23a|osteosarcoma|down|MiR-23a Functions as a Tumor Suppressor in Osteosarcoma.
hsa-mir-23a|osteosarcoma|down|miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.
hsa-mir-23a|prostate cancer|down|Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
hsa-mir-23b|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23b|bladder cancer|down|MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
hsa-mir-23b|cervical cancer|down|miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer.
hsa-mir-23b|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23b|gastric cancer|up|Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
hsa-mir-23b|gastric cancer|down|The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
hsa-mir-23b|gastric cancer|up|Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
hsa-mir-23b|glioma|down|miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.
hsa-mir-23b|nasopharyngeal carcinoma|up|MicroRNA-23b regulates nasopharyngeal carcinoma cell proliferation and metastasis by targeting E-cadherin.
hsa-mir-23b|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-23b|prostate cancer|down|miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
hsa-mir-23b|renal cell carcinoma|down|MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
hsa-mir-24|bladder cancer|down|MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
hsa-mir-24|breast cancer|up|Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
hsa-mir-24|breast carcinoma|up|MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
hsa-mir-24|colorectal cancer|down|Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-24|gastric cancer|down|Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV.
hsa-mir-24|glioma|up|MiR-24 regulates the proliferation and invasion of glioma by ST7L via ?-catenin/Tcf-4 signaling.
hsa-mir-24|hepatocellular carcinoma|up|MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis.
hsa-mir-24|hepatocellular carcinoma|up|miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.
hsa-mir-24|laryngeal squamous cell carcinoma|down|miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
hsa-mir-24|lung cancer|up|Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-24|nasopharyngeal carcinoma|down|Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
hsa-mir-24|nasopharyngeal carcinoma|down|MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
hsa-mir-24|nasopharyngeal carcinoma|down|MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
hsa-mir-24|nasopharyngeal carcinoma|up|[Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma].
hsa-mir-24|non-small cell lung cancer|up|Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-24|non-small cell lung cancer|up|Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.
hsa-mir-24|oral squamous cell carcinoma|up|miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
hsa-mir-24|oral squamous cell carcinoma|up|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-24|osteosarcoma|down|MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT?.
hsa-mir-24|prostate cancer|down|miR-24 regulates CDKN1B/p27 expression in prostate cancer.
hsa-mir-24-2-5p|breast cancer|up|c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-24-3p|breast cancer|up|miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.
hsa-mir-24-3p|colorectal cancer|down|Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
hsa-mir-24-3p|glioma|up|miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-25|astrocytoma|up|miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
hsa-mir-25|cervical carcinoma|up|[miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].
hsa-mir-25|colon cancer|down|MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.
hsa-mir-25|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-25|colorectal cancer|up|The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.
hsa-mir-25|endometrial cancer|up|TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-25|esophageal squamous cell carcinoma|up|MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-25|esophageal squamous cell carcinoma|up|Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-25|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-25|gastric cancer|up|miR-25 promotes gastric cancer cells growth and motility by targeting RECK.
hsa-mir-25|gastric cancer|up|MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
hsa-mir-25|gastric cancer|up|MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
hsa-mir-25|glioblastoma|up|miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
hsa-mir-25|glioma|up|miR-25 promotes glioma cell proliferation by targeting CDKN1C.
hsa-mir-25|head and neck squamous cell carcinoma|up|Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-25|hepatocellular carcinoma|up|Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.
hsa-mir-25|hepatocellular carcinoma|up|miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1.
hsa-mir-25|hepatocellular carcinoma|up|Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
hsa-mir-25|non-small cell lung cancer|up|Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3.
hsa-mir-25|non-small cell lung cancer|up|Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
hsa-mir-25|non-small cell lung cancer|up|miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
hsa-mir-25|non-small cell lung cancer|up|miR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
hsa-mir-25|ovarian cancer|up|MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
hsa-mir-25|ovarian cancer|up|MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
hsa-mir-25|prostate cancer|down|miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of ?v- and ?6-Integrin Expression.
hsa-mir-25|small cell lung cancer|up|MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
hsa-mir-26a|acute myeloid leukemia|down|Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.
hsa-mir-26a|bladder cancer|down|miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
hsa-mir-26a|breast cancer|down|Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
hsa-mir-26a|breast cancer|down|miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.
hsa-mir-26a|breast cancer|down|MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1.
hsa-mir-26a|breast cancer|down|MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
hsa-mir-26a|cholangiocarcinoma|up|MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin.
hsa-mir-26a|cholangiocarcinoma|up|MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin.
hsa-mir-26a|chronic myelogenous leukemia|down|ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-26a|esophageal squamous cell carcinoma|down|MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
hsa-mir-26a|gastric cancer|down|miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer.
hsa-mir-26a|glioma|up|MicroRNA-26a Promotes Tumor Growth and Angiogenesis in Glioma by Directly Targeting Prohibitin.
hsa-mir-26a|hepatocellular carcinoma|down|MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
hsa-mir-26a|hepatocellular carcinoma|down|MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
hsa-mir-26a|hepatocellular carcinoma|down|Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
hsa-mir-26a|hepatocellular carcinoma|down|microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.
hsa-mir-26a|hepatocellular carcinoma|down|IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells.
hsa-mir-26a|hepatocellular carcinoma|down|Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-26a|hepatocellular carcinoma|down|MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway.
hsa-mir-26a|hepatocellular carcinoma|down|MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2?/Akt/HIF-1? Pathway in Hepatocellular Carcinoma.
hsa-mir-26a|hepatocellular carcinoma|down|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-26a|hepatocellular carcinoma|down|MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-cmet pathway.
hsa-mir-26a|lung cancer|down|MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.
hsa-mir-26a|malignant melanoma|down|MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD).
hsa-mir-26a|oral squamous cell carcinoma|down|MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
hsa-mir-26a|osteosarcoma|down|MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
hsa-mir-26a|osteosarcoma|down|Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
hsa-mir-26a|ovarian cancer|up|MiR-26a promotes ovarian cancer proliferation and tumorigenesis.
hsa-mir-26a|papillary thyroid carcinoma|down|miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
hsa-mir-26a|primary thyroid lymphoma|down|A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-26a|prostate cancer|down|Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-26a|prostate cancer|down|MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
hsa-mir-26a|renal cell carcinoma|down|Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
hsa-mir-26a-5p|colorectal cancer|down|Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.
hsa-mir-26b|b-cell lymphoma|down|Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-26b|bladder cancer|up|Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-26b|breast cancer|down|MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer.
hsa-mir-26b|breast cancer|down|MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
hsa-mir-26b|breast cancer|down|MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.
hsa-mir-26b|colorectal cancer|down|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-26b|glioma|down|Role of microRNA-26b in glioma development and its mediated regulation on EphA2.
hsa-mir-26b|hepatocellular carcinoma|down|MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
hsa-mir-26b|hepatocellular carcinoma|down|MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
hsa-mir-26b|hepatocellular carcinoma|down|Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-26b|lung cancer|down|MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.
hsa-mir-26b|lung cancer|down|MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer.
hsa-mir-26b|malignant melanoma|down|MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation.
hsa-mir-26b|non-small cell lung cancer|down|MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-?B/MMP-9/VEGF pathways.
hsa-mir-26b|non-small cell lung cancer|down|Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.
hsa-mir-26b|oral squamous cell carcinoma|down|MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
hsa-mir-26b|osteosarcoma|down|miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
hsa-mir-26b|osteosarcoma|down|MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.
hsa-mir-26b|osteosarcoma|down|MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
hsa-mir-26b|prostate cancer|down|miR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
hsa-mir-26b|prostate cancer|down|Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-26b|renal cell carcinoma|down|Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
hsa-mir-26b-5p|hepatocellular carcinoma|down|Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.
hsa-mir-27a|acute leukemia|down|MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3?.
hsa-mir-27a|acute myeloid leukemia|down|MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-27a|breast cancer|up|miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
hsa-mir-27a|breast cancer|up|c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-27a|breast cancer|up|Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
hsa-mir-27a|cervical cancer|up|B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells.
hsa-mir-27a|chronic myelogenous leukemia|up|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-27a|colorectal cancer|down|Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2.
hsa-mir-27a|colorectal cancer|up|Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.
hsa-mir-27a|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-27a|esophageal squamous cell carcinoma|down|microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
hsa-mir-27a|esophageal squamous cell carcinoma|down|MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.
hsa-mir-27a|gastric adenocarcinoma|up|MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
hsa-mir-27a|gastric cancer|up|Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer.
hsa-mir-27a|gastric cancer|up|Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells.
hsa-mir-27a|gastric cancer|up|miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
hsa-mir-27a|glioma|down|Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
hsa-mir-27a|glioma|up|MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
hsa-mir-27a|hepatocellular carcinoma|up|MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor ?.
hsa-mir-27a|laryngeal carcinoma|up|MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma.
hsa-mir-27a|liver cancer|up|Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals.
hsa-mir-27a|non-small cell lung cancer|down|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-27a|osteosarcoma|up|MicroRNA-27a Promotes Proliferation, Migration and Invasion by Targeting MAP2K4 in Human Osteosarcoma Cells.
hsa-mir-27a|osteosarcoma|up|Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
hsa-mir-27a|osteosarcoma|up|Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
hsa-mir-27a|ovarian cancer|up|Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells.
hsa-mir-27a|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-27a|pancreatic cancer|up|Genistein Inhibits Cell Growth and Invasion Through Regulation of MiR-27a in Pancreatic Cancer Cells.
hsa-mir-27a|renal cell carcinoma|up|miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
hsa-mir-27a|small cell lung cancer|down|miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
hsa-mir-27a|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-27a*|head and neck squamous cell carcinoma|down|Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*
hsa-mir-27a-3p|esophageal squamous cell carcinoma|up|MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.
hsa-mir-27a-3p|glioma|up|miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-27a-3p|hepatocellular carcinoma|down|miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
hsa-mir-27b|acute myeloid leukemia|down|MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-27b|cervical cancer|up|miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
hsa-mir-27b|cervical cancer|up|MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
hsa-mir-27b|cervical carcinoma|up|Elevation of miR-27b by HPV16 E7 inhibits PPAR? expression and promotes proliferation and invasion in cervical carcinoma cells.
hsa-mir-27b|gastric cancer|up|miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
hsa-mir-27b|gastric cancer|down|MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-27b|glioma|up|Expression and function of miR-27b in human glioma.
hsa-mir-27b|glioma|up|MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells.
hsa-mir-27b|non-small cell lung cancer|down|MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.
hsa-mir-27b|oral squamous cell carcinoma|up|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-27b|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-27b-3p|gastric cancer|down|miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
hsa-mir-28-3p|colorectal cancer|down|Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-28-3p|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-28-5p|colorectal cancer|down|Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-28-5p|hepatocellular carcinoma|down|miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
hsa-mir-28-5p|renal cell carcinoma|down|A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-296-5p|gastric cancer|up|MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1.
hsa-mir-296-5p|glioblastoma|down|Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
hsa-mir-29a|acute myeloid leukemia|up|microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
hsa-mir-29a|acute myeloid leukemia|down|MicroRNA29a regulates the expression of the nuclear oncogene Ski.
hsa-mir-29a|breast cancer|up|Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-29a|breast cancer|up|microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29a|breast cancer|down|MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-29a|cervical squamous cell carcinoma|down|Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
hsa-mir-29a|colorectal cancer|up|MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.
hsa-mir-29a|colorectal cancer|up|Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-29a|colorectal cancer|up|microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-29a|gastric cancer|down|MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells.
hsa-mir-29a|gastric cancer|down|Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29a|gastric cancer|down|MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.
hsa-mir-29a|gastric cancer|down|miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.
hsa-mir-29a|gastric cancer|down|Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
hsa-mir-29a|gastric cancer|down|MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29a|head and neck squamous cell carcinoma|down|Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29a|hepatocellular carcinoma|down|Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29a|hepatocellular carcinoma|down|microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
hsa-mir-29a|hepatocellular carcinoma|down|Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a|hepatocellular carcinoma|down|Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a|hepatocellular carcinoma|down|Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29a|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29a|mesenchymal cancer|down|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29a|monocytic leukemia|down|Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.
hsa-mir-29a|neuroblastoma|down|Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
hsa-mir-29a|non-small cell lung cancer|down|Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29a|oral squamous cell carcinoma|down|MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.
hsa-mir-29a|pancreatic cancer|up|MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.
hsa-mir-29a|papillary thyroid carcinoma|down|miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
hsa-mir-29a-3p|gastric cancer|down|Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
hsa-mir-29b|acute myeloid leukemia|down|The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
hsa-mir-29b|chronic lymphocytic leukemia|down|Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-29b|colorectal cancer|down|miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.
hsa-mir-29b|esophageal squamous cell carcinoma|down|miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2.
hsa-mir-29b|gastric cancer|down|MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29b|gastric cancer|down25428377|MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29b|gastric cancer|down|Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
hsa-mir-29b|glioblastoma|down|Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme.
hsa-mir-29b|glioblastoma|down|miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-29b|glioblastoma|down|miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
hsa-mir-29b|lung adenocarcinoma|down|MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
hsa-mir-29b|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29b|monocytic leukemia|down|Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.
hsa-mir-29b|non-small cell lung cancer|down|Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
hsa-mir-29b|non-small cell lung cancer|down|Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29b|non-small cell lung cancer|down|MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
hsa-mir-29b|oral squamous cell carcinoma|up|Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-29b|osteosarcoma|down|MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-29b|osteosarcoma|down|Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults' age groups and their association with prediction of poor prognosis in human osteosarcoma.
hsa-mir-29b|ovarian cancer|down|MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
hsa-mir-29b|prostate cancer|down|miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.
hsa-mir-29b-1|breast cancer|up|microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29b-1|gastric cancer|down|Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29b-1|head and neck squamous cell carcinoma|down|Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29b-1|hepatocellular carcinoma|down|Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-1|hepatocellular carcinoma|down|Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-1|hepatocellular carcinoma|down|Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29b-1|hepatocellular carcinoma|down|Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-1|mesenchymal cancer|down|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29b-1-5p|mesenchymal cancer|down|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29b-2|breast cancer|up|microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29b-2|gastric cancer|down|Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29b-2|head and neck squamous cell carcinoma|down|Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29b-2|hepatocellular carcinoma|down|Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-2|hepatocellular carcinoma|down|Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29b-2|hepatocellular carcinoma|down|Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-2|hepatocellular carcinoma|down|Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-2|mesenchymal cancer|down|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29c|bladder cancer|down|Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.
hsa-mir-29c|breast cancer|up|microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29c|esophageal squamous cell carcinoma|down|miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression.
hsa-mir-29c|esophageal squamous cell carcinoma|down|Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
hsa-mir-29c|gastric cancer|down|Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
hsa-mir-29c|gastric cancer|down|MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
hsa-mir-29c|gastric cancer|down|MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29c|gastric cancer|down|Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29c|gastric cancer|down|Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
hsa-mir-29c|gastric cancer|down|The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.
hsa-mir-29c|gastric cancer|down|MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
hsa-mir-29c|gastric cancer|down|[Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
hsa-mir-29c|glioma|down|MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis.
hsa-mir-29c|head and neck squamous cell carcinoma|down|Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29c|hepatocellular carcinoma|down|PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
hsa-mir-29c|hepatocellular carcinoma|down|MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
hsa-mir-29c|hepatocellular carcinoma|down|Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29c|hepatocellular carcinoma|down|Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29c|hepatocellular carcinoma|down|Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29c|hepatocellular carcinoma|down|A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
hsa-mir-29c|hepatocellular carcinoma|down|Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29c|lung cancer|down|miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin ?1 and Matrix Metalloproteinase2 (MMP2).
hsa-mir-29c|mantle cell lymphoma|down|microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29c|mesenchymal cancer|down|miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29c|nasopharyngeal cancer|down|Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-29c|nasopharyngeal carcinoma|down|MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
hsa-mir-29c|non-small cell lung cancer|up|Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-29c|non-small cell lung cancer|down|Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29c|non-small cell lung cancer|up|Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-29c|pancreatic cancer|down|miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.
hsa-mir-300|breast cancer|down|miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300|glioblastoma|down|MicroRNA-300 inhibited glioblastoma progression through ROCK1.
hsa-mir-300|head and neck squamous cell carcinoma|down|miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300|osteosarcoma|up|Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.
hsa-mir-300|osteosarcoma|up|Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.
hsa-mir-301a|colorectal cancer|up|MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.
hsa-mir-301a|colorectal cancer|up|MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6.
hsa-mir-301a|endometrial cancer|down|Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-301a|gastric cancer|up|Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.
hsa-mir-301a|gastric cancer|up|Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
hsa-mir-301a|hepatocellular carcinoma|up|miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma.
hsa-mir-301a|multiple myeloma|up|miR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.
hsa-mir-301a|pancreatic adenocarcinoma|up|miR-301a as an NF-?B activator in pancreatic cancer cells.
hsa-mir-301a|pancreatic cancer|up|miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
hsa-mir-301a|prostate cancer|up|Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.
hsa-mir-301a|prostate cancer|up|MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
hsa-mir-301a-3p|laryngeal squamous cell carcinoma|up|Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4.
hsa-mir-301a-3p|pancreatic cancer|up|MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
hsa-mir-301b|endometrial cancer|down|Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-301b|pancreatic carcinoma|up|MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells.
hsa-mir-301b|prostate cancer|up|Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.
hsa-mir-302a|colon cancer|down|MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt.
hsa-mir-302a|prostate cancer|down|MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.
hsa-mir-302b|esophageal squamous cell carcinoma|down|miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.
hsa-mir-302b|gastric adenocarcinoma|down|Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma.
hsa-mir-302b|hepatocellular carcinoma|down|MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.
hsa-mir-302b|hepatocellular carcinoma|down|miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2.
hsa-mir-302b|hepatocellular carcinoma|down|miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells.
hsa-mir-302b|lung cancer|down|Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGF?RII Inhibition.
hsa-mir-302c|hepatocellular carcinoma|down|MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells.
hsa-mir-302f|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-30a|breast cancer|down|MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
hsa-mir-30a|breast cancer|down|miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
hsa-mir-30a|breast cancer|down|MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
hsa-mir-30a|breast cancer|down|MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
hsa-mir-30a|breast cancer|down|Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.
hsa-mir-30a|chondrosarcoma|down|Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.
hsa-mir-30a|colorectal carcinoma|down|miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.
hsa-mir-30a|hepatocellular carcinoma|down|Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.
hsa-mir-30a|lung adenocarcinoma|down|Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.
hsa-mir-30a|non-small cell lung cancer|down|MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
hsa-mir-30a|non-small cell lung cancer|down|MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
hsa-mir-30a|non-small cell lung cancer|down|Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
hsa-mir-30a|ovarian carcinoma|down|miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.
hsa-mir-30a|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30a|renal cell carcinoma|down|MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
hsa-mir-30a-3p|colorectal cancer|down|Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-30a-3p|hepatocellular carcinoma|down|MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
hsa-mir-30a-5p|colon carcinoma|down|MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.
hsa-mir-30a-5p|esophageal squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30a-5p|gastric cancer|down|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-30a-5p|glioma|up|Analysis of hsa-miR-30a-5p Expression in Human Gliomas.
hsa-mir-30a-5p|glioma|up|MiR-30a-5p is induced by Wnt/?-catenin pathway and promotes glioma cell invasion by repressing NCAM.
hsa-mir-30a-5p|head and neck squamous cell carcinoma|up|Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30a-5p|liver cancer|down|Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
hsa-mir-30b|colorectal cancer|down|MiR-30b regulates migration and invasion of human colorectal cancer via SIX1.
hsa-mir-30b|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-30b|gastric cancer|down|miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1.
hsa-mir-30b|gastric cancer|down|MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.
hsa-mir-30b|medulloblastoma|up|Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30b|non-small cell lung cancer|down|MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
hsa-mir-30b|non-small cell lung cancer|down|microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer.
hsa-mir-30b|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30b-5p|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-30c|acute myeloid leukemia|down|Transcription factor C/EBP?-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
hsa-mir-30c|endometrial cancer|down|microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
hsa-mir-30c|endometrial cancer|down|Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.
hsa-mir-30c|non-small cell lung cancer|down|Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer.
hsa-mir-30c|non-small cell lung cancer|down|MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
hsa-mir-30c|renal cell carcinoma|down|Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
hsa-mir-30c-1|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30c-2|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30d|hepatocellular carcinoma|up|MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
hsa-mir-30d|lung cancer|up|Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-30d|medulloblastoma|up|Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30d|non-small cell lung cancer|down|Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-30d|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30d|prostate cancer|down|Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-30d|renal cell carcinoma|down|Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.
hsa-mir-30d-5p|non-small cell lung cancer|down|MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer.
hsa-mir-30e|breast cancer|down|Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.
hsa-mir-30e|chronic myelogenous leukemia|down|MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
hsa-mir-30e|glioma|up|Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.
hsa-mir-30e|hepatocellular carcinoma|down|Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
hsa-mir-30e|liver cancer|down|MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
hsa-mir-30e|prostate cancer|down|miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30e*|glioma|up|MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-?B/I?B? negative feedback loop.
hsa-mir-30e-5p|non-small cell lung cancer|down|Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-31|breast cancer|down|Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
hsa-mir-31|breast cancer|down|miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
hsa-mir-31|cervical cancer|up|MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
hsa-mir-31|cervical cancer|up|miR-31 functions as an oncogene in cervical cancer.
hsa-mir-31|chordoma|down|MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-31|chronic myelogenous leukemia|down|Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-31|colon cancer|up|The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
hsa-mir-31|colorectal cancer|up|Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.
hsa-mir-31|colorectal cancer|up|Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.
hsa-mir-31|colorectal cancer|up|Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.
hsa-mir-31|colorectal cancer|up|SATB1 and 2 in colorectal cancer.
hsa-mir-31|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-31|colorectal cancer|up|The potential role of microRNA-31 expression in early colorectal cancer.
hsa-mir-31|colorectal cancer|up|MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-31|colorectal cancer|up|Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-31|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-31|esophageal squamous cell carcinoma|up|The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
hsa-mir-31|gastric cancer|down|Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.
hsa-mir-31|gastric cancer|down|Upregulation of microRNA-31 targeting integrin ?5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
hsa-mir-31|gastric cancer|down|Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
hsa-mir-31|gastric cancer|down|Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.
hsa-mir-31|glioblastoma|down|Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.
hsa-mir-31|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-31|head and neck squamous cell carcinoma|up|Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-31|hepatocellular carcinoma|up|Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-31|intrahepatic cholangiocarcinoma|up|miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.
hsa-mir-31|liver cancer|down|MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
hsa-mir-31|lung adenocarcinoma|down|MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.
hsa-mir-31|lung adenocarcinoma|up|MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.
hsa-mir-31|lung adenocarcinoma|up|MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma.
hsa-mir-31|lung cancer|up|BAP1 suppresses lung cancer progression and is inhibited by miR-31.
hsa-mir-31|lung carcinoma|down|MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.
hsa-mir-31|malignant melanoma|down|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-31|malignant melanoma|down|Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
hsa-mir-31|medulloblastoma|down|MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.
hsa-mir-31|non-small cell lung cancer|up|Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-31|oral carcinoma|up|Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
hsa-mir-31|oral carcinoma|up|Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-31|oral squamous cell carcinoma|up|miR-31 is up-regulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.
hsa-mir-31|oral squamous cell carcinoma|up|EGF up-regulates miR-31 through the C/EBP? signal cascade in oral carcinoma.
hsa-mir-31|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-31|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-31|prostate cancer|down|Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.
hsa-mir-31|prostate cancer|up|Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays.
hsa-mir-31|prostate cancer|down|Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
hsa-mir-3127|hepatocellular carcinoma|up|MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
hsa-mir-3163|retinoblastoma|down|Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.
hsa-mir-3175|glioma|up|HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.
hsa-mir-3189-3p|astrocytoma|down|Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.
hsa-mir-3189-3p|glioblastoma|down|Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.
hsa-mir-32|acute myeloid leukemia|up|MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
hsa-mir-32|colorectal cancer|up|The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
hsa-mir-32|gastric cancer|up|MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4.
hsa-mir-32|hepatocellular carcinoma|up|MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.
hsa-mir-32|non-small cell lung cancer|down|Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
hsa-mir-32|non-small cell lung cancer|down|Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.
hsa-mir-32|non-small cell lung cancer|down|miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer.
hsa-mir-32|oral squamous cell carcinoma|down|MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
hsa-mir-32|osteosarcoma|down|MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.
hsa-mir-320|cervical cancer|down|Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
hsa-mir-320|chronic myelogenous leukemia|down|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-320|colon cancer|down|miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.
hsa-mir-320|glioblastoma|down|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-320|glioma|down|MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.
hsa-mir-320|non-small cell lung cancer|down|MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.
hsa-mir-320|osteosarcoma|down|MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase.
hsa-mir-320a|breast cancer|down|MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
hsa-mir-320a|colon cancer|down|MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting ?-catenin.
hsa-mir-320a|colorectal cancer|down|miR-320a suppresses colorectal cancer progression by targeting Rac1.
hsa-mir-320a|colorectal cancer|down|[Corrigendum] microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
hsa-mir-320a|colorectal cancer|down|Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-320a|colorectal cancer|down|microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer.
hsa-mir-320a|glioblastoma|down|MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
hsa-mir-320a|nasopharyngeal carcinoma|down|MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.
hsa-mir-320a|osteosarcoma|up|Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-320a|pancreatic cancer|up|MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells.
hsa-mir-320b|colorectal cancer|up|MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.
hsa-mir-320c|bladder cancer|down|MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
hsa-mir-323|prostate cancer|down|MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor.
hsa-mir-323-3p|pancreatic ductal adenocarcinoma|down|MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
hsa-mir-323-5p|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-324-3p|nasopharyngeal carcinoma|down|MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
hsa-mir-324-3p|nasopharyngeal carcinoma|down|[The expression and significance of miRNA-324-3p and WNT2B in nasopharyngeal carcinoma].
hsa-mir-324-5p|hepatocellular carcinoma|down|MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
hsa-mir-325|hepatocellular carcinoma|down|The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
hsa-mir-326|chronic myelogenous leukemia|down|Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34(+) CML stem/progenitor cells.
hsa-mir-326|colorectal cancer|up|MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
hsa-mir-326|gastric cancer|down|Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
hsa-mir-326|glioblastoma|down|Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
hsa-mir-326|glioma|down|The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.
hsa-mir-326|glioma|down|MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
hsa-mir-326|glioma|down|Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness.
hsa-mir-326|glioma|down|Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.
hsa-mir-326|lung cancer|down|MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR.
hsa-mir-328|acute myeloid leukemia|down|Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
hsa-mir-328|cervical cancer|down|microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.
hsa-mir-328|colorectal cancer|down|MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
hsa-mir-328|esophageal cancer|down|MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1.
hsa-mir-328|gastric cancer|down|Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
hsa-mir-328|glioma|down|microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
hsa-mir-328|glioma|up|MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
hsa-mir-328|non-small cell lung cancer|up|Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-329|breast cancer|down|Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
hsa-mir-329|gastric cancer|down|By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
hsa-mir-329|hepatocellular carcinoma|down|Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
hsa-mir-329|non-small cell lung cancer|down|Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
hsa-mir-329|oral squamous cell carcinoma|down|Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
hsa-mir-329|pancreatic cancer|down|mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer.
hsa-mir-330|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-330|prostate cancer|down|MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
hsa-mir-330|prostate cancer|down|microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
hsa-mir-330-3p|esophageal squamous cell carcinoma|up|MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.
hsa-mir-330-3p|non-small cell lung cancer|up|miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
hsa-mir-331|acute myeloid leukemia|up|Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.
hsa-mir-331-3p|colorectal cancer|down|miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
hsa-mir-331-3p|gastric cancer|down|miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
hsa-mir-331-3p|glioblastoma|down|miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
hsa-mir-331-3p|hepatocellular carcinoma|up|Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines.
hsa-mir-331-3p|hepatocellular carcinoma|up|Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
hsa-mir-331-3p|prostate cancer|down|miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.
hsa-mir-331-3p|prostate cancer|down|Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
hsa-mir-335|adrenal cortical carcinoma|down|miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-335|astrocytoma|up|Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells.
hsa-mir-335|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-335|breast cancer|down|MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.
hsa-mir-335|breast cancer|down|MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.
hsa-mir-335|cervical cancer|down|MicroRNA-335 represents an independent prognostic marker in cervical cancer.
hsa-mir-335|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-335|colorectal cancer|up|Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells.
hsa-mir-335|esophageal squamous cell carcinoma|down|Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
hsa-mir-335|glioma|up|Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
hsa-mir-335|hepatocellular carcinoma|down|Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma.
hsa-mir-335|hepatocellular carcinoma|down|MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
hsa-mir-335|meningioma|up|miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
hsa-mir-335|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-335|neuroblastoma|down|MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-? Signalling Pathway.
hsa-mir-335|non-small cell lung cancer|down|Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.
hsa-mir-335|osteosarcoma|down|miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells.
hsa-mir-335|ovarian cancer|down|miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
hsa-mir-335|ovarian cancer|down|Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-335|pancreatic cancer|down|miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.
hsa-mir-335|primary gallbladder carcinoma|down|Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma.
hsa-mir-335|prostate cancer|down|MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
hsa-mir-335|renal clear cell carcinoma|down|miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-335-5p|gastric cancer|down|The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-337|pancreatic ductal adenocarcinoma|down|miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7.
hsa-mir-337-3p|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-337-3p|gastric cancer|down|miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
hsa-mir-337-3p|neuroblastoma|down|miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.
hsa-mir-338|gastric cancer|down|MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression.
hsa-mir-338|nasopharyngeal carcinoma|down|MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1? in nasopharyngeal carcinoma.
hsa-mir-338|oral squamous cell carcinoma|down|miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
hsa-mir-338-3p|colorectal cancer|down|Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.
hsa-mir-338-3p|colorectal carcinoma|down|MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened.
hsa-mir-338-3p|gastric cancer|down|MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
hsa-mir-338-3p|gastric cancer|down|miR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
hsa-mir-338-3p|gastric cancer|down|Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.
hsa-mir-338-3p|gastric cancer|down|miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a.
hsa-mir-338-3p|glioma|down|Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.
hsa-mir-338-3p|hepatocellular carcinoma|down|MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1?.
hsa-mir-338-3p|hepatocellular carcinoma|down|MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
hsa-mir-338-3p|hepatocellular carcinoma|down|miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1.
hsa-mir-338-3p|liver cancer|down|miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
hsa-mir-338-3p|neuroblastoma|down|miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.
hsa-mir-338-3p|non-small cell lung cancer|down|microRNA-338-3p functions as a tumor suppressor in human non?small?cell lung carcinoma and targets Ras-related protein 14.
hsa-mir-339|gastric cancer|down|MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.
hsa-mir-339|non-small cell lung cancer|up|Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-339-3p|colorectal cancer|down|miR-339-3p inhibits proliferation and metastasis of colorectal cancer.
hsa-mir-339-3p|malignant melanoma|down|miR-339-3p Is a Tumor Suppressor in Melanoma.
hsa-mir-339-5p|breast cancer|down|MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
hsa-mir-339-5p|hepatocellular carcinoma|down|Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
hsa-mir-339-5p|ovarian cancer|down|miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
hsa-mir-339-5p|papillary thyroid carcinoma|up|microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
hsa-mir-33a|breast cancer|down|MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1.
hsa-mir-33a|cervical cancer|up|[MicroRNA-33a regulates the invasion of cervical cancer cells via targeting Twist1].
hsa-mir-33a|glioma|up|miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
hsa-mir-33a|hepatocellular carcinoma|down|Aflatoxin B1 Negatively Regulates Wnt/?-Catenin Signaling Pathway through Activating miR-33a.
hsa-mir-33a|lung cancer|down|MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.
hsa-mir-33a|lung cancer|down|MicroRNA-33a inhibits lung cancer cell proliferation and invasion by regulating the expression of ?-catenin.
hsa-mir-33a|malignant melanoma|down|miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1?.
hsa-mir-33a|pancreatic cancer|down|miR-33a suppresses the nuclear translocation of ?-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.
hsa-mir-33a-3p|hepatocellular carcinoma|down|MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.
hsa-mir-33a-5p|osteosarcoma|down|MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma.
hsa-mir-33b|breast cancer|down|MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.
hsa-mir-33b|colorectal cancer|down|MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.
hsa-mir-33b|lung adenocarcinoma|down|MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/?-catenin/ZEB1 signaling.
hsa-mir-33b|osteosarcoma|down|MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.
hsa-mir-340|breast cancer|down|miR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.
hsa-mir-340|endometrial cancer|down|MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.
hsa-mir-340|esophageal squamous cell carcinoma|down|MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
hsa-mir-340|gastric cancer|up|Effect of miR-340 on gastric cancer cell proliferation and apoptosis.
hsa-mir-340|glioblastoma|up|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-340|glioblastoma|down|miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.
hsa-mir-340|glioblastoma|down|miR-340 suppresses glioblastoma multiforme.
hsa-mir-340|non-small cell lung cancer|down|miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
hsa-mir-340|oral cancer|down|MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.
hsa-mir-340|osteosarcoma|down|MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.
hsa-mir-340|prostate cancer|down|microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
hsa-mir-340|prostate cancer|down|MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
hsa-mir-340*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-342|acute promyelocytic leukemia|down|A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-342|colorectal cancer|down|MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
hsa-mir-342|colorectal cancer|down|FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor suppressive miR-342 in human colorectal cancer.
hsa-mir-342|glioblastoma|down|Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-342-3p|cervical cancer|down|miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.
hsa-mir-342-3p|non-small cell lung cancer|down|miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.
hsa-mir-342-5p|colon cancer|down|microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
hsa-mir-345|colorectal cancer|down|MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
hsa-mir-345|non-small cell lung cancer|down|Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer.
hsa-mir-345|oral squamous cell carcinoma|up|Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-345|prostate cancer|down|MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
hsa-mir-346|follicular thyroid carcinoma|up|A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-346|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-34a|b-cell lymphoma|down|The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
hsa-mir-34a|bladder cancer|down|MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
hsa-mir-34a|breast cancer|down|The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
hsa-mir-34a|breast cancer|down|Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion.
hsa-mir-34a|breast cancer|down|MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line.
hsa-mir-34a|breast cancer|down|MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.
hsa-mir-34a|breast cancer|down|Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a|breast cancer|down|MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34a|breast cancer|down|Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
hsa-mir-34a|cervical cancer|down|HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.
hsa-mir-34a|cervical cancer|down|MicroRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells.
hsa-mir-34a|cervical carcinoma|down|MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a|cholangiocarcinoma|down|microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
hsa-mir-34a|cholangiocarcinoma|up|miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
hsa-mir-34a|chordoma|down|MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
hsa-mir-34a|choriocarcinoma|down|MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a|choriocarcinoma|down|MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
hsa-mir-34a|clear cell renal cell cancer|up|The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
hsa-mir-34a|colon cancer|down|MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor ?.
hsa-mir-34a|colon cancer|down|MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
hsa-mir-34a|colon cancer|down|Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34a|colorectal cancer|down|Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.
hsa-mir-34a|colorectal cancer|down|MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
hsa-mir-34a|colorectal cancer|down|Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-34a|colorectal cancer|down|Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a|colorectal cancer|down|Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF.
hsa-mir-34a|endometrial cancer|down|The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.
hsa-mir-34a|endometrial cancer|down|Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.
hsa-mir-34a|esophageal cancer|down|miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.
hsa-mir-34a|esophageal squamous cell carcinoma|down|miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
hsa-mir-34a|extrahepatic cholangiocarcinoma|down|microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
hsa-mir-34a|gastric cancer|down|MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.
hsa-mir-34a|gastric cancer|down|Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.
hsa-mir-34a|gastric cancer|down|Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
hsa-mir-34a|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-34a|gastric cancer|down|MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
hsa-mir-34a|gastric cancer|down|The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival.
hsa-mir-34a|gastric cancer|down|Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
hsa-mir-34a|gastric cancer|down|Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-34a|gastric cancer|down|microRNA-34a Inhibits the Growth, Invasion and Metastasis of Gastric Cancer by Targeting PDGFR and MET Expression.
hsa-mir-34a|glioblastoma|down|MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a|glioblastoma|down|MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.
hsa-mir-34a|glioblastoma|down|miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
hsa-mir-34a|glioma|down|MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a|glioma|down|microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
hsa-mir-34a|glioma|down|MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression.
hsa-mir-34a|head and neck squamous cell carcinoma|down|Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
hsa-mir-34a|hepatocellular carcinoma|down|Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.
hsa-mir-34a|hepatocellular carcinoma|down|MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment.
hsa-mir-34a|hepatocellular carcinoma|down|Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
hsa-mir-34a|hepatocellular carcinoma|down|miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
hsa-mir-34a|hepatocellular carcinoma|down|Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.
hsa-mir-34a|laryngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-34a|laryngeal carcinoma|down|Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
hsa-mir-34a|lung cancer|down|Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34a|malignant melanoma|down|Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-34a|malignant melanoma|down|Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34a|malignant melanoma|down|Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
hsa-mir-34a|malignant melanoma|down|MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-34a|neuroblastoma|down|MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
hsa-mir-34a|neuroblastoma|down|A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
hsa-mir-34a|non-small cell lung cancer|down|Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
hsa-mir-34a|non-small cell lung cancer|down|The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells.
hsa-mir-34a|non-small cell lung cancer|up|Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-34a|oral cancer|down|MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.
hsa-mir-34a|oral squamous cell carcinoma|down|Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
hsa-mir-34a|oropharyngeal cancer|up|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-34a|osteosarcoma|down|MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.
hsa-mir-34a|osteosarcoma|down|MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether  go-go 1 expression.
hsa-mir-34a|osteosarcoma|down|Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34a|ovarian cancer|down|Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34a|ovarian cancer|down|MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
hsa-mir-34a|pancreatic cancer|down|MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34a|pancreatic cancer|down|Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.
hsa-mir-34a|pancreatic ductal adenocarcinoma|up|MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-34a|papillary thyroid carcinoma|up|MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
hsa-mir-34a|prostate cancer|down|MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
hsa-mir-34a|prostate cancer|down|LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a.
hsa-mir-34a|prostate cancer|down|Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.
hsa-mir-34a|prostate cancer|down|Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a|prostate cancer|down|miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression.
hsa-mir-34a|prostate cancer|down|The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a|rectal cancer|up|The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-34a|renal cell carcinoma|down|MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
hsa-mir-34a|renal cell carcinoma|down|Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma.
hsa-mir-34a|renal cell carcinoma|down|MicroRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cell.
hsa-mir-34a|retinoblastoma|down|Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
hsa-mir-34a|squamous carcinoma|up|Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-34a|uveal melanoma|down|MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
hsa-mir-34a-5p|colorectal cancer|down|miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
hsa-mir-34a-5p|hepatocellular carcinoma|down|MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells.
hsa-mir-34b|breast cancer|down|MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34b|breast cancer|down|The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-34b|chronic lymphocytic leukemia|down|Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
hsa-mir-34b|endometrial serous adenocarcinoma|down|MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
hsa-mir-34b|gastric cancer|down|Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-34b|hepatocellular carcinoma|down|Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
hsa-mir-34b|lung cancer|down|Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34b|non-small cell lung cancer|down|MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
hsa-mir-34b|osteosarcoma|down|Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34b|ovarian cancer|down|Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34b|ovarian carcinoma|down|MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34b|pancreatic cancer|down|MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34b|pancreatic cancer|down|MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.
hsa-mir-34b|papillary thyroid carcinoma|down|MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-34b|papillary thyroid carcinoma|up|Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
hsa-mir-34b|prostate cancer|down|miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
hsa-mir-34b|uveal melanoma|down|MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34c|breast cancer|down|Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells.
hsa-mir-34c|breast cancer|down|The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-34c|breast cancer|down|MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34c|chronic lymphocytic leukemia|down|Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
hsa-mir-34c|colon cancer|down|Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34c|colorectal cancer|down|Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation.
hsa-mir-34c|endometrial cancer|down|MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis.
hsa-mir-34c|endometrial cancer|down|miR-34c plays a role of tumor suppressor in HEC?1-B cells by targeting E2F3 protein.
hsa-mir-34c|gastric cancer|down|Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
hsa-mir-34c|lung cancer|down|Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-34c|lung cancer|down|Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34c|malignant melanoma|down|Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34c|nasopharyngeal carcinoma|down|MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
hsa-mir-34c|osteosarcoma|down|Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34c|osteosarcoma|down|MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
hsa-mir-34c|ovarian cancer|down|Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34c|ovarian carcinoma|down|MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34c|pancreatic cancer|down|MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34c|prostate cancer|down|miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
hsa-mir-34c|uveal melanoma|down|MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34c-3p|glioma|down|Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.
hsa-mir-34c-3p|hepatocellular carcinoma|down|miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
hsa-mir-34c-3p|non-small cell lung cancer|down|MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
hsa-mir-34c-5p|glioma|down|Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.
hsa-mir-361-3p|non-small cell lung cancer|down|MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
hsa-mir-361-3p|non-small cell lung cancer|down|Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-361-5p|colorectal cancer|down|MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
hsa-mir-361-5p|gastric cancer|down|MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
hsa-mir-361-5p|hepatocellular carcinoma|down|MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.
hsa-mir-3613|papillary thyroid carcinoma|up|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-362|renal cell carcinoma|up|A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-362-3p|breast cancer|down|Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
hsa-mir-362-3p|gastric cancer|up|Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.
hsa-mir-362-3p|gastric cancer|up|Erratum to: Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.
hsa-mir-362-3p|hepatocellular carcinoma|up|Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma.
hsa-mir-362-3p|renal cell carcinoma|down|miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells.
hsa-mir-362-5p|hepatocellular carcinoma|up|MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
hsa-mir-362-5p|neuroblastoma|down|miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2?.
hsa-mir-363|gastric cancer|up|miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.
hsa-mir-363|head and neck cancer|down|MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
hsa-mir-363|head and neck squamous cell carcinoma|down|Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin.
hsa-mir-363|hepatocellular carcinoma|down|Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
hsa-mir-363|osteosarcoma|down|microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.
hsa-mir-363-3p|gastric cancer|down|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-3646|breast cancer|up|miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.
hsa-mir-365|colon cancer|down|microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.
hsa-mir-365|hepatocellular carcinoma|down|Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.
hsa-mir-365|lung cancer|down|MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.
hsa-mir-365|malignant melanoma|down|MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
hsa-mir-365|malignant melanoma|down|MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
hsa-mir-365|non-small cell lung cancer|down|Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
hsa-mir-365|non-small cell lung cancer|down|Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
hsa-mir-365a-3p|laryngeal squamous cell carcinoma|up|MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
hsa-mir-365b-3p|retinoblastoma|down|MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6.
hsa-mir-3662|lung cancer|up|Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
hsa-mir-367|gastric cancer|down|The microRNA-367 Inhibits the Invasion and Metastasis of Gastric Cancer by Directly Repressing Rab23.
hsa-mir-367|hepatocellular carcinoma|up|miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
hsa-mir-367|medulloblastoma|up|miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.
hsa-mir-367|pancreatic cancer|up|miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-? signalling pathway.
hsa-mir-369-5p|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-370|acute myeloid leukemia|up|Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
hsa-mir-370|bladder cancer|down|Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-370|breast cancer|up|High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer.
hsa-mir-370|gastric cancer|up|Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
hsa-mir-370|gastric cancer|up|Overexpression of miR-370 and downregulation of its novel target TGF?-RII contribute to the progression of gastric carcinoma.
hsa-mir-370|hepatocellular carcinoma|down|Perturbation of miR-370-LIN28A-NF-?B regulatory circuit contributes to the development of hepatocellular carcinoma.
hsa-mir-370|laryngeal squamous cell carcinoma|down|miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
hsa-mir-370|liver cancer|down|MiR-370 promotes cell death of liver cancer cells by Akt/FoxO3a signalling pathway.
hsa-mir-370|non-small cell lung cancer|down|MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
hsa-mir-370|oral squamous cell carcinoma|down|miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
hsa-mir-370|osteosarcoma|down|MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
hsa-mir-370-3p|glioma|down|MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting ?-catenin.
hsa-mir-371-5p|gastric cancer|up|MicroRNA-371-5p targets SOX2 in gastric cancer.
hsa-mir-371-5p|hepatocellular carcinoma|up|miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells.
hsa-mir-372|cervical cancer|down|MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.
hsa-mir-372|colorectal cancer|up|Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer.
hsa-mir-372|endometrial cancer|down|MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
hsa-mir-372|epithelial ovarian cancer|up|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-372|glioma|up|Correlation of microrna-372 upregulation with poor prognosis in human glioma.
hsa-mir-372|head and neck squamous cell carcinoma|up|miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.
hsa-mir-372|hepatocellular carcinoma|up|Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
hsa-mir-372|hepatocellular carcinoma|down|miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.
hsa-mir-372|oral squamous cell carcinoma|up|Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.
hsa-mir-372|renal cell carcinoma|down|miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.
hsa-mir-373|breast cancer|up|The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
hsa-mir-373|breast cancer|up|MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1?-TWIST signaling axis in breast cancer.
hsa-mir-373|breast cancer|up|Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer.
hsa-mir-373|cervical carcinoma|up|MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
hsa-mir-373|colon cancer|down|Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.
hsa-mir-373|epithelial ovarian cancer|up|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-373|esophageal squamous cell carcinoma|up|MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
hsa-mir-373|gastric adenocarcinoma|up|MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis.
hsa-mir-373|glioma|down|miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.
hsa-mir-373|hepatocellular carcinoma|up|MicroRNA-373, a new regulator of protein phosphatase?6, functions as an oncogene in hepatocellular carcinoma.
hsa-mir-373|non-small cell lung cancer|down|Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.
hsa-mir-373|oral squamous cell carcinoma|up|Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.
hsa-mir-373|pancreatic cancer|down|Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell Invasion.
hsa-mir-374a|breast cancer|down|Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis.
hsa-mir-374a|colon cancer|down|microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
hsa-mir-374a|esophageal cancer|up|MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression.
hsa-mir-374a|gastric cancer|up|miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.
hsa-mir-374a|lung adenocarcinoma|down|MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
hsa-mir-374a-5p|osteosarcoma|up|Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-374b|prostate cancer|down|Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
hsa-mir-374b|t-cell lymphoblastic lymphoma|down|MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16.
hsa-mir-375|cervical squamous cell carcinoma|down|miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.
hsa-mir-375|colon cancer|down|Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.
hsa-mir-375|colorectal cancer|down|Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-375|colorectal cancer|down|MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
hsa-mir-375|colorectal cancer|down|MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8.
hsa-mir-375|colorectal cancer|down|miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
hsa-mir-375|colorectal cancer|down|Expression levels of microRNA-375 in colorectal carcinoma.
hsa-mir-375|esophageal cancer|down|Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.
hsa-mir-375|esophageal cancer|down|The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
hsa-mir-375|esophageal squamous cell carcinoma|down|Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-375|esophageal squamous cell carcinoma|down|Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.
hsa-mir-375|esophageal squamous cell carcinoma|down|Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-375|gastric cancer|down|MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
hsa-mir-375|gastric cancer|down|MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
hsa-mir-375|gastric cancer|down|miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression.
hsa-mir-375|gastric cancer|down|Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.
hsa-mir-375|glioma|down|Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
hsa-mir-375|head and neck squamous cell carcinoma|down|Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-375|head and neck squamous cell carcinoma|down|MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
hsa-mir-375|hepatocellular carcinoma|down|MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
hsa-mir-375|hepatocellular carcinoma|down|miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.
hsa-mir-375|hepatocellular carcinoma|down|Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
hsa-mir-375|laryngeal cancer|down|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-375|laryngeal squamous cell carcinoma|down|miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma.
hsa-mir-375|nasopharyngeal carcinoma|down|Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
hsa-mir-375|non-small cell lung cancer|down|Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.
hsa-mir-375|non-small cell lung cancer|up|Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
hsa-mir-375|oral cancer|down|MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
hsa-mir-375|oral cancer|down|Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells.
hsa-mir-375|oral carcinoma|down|Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-375|oropharyngeal cancer|down|MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-375|osteosarcoma|down|MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.
hsa-mir-375|pancreatic cancer|down|Deregulation of MicroRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3.
hsa-mir-375|pancreatic cancer|down|MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.
hsa-mir-375|pancreatic cancer|down|Expression levels of microRNA-375 in pancreatic cancer.
hsa-mir-375|pancreatic carcinoma|down|MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway.
hsa-mir-375|pancreatic ductal adenocarcinoma|down|Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-375|pancreatic ductal adenocarcinoma|down|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-375|papillary thyroid carcinoma|down|Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
hsa-mir-375|squamous carcinoma|down|Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.
hsa-mir-376a|chondrosarcoma|down|Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-376a|glioblastoma|down|Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-376a|hepatocellular carcinoma|down|miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma.
hsa-mir-376a|malignant melanoma|down|Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376a|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-376c|malignant melanoma|down|Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376c|osteosarcoma|down|MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-376c|osteosarcoma|down|MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha.
hsa-mir-377|gastric cancer|up|MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
hsa-mir-377|hepatocellular carcinoma|down|Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
hsa-mir-377|hepatocellular carcinoma|down|MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma.
hsa-mir-377|non-small cell lung cancer|down|microRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1.
hsa-mir-377|renal clear cell carcinoma|down|miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
hsa-mir-378|acute myeloid leukemia|up|Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
hsa-mir-378|breast cancer|up|Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
hsa-mir-378|colorectal cancer|down|Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-378|colorectal cancer|down|MicroRNA-378 inhibits cell growth and enhances l-OHP-induced apoptosis in human colorectal cancer.
hsa-mir-378|gastric cancer|down|MicroRNA profiling of human gastric cancer.
hsa-mir-378|gastric cancer|down|MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-378|glioma|down|Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
hsa-mir-378|nasopharyngeal carcinoma|down|MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
hsa-mir-378|ovarian cancer|up|MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.
hsa-mir-378|ovarian cancer|up|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-378|prostate cancer|down|MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo.
hsa-mir-378|renal cell carcinoma|down|A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-378a-3p|colorectal cancer|down|Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
hsa-mir-378a-5p|colorectal cancer|down|Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-378a-5p|colorectal cancer|down|Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
hsa-mir-379|breast cancer|down|miR-379 regulates cyclin B1 expression and is decreased in breast cancer.
hsa-mir-379-5p|hepatocellular carcinoma|down|MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
hsa-mir-381|breast cancer|down|miR-381 suppresses C/EBP?-dependent Cx43 expression in breast cancer cells.
hsa-mir-381|breast cancer|down|Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-381|colon cancer|down|Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
hsa-mir-381|colon cancer|down|[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-381|hepatocellular carcinoma|down|MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
hsa-mir-381|lung adenocarcinoma|down|MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.
hsa-mir-382|colorectal cancer|down|MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer.
hsa-mir-382|osteosarcoma|down|miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
hsa-mir-382|osteosarcoma|down|miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1.
hsa-mir-382|ovarian cancer|down|miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
hsa-mir-382-5p|esophageal adenocarcinoma|up|Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-383|breast cancer|down|MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g.
hsa-mir-383|glioma|down|MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
hsa-mir-383|glioma|down|MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
hsa-mir-383|glioma|down|Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.
hsa-mir-383|hepatocellular carcinoma|down|miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
hsa-mir-383|medulloblastoma|down|MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3).
hsa-mir-3928|osteosarcoma|down|Down-Regulation of miR-3928 Promoted Osteosarcoma Growth.
hsa-mir-409-3p|bladder cancer|down|MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.
hsa-mir-409-3p|breast cancer|down|miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.
hsa-mir-409-3p|colon cancer|down|miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
hsa-mir-409-3p|colorectal cancer|down|Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
hsa-mir-409-3p|colorectal cancer|down|MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
hsa-mir-409-3p|gastric cancer|down|MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
hsa-mir-409-3p|gastric cancer|down|MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.
hsa-mir-409-3p|lung adenocarcinoma|down|MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.
hsa-mir-409-3p|osteosarcoma|down|MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-?1.
hsa-mir-409-3p|ovarian cancer|down|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-410|gastric cancer|down|MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.
hsa-mir-410|non-small cell lung cancer|up|MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.
hsa-mir-410|oral squamous cell carcinoma|down|Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
hsa-mir-410|pancreatic cancer|down|MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
hsa-mir-410-3p|breast cancer|down|miR-410-3p suppresses breast cancer progression by targeting Snail.
hsa-mir-411|lung cancer|up|miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.
hsa-mir-411|ovarian cancer|down|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-411-5p|breast cancer|down|miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
hsa-mir-421|gastric cancer|up|Increased expression of miR-421 in human gastric carcinoma and its clinical association.
hsa-mir-421|gastric cancer|up|MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3.
hsa-mir-421|gastric cancer|up|MicroRNA-421 regulated by HIF-1? promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
hsa-mir-421|gastric cancer|up|MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
hsa-mir-421|nasopharyngeal carcinoma|up|miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.
hsa-mir-421|neuroblastoma|up|Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.
hsa-mir-421|osteosarcoma|up|miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
hsa-mir-421|prostate cancer|down|A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
hsa-mir-422a|colorectal cancer|down|Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-422a|head and neck squamous cell carcinoma|down|MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
hsa-mir-422a|hepatocellular carcinoma|down|A double-negative feedback loop between MicroRNA-422a and FOXG1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.
hsa-mir-422a|osteosarcoma|down|Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults' age groups and their association with prediction of poor prognosis in human osteosarcoma.
hsa-mir-423|breast cancer|up|Genetic analysis and preliminary function study of miR-423 in breast cancer.
hsa-mir-423|hepatocellular carcinoma|up|MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
hsa-mir-423-3p|colorectal cancer|up|MiR-423-3p Enhances Cell Growth Through Inhibition of p21Cip1/Waf1 in Colorectal Cancer.
hsa-mir-423-3p|laryngeal carcinoma|up|microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.
hsa-mir-423-5p|colorectal cancer|down|Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-424|acute myeloid leukemia|down|MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-424|bladder cancer|down|DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.
hsa-mir-424|cervical cancer|down|Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
hsa-mir-424|chronic lymphocytic leukemia|down|miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.
hsa-mir-424|chronic myelogenous leukemia|up|Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
hsa-mir-424|colon cancer|down|MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-424|colorectal cancer|up|Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-424|endometrial cancer|down|MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
hsa-mir-424|endometrial cancer|down|MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
hsa-mir-424|hepatocellular carcinoma|down|Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
hsa-mir-424|hepatocellular carcinoma|down|MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.
hsa-mir-424|hepatocellular carcinoma|down|MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
hsa-mir-424|osteosarcoma|down|Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.
hsa-mir-424|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-424-5p|hepatocellular carcinoma|down|MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
hsa-mir-424-5p|pancreatic cancer|up|MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer.
hsa-mir-425|breast cancer|down|Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-425|esophageal squamous cell carcinoma|up|Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2.
hsa-mir-425|gastric cancer|up|NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1? induction.
hsa-mir-425|malignant melanoma|down|miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.
hsa-mir-425-5p|cervical cancer|up|MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
hsa-mir-425-5p|gastric cancer|up|microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo.
hsa-mir-4262|hepatocellular carcinoma|up|MicroRNA-4262 activates the NF-?B and enhances the proliferation of hepatocellular carcinoma cells.
hsa-mir-429|bladder cancer|down|Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-429|breast cancer|up|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-429|breast cancer|down|miR-429 inhibits migration and invasion of breast cancer cells in vitro.
hsa-mir-429|colon cancer|down|MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.
hsa-mir-429|colorectal cancer|down|MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-429|colorectal cancer|up|MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
hsa-mir-429|colorectal carcinoma|down|miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.
hsa-mir-429|gastric cancer|down|miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
hsa-mir-429|gastric cancer|down|MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins.
hsa-mir-429|gastric cancer|up|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-429|gastric cancer|down|MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2.
hsa-mir-429|glioblastoma|down|MiR-429 induces apoptosis of glioblastoma cell through Bcl-2.
hsa-mir-429|glioma|up|The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
hsa-mir-429|glioma|down|miR-429 inhibits glioma invasion through BMK1 suppression.
hsa-mir-429|hepatocellular carcinoma|up|Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
hsa-mir-429|hepatocellular carcinoma|up|MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.
hsa-mir-429|lung adenocarcinoma|down|miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-429|lung cancer|up|MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-429|malignant melanoma|up|MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-429|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-429|non-small cell lung cancer|down|Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-429|oral cancer|down|Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-429|oral squamous cell carcinoma|down|MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1.
hsa-mir-429|osteosarcoma|down|Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma.
hsa-mir-429|ovarian cancer|down|A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-429|ovarian cancer|down|Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
hsa-mir-429|prostate cancer|up|Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
hsa-mir-429|renal cell carcinoma|down|MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma.
hsa-mir-4295|anaplastic thyroid carcinoma|up|miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
hsa-mir-4295|glioma|up|RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.
hsa-mir-431|hepatocellular carcinoma|down|MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.
hsa-mir-432|lung adenocarcinoma|down|MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.
hsa-mir-432|ovarian cancer|down|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-4328|mucinous cystadenocarcinoma|down|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-433|gastric cancer|down|Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-433|gastric cancer|down|The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.
hsa-mir-433|hepatocellular carcinoma|down|MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).
hsa-mir-433|liver cancer|down|The microRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element binding protein.
hsa-mir-433|oral squamous cell carcinoma|down|miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
hsa-mir-4423|lung cancer|up|MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis.
hsa-mir-4458|colon cancer|down|miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells.
hsa-mir-4458|hepatocellular carcinoma|down|Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma.
hsa-mir-448|gastric cancer|up|MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.
hsa-mir-448|gastric cancer|down|miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.
hsa-mir-448|hepatocellular carcinoma|down|Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma.
hsa-mir-448|ovarian cancer|down|miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.
hsa-mir-4487|colorectal cancer|down|Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
hsa-mir-449|gastric cancer|down|miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.
hsa-mir-449a|breast cancer|up|MiR-449a promotes breast cancer progression by targeting CRIP2.
hsa-mir-449a|endometrial cancer|down|MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.
hsa-mir-449a|gastric adenocarcinoma|down|microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.
hsa-mir-449a|gastric cancer|down|miR-449a and CDK6 in gastric carcinoma.
hsa-mir-449a|gastric cancer|down|MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.
hsa-mir-449a|gastric cancer|down|miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells.
hsa-mir-449a|glioblastoma|down|MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
hsa-mir-449a|hepatocellular carcinoma|down|Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.
hsa-mir-449a|liver cancer|down|miR-449a promotes liver cancer cell apoptosis by down-regulation of Calpain6 and POU2F1.
hsa-mir-449a|lung cancer|down|Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-449a|lung cancer|down|MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1.
hsa-mir-449a|neuroblastoma|down|microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
hsa-mir-449a|non-small cell lung cancer|down|MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.
hsa-mir-449a|non-small cell lung cancer|down|MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met.
hsa-mir-449a|non-small cell lung cancer|down|microRNA-449a Suppresses Non-small Cell Lung Cancer.
hsa-mir-449a|osteosarcoma|down|miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
hsa-mir-449a|ovarian cancer|down|MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells.
hsa-mir-449a|prostate cancer|down|miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
hsa-mir-449a|prostate cancer|down|miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
hsa-mir-449b|lung cancer|down|Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-449c|gastric cancer|down|MiR-449c inhibits gastric carcinoma growth.
hsa-mir-4500|non-small cell lung cancer|down|Down-regulation of miR-4500 promoted non-small cell lung cancer growth.
hsa-mir-450a|hepatocellular carcinoma|down|microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.
hsa-mir-450b-3p|breast cancer|down|Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.
hsa-mir-450b-5p|colorectal cancer|down|miR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer.
hsa-mir-451|bladder cancer|down|miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
hsa-mir-451|chronic myelogenous leukemia|down|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-451|colon cancer|down|miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer.
hsa-mir-451|colorectal carcinoma|down|MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway.
hsa-mir-451|esophageal carcinoma|down|Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706.
hsa-mir-451|glioma|down|MiRNA-451 plays a role as tumor suppressor in human glioma cells.
hsa-mir-451|glioma|down|MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
hsa-mir-451|head and neck squamous cell carcinoma|down|MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
hsa-mir-451|hepatocellular carcinoma|down|miR-451: Potential role as tumor suppressor of human hepatoma cell growth and invasion.
hsa-mir-451|hepatocellular carcinoma|down|MicroRNA-451 regulates activating transcription factor?2 expression and inhibits liver cancer cell migration.
hsa-mir-451|hepatocellular carcinoma|down|MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
hsa-mir-451|hepatocellular carcinoma|down|miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct Suppression of IKK-?
hsa-mir-451|lung adenocarcinoma|down|Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.
hsa-mir-451|mucinous cystadenocarcinoma|up|Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-451|nasopharyngeal carcinoma|down|MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.
hsa-mir-451|non-small cell lung cancer|down|The expression and function of miRNA-451 in non-small cell lung cancer.
hsa-mir-451|non-small cell lung cancer|down|Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-451|non-small cell lung cancer|down|MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
hsa-mir-451|osteosarcoma|down|Tumor-Suppressing Effects of miR451 in Human Osteosarcoma.
hsa-mir-451|osteosarcoma|down|MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients
hsa-mir-451|osteosarcoma|down|Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells.
hsa-mir-451|renal cell carcinoma|down|microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.
hsa-mir-451a|breast cancer|down|miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor.
hsa-mir-451a|hypopharyngeal squamous cell carcinoma|down|Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.
hsa-mir-451a|papillary thyroid carcinoma|down|miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
hsa-mir-452|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-452|glioma|down|Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas.
hsa-mir-452|hepatocellular carcinoma|up|MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B.
hsa-mir-452|non-small cell lung cancer|down|Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1.
hsa-mir-452|osteosarcoma|down|Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
hsa-mir-454|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-454|glioblastoma|down|MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.
hsa-mir-454|hepatocellular carcinoma|up|Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.
hsa-mir-454|hepatocellular carcinoma|up|miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.
hsa-mir-454|non-small cell lung cancer|up|MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
hsa-mir-454|osteosarcoma|down|miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.
hsa-mir-454|uveal melanoma|up|MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.
hsa-mir-455|colon cancer|down|MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-455|non-small cell lung cancer|down|MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1.
hsa-mir-455-5p|malignant melanoma|up|Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
hsa-mir-4649-3p|nasopharyngeal carcinoma|down|MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.
hsa-mir-4723-5p|prostate cancer|down|MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases.
hsa-mir-4782-3p|non-small cell lung cancer|down|miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14.
hsa-mir-4792|nasopharyngeal carcinoma|down|miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.
hsa-mir-483|colorectal cancer|down|Extracellular metabolic energetics can promote cancer progression.
hsa-mir-483-3p|adrenal cortical carcinoma|up|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-3p|esophageal squamous cell carcinoma|up|miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
hsa-mir-483-3p|hepatocellular carcinoma|up|Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.
hsa-mir-483-5p|adrenal cortical carcinoma|up|miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-483-5p|adrenal cortical carcinoma|up|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-5p|glioblastoma|down|MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-483-5p|glioma|down|MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-483-5p|hepatocellular carcinoma|up|Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.
hsa-mir-483-5p|hepatocellular carcinoma|up|Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
hsa-mir-483-5p|oral squamous cell carcinoma|up|Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
hsa-mir-484|colon cancer|down|MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-485|lung adenocarcinoma|down|MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2.
hsa-mir-485-3p|breast cancer|down|MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.
hsa-mir-485-3p|hepatocellular carcinoma|up|MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-485-5p|breast cancer|down|MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.
hsa-mir-485-5p|gastric cancer|down|miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.
hsa-mir-485-5p|gastric cancer|down|Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
hsa-mir-485-5p|hepatocellular carcinoma|down|Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
hsa-mir-485-5p|hepatocellular carcinoma|down|MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.
hsa-mir-486|acute myeloid leukemia|up|Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-mir-486|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-486|glioma|up|miR-486 sustains NF-?B activity by disrupting multiple NF-?B-negative feedback loops.
hsa-mir-486-3p|retinoblastoma|down|Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
hsa-mir-486-5p|hepatocellular carcinoma|down|MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
hsa-mir-486-5p|lung cancer|down|Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
hsa-mir-486-5p|papillary thyroid carcinoma|down|miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
hsa-mir-488|gastric cancer|down|miR-488 acts as a tumor suppressor gene in gastric cancer.
hsa-mir-489|breast cancer|down|A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.
hsa-mir-489-5p|breast cancer|down|GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
hsa-mir-490|gastric cancer|down|The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1.
hsa-mir-490-3p|colorectal cancer|down|MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?R1.
hsa-mir-490-3p|gastric cancer|down|Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori-Induced Gastric Carcinogenesis.
hsa-mir-490-3p|hepatocellular carcinoma|up|miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3).
hsa-mir-490-3p|osteosarcoma|down|MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
hsa-mir-490-5p|bladder cancer|down|MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-490-5p|bladder cancer|down|MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos.
hsa-mir-490-5p|bladder cancer|down|MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.
hsa-mir-490-5p|renal cell carcinoma|down|miR-490-5p suppresses tumor growth in renal cell carcinoma through targeting PIK3CA.
hsa-mir-491|esophageal cancer|down|Low Expression of miR-491 Promotes Esophageal Cancer Cell Invasion by Targeting TPX2.
hsa-mir-491-5p|cervical cancer|down|MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT.
hsa-mir-491-5p|non-small cell lung cancer|down|MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.
hsa-mir-492|hepatoblastoma|up|MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
hsa-mir-493|bladder cancer|down|Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
hsa-mir-493|gastric cancer|down|MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.
hsa-mir-493|gastric cancer|up|miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
hsa-mir-493|pituitary carcinoma|up|MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-494|breast cancer|down|miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/?-catenin signaling pathway.
hsa-mir-494|cervical cancer|up|MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
hsa-mir-494|colorectal cancer|up|miR?494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN.
hsa-mir-494|esophageal squamous cell carcinoma|down|Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.
hsa-mir-494|gastric cancer|down|miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.
hsa-mir-494|glioma|up|Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP.
hsa-mir-494|hepatocellular carcinoma|up|MiR-494 within an oncogenic MicroRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of MCC.
hsa-mir-494|hepatocellular carcinoma|up|MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
hsa-mir-494|hepatocellular carcinoma|up|miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
hsa-mir-494|nasopharyngeal carcinoma|down|Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node
hsa-mir-494|non-small cell lung cancer|up|Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
hsa-mir-494|non-small cell lung cancer|up|Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer.
hsa-mir-494|oral cancer|down|miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.
hsa-mir-494|ovarian cancer|down|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-494|pancreatic cancer|down|Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
hsa-mir-494|pancreatic ductal adenocarcinoma|down|Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and ?-catenin signaling in pancreatic ductal adenocarcinoma cells.
hsa-mir-495|breast cancer|up|miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
hsa-mir-495|breast cancer|down|Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.
hsa-mir-495|endometrial cancer|down|Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.
hsa-mir-495|gastric cancer|up|Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.
hsa-mir-495|glioma|down|Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB.
hsa-mir-495|glioma|down|MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.
hsa-mir-495|glioma|down|miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
hsa-mir-495|hepatocellular carcinoma|up|MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-495|medulloblastoma|down|MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
hsa-mir-495|renal cell carcinoma|down|MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.
hsa-mir-497|adrenal cortical carcinoma|down|The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-497|breast cancer|down|Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-497|breast cancer|down26338045|microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
hsa-mir-497|breast carcinoma|down|miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1?.
hsa-mir-497|breast carcinoma|down|miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
hsa-mir-497|cervical cancer|down|MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
hsa-mir-497|colorectal cancer|up|MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
hsa-mir-497|colorectal cancer|up|MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.
hsa-mir-497|colorectal cancer|down|MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
hsa-mir-497|colorectal cancer|down|MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
hsa-mir-497|colorectal cancer|down|MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
hsa-mir-497|gastric cancer|down|The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.
hsa-mir-497|glioma|up|Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.
hsa-mir-497|hepatocellular carcinoma|down|MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
hsa-mir-497|hepatocellular carcinoma|down|Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.
hsa-mir-497|hepatocellular carcinoma|down|microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.
hsa-mir-497|kidney cancer|down|Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
hsa-mir-497|nasopharyngeal carcinoma|down|The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.
hsa-mir-497|non-small cell lung cancer|down|MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer.
hsa-mir-497|non-small cell lung cancer|down|Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.
hsa-mir-497|non-small cell lung cancer|down|Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
hsa-mir-497|osteosarcoma|down|MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.
hsa-mir-497|osteosarcoma|down|MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells.
hsa-mir-497|osteosarcoma|down|The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma.
hsa-mir-497|ovarian cancer|down|MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1.
hsa-mir-497|ovarian cancer|down|MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.
hsa-mir-497|pancreatic cancer|down|Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.
hsa-mir-497|pancreatic cancer|down|MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.
hsa-mir-497|prostate cancer|down|MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells.
hsa-mir-497|prostate cancer|down|Tumor-suppressive microRNA-497 targets IKK? to regulate NF-?B signaling pathway in human prostate cancer cells.
hsa-mir-498|breast cancer|down|MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
hsa-mir-498|colorectal cancer|down|Downregulation of microRNA-498 in colorectal cancers and its cellular effects.
hsa-mir-498|non-small cell lung cancer|down|MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.
hsa-mir-498|ovarian cancer|down|1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498.
hsa-mir-498|ovarian cancer|down|MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
hsa-mir-498|ovarian cancer|down|Low miR-498 expression levels are associated with poor prognosis in ovarian cancer.
hsa-mir-499-5p|colorectal cancer|up|MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
hsa-mir-499-5p|non-small cell lung cancer|down|Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
hsa-mir-499a-5p|oral squamous cell carcinoma|down|The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
hsa-mir-500|gastric cancer|up|MicroRNA-500 sustains nuclear factor-?B activation and induces gastric cancer cell proliferation and resistance to apoptosis.
hsa-mir-500|hepatocellular carcinoma|up|MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
hsa-mir-5003-3p|breast cancer|up|miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin.
hsa-mir-500a|hepatocellular carcinoma|up|Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
hsa-mir-501|hepatocellular carcinoma|up|MicroRNA-501 promotes HBV replication by targeting HBXIP.
hsa-mir-501-5p|hepatocellular carcinoma|up|MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.
hsa-mir-502|colon cancer|down|Inhibition of autophagy and tumor growth in colon cancer by miR-502.
hsa-mir-502|hepatocellular carcinoma|down|miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.
hsa-mir-502-5p|breast cancer|down|Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
hsa-mir-503|breast cancer|up|MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
hsa-mir-503|colon cancer|down|MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-503|colorectal cancer|up|miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
hsa-mir-503|colorectal cancer|down|miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
hsa-mir-503|esophageal cancer|up|MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer.
hsa-mir-503|gastric cancer|down|MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
hsa-mir-503|gastric cancer|down|microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition.
hsa-mir-503|glioblastoma|down|MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.
hsa-mir-503|glioma|down|miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.
hsa-mir-503|hepatocellular carcinoma|down|MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
hsa-mir-503|hepatocellular carcinoma|down|miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1.
hsa-mir-503|non-small cell lung cancer|down|Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.
hsa-mir-503|non-small cell lung cancer|down|Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
hsa-mir-503|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-503|osteosarcoma|down|MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.
hsa-mir-503|osteosarcoma|down|Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.
hsa-mir-503|osteosarcoma|down|MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
hsa-mir-503|ovarian cancer|up|MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-503|prostate cancer|down|miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer.
hsa-mir-503|prostate cancer|down|GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.
hsa-mir-504|hypopharyngeal squamous cell carcinoma|down|microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
hsa-mir-504|hypopharyngeal squamous cell carcinoma|down|Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
hsa-mir-505|endometrial cancer|down|MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-?.
hsa-mir-505|hepatocellular carcinoma|down|MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1.
hsa-mir-506|breast cancer|down|Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.
hsa-mir-506|cervical cancer|down|Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
hsa-mir-506|colon cancer|down|MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
hsa-mir-506|colorectal cancer|down|miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
hsa-mir-506|esophageal cancer|down|MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.
hsa-mir-506|gastric cancer|down|MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
hsa-mir-506|gastric cancer|down|miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
hsa-mir-506|glioblastoma|down|miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.
hsa-mir-506|glioma|down|miR-506 functions as a tumor suppressor in glioma by targeting STAT3.
hsa-mir-506|hepatocellular carcinoma|down|MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
hsa-mir-506|hepatocellular carcinoma|down|MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.
hsa-mir-506|hepatocellular carcinoma|down|microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1).
hsa-mir-506|liver cancer|down|MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
hsa-mir-506|nasopharyngeal carcinoma|down|MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.
hsa-mir-506|oral squamous cell carcinoma|down|MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.
hsa-mir-506|renal clear cell carcinoma|down|MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.
hsa-mir-506|renal clear cell carcinoma|down|Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.
hsa-mir-508-3p|gastric cancer|down|miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-?B signaling in gastric carcinogenesis.
hsa-mir-508-3p|kidney cancer|down|Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-509-3p|kidney cancer|down|Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-509-3p|ovarian cancer|down|MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis.
hsa-mir-509-3p|renal cell carcinoma|down|MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
hsa-mir-509-5p|renal cell carcinoma|down|Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
hsa-mir-510|breast cancer|up|MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
hsa-mir-510-5p|renal cell carcinoma|down|Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
hsa-mir-5100|lung cancer|up|miR-5100 promotes tumor growth in lung cancer by targeting Rab6.
hsa-mir-511|lung adenocarcinoma|down|miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-512-3p|non-small cell lung cancer|down|Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
hsa-mir-512-5p|non-small cell lung cancer|down|miR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
hsa-mir-513b|gastric cancer|down|Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.
hsa-mir-517a|breast cancer|down|Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
hsa-mir-517c|glioblastoma|down|MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
hsa-mir-518a-3p|colorectal cancer|down|Downregulation of miR-518a-3p activates the NIK-dependent NF-?B pathway in colorectal cancer.
hsa-mir-518b|esophageal squamous cell carcinoma|down|miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.
hsa-mir-519a|glioblastoma|down|MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
hsa-mir-519a|glioma|down|MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
hsa-mir-519a|hepatocellular carcinoma|up|MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
hsa-mir-519d|breast cancer|down|miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
hsa-mir-519d|hepatocellular carcinoma|down|MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.
hsa-mir-519d|hepatocellular carcinoma|up|In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
hsa-mir-519d|osteosarcoma|down|CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.
hsa-mir-519d|ovarian cancer|down|MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.
hsa-mir-520a|hepatocellular carcinoma|down|MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.
hsa-mir-520a-3p|non-small cell lung cancer|down|The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer.
hsa-mir-520b|hepatocellular carcinoma|down|MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
hsa-mir-520c|breast cancer|up|The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
hsa-mir-520c-3p|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-520c-3p|hepatocellular carcinoma|down|MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.
hsa-mir-520d-3p|gastric cancer|down|MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.
hsa-mir-520d-5p|colorectal cancer|down|SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1.
hsa-mir-520g|breast cancer|up|Study on the relationship between miR-520g and the development of breast cancer.
hsa-mir-520g|hepatocellular carcinoma|up|MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
hsa-mir-522|hepatocellular carcinoma|up|miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.
hsa-mir-524-5p|gastric cancer|down|MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.
hsa-mir-525-3p|liver cancer|up|MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395.
hsa-mir-525-5p|laryngeal cancer|up|New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-526b|breast cancer|up|COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
hsa-mir-526b|non-small cell lung cancer|down|By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
hsa-mir-532-5p|malignant melanoma|up|Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
hsa-mir-532-5p|ovarian carcinoma|down|MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
hsa-mir-532-5p|retinoblastoma|down|Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
hsa-mir-539|nasopharyngeal carcinoma|down|miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
hsa-mir-539|osteosarcoma|down|MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8.
hsa-mir-539|thyroid cancer|down|MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1.
hsa-mir-541|pancreatic ductal adenocarcinoma|up|Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-542-3p|astrocytoma|down|MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.
hsa-mir-542-3p|bladder cancer|down|MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
hsa-mir-542-3p|colorectal cancer|down|miR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin.
hsa-mir-542-3p|gastric cancer|down|MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1.
hsa-mir-542-3p|glioblastoma|down|MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.
hsa-mir-542-5p|osteosarcoma|up|MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
hsa-mir-543|colorectal cancer|down|MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
hsa-mir-543|endometrial cancer|down|MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.
hsa-mir-543|gastric cancer|up|miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.
hsa-mir-543|prostate cancer|down|MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
hsa-mir-544|breast cancer|down|MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
hsa-mir-544|cervical cancer|down|Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer.
hsa-mir-544|gastric cancer|up|Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer.
hsa-mir-544|glioma|down|MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7.
hsa-mir-545|hepatocellular carcinoma|up|Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.
hsa-mir-545|lung cancer|down|MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells.
hsa-mir-548c|ovarian cancer|down|MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
hsa-mir-548p|hepatocellular carcinoma|down|MicroRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein HBXIP.
hsa-mir-551a|colorectal cancer|down|Extracellular metabolic energetics can promote cancer progression.
hsa-mir-551b-3p|gastric cancer|down|Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-551b-3p|ovarian cancer|up|Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
hsa-mir-558|neuroblastoma|up|microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
hsa-mir-564|chronic myelogenous leukemia|down|Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-564|lung cancer|down|MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3.
hsa-mir-566|glioma|up|MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
hsa-mir-570|hepatocellular carcinoma|up|MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma.
hsa-mir-570|lung cancer|up|MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.
hsa-mir-572|ovarian cancer|up|Upregulation of MiR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
hsa-mir-572|renal cell carcinoma|up|A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-573|hepatocellular carcinoma|up|The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis.
hsa-mir-573|malignant melanoma|down|miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
hsa-mir-573|prostate cancer|down|miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
hsa-mir-574|chronic myelogenous leukemia|down|microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-574-3p|breast cancer|down|Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
hsa-mir-574-3p|esophageal cancer|down|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-574-3p|hepatocellular carcinoma|up|Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-574-5p|colorectal cancer|down|Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis.
hsa-mir-575|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-576-3p|bladder cancer|down|MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1.
hsa-mir-576-5p|glioblastoma|up|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-577|gastric cancer|down|MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3.
hsa-mir-577|glioblastoma|down|miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
hsa-mir-577|hepatocellular carcinoma|down|Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting ?-catenin.
hsa-mir-582-5p|colorectal cancer|down|Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
hsa-mir-582-5p|hepatocellular carcinoma|down|miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.
hsa-mir-584|glioma|down|MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.
hsa-mir-586|osteosarcoma|up|Downregulation of microRNA-586 Inhibits Proliferation, Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line.
hsa-mir-590-3p|colon cancer|up|[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-590-3p|glioblastoma|down|miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
hsa-mir-590-5p|cervical cancer|up|MicroRNA-590 Promotes Cervical Cancer Cell Growth and Invasion by Targeting CHL1.
hsa-mir-590-5p|hepatocellular carcinoma|up|MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-? RII.
hsa-mir-590-5p|hepatocellular carcinoma|down|MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway.
hsa-mir-592|colorectal cancer|up|Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
hsa-mir-592|colorectal cancer|up|An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
hsa-mir-592|hepatocellular carcinoma|down|miR-592/WSB1/HIF-1? axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
hsa-mir-592|hepatocellular carcinoma|down|MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
hsa-mir-601|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-603|glioma|up|miR-603 promotes glioma cell growth via Wnt/?-catenin pathway by inhibiting WIF1 and CTNNBIP1.
hsa-mir-608|chordoma|down|MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
hsa-mir-608|colon cancer|down|microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
hsa-mir-610|colorectal cancer|down|MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.
hsa-mir-610|hepatocellular carcinoma|down|Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/?-catenin signaling in human hepatocellular carcinoma.
hsa-mir-610|lung cancer|down|[miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3].
hsa-mir-612|hepatocellular carcinoma|down|miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.
hsa-mir-613|esophageal squamous cell carcinoma|down|MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
hsa-mir-613|ovarian cancer|down|MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
hsa-mir-613|papillary thyroid carcinoma|down|MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
hsa-mir-613|papillary thyroid carcinoma|down|Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-613|prostate cancer|down|MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
hsa-mir-614|lung cancer|down|[MiR-614 Inhibited Lung Cancer Cell Invasion and Proliferation via Targeting PSA].
hsa-mir-615-5p|hepatocellular carcinoma|up|miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
hsa-mir-615-5p|pancreatic cancer|down|MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
hsa-mir-615-5p|pancreatic ductal adenocarcinoma|down|Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2.
hsa-mir-615-5p|pancreatic ductal adenocarcinoma|down|miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
hsa-mir-616*|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-622|gastric cancer|down|Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.
hsa-mir-622|glioblastoma|down|Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.
hsa-mir-622|glioma|down|miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.
hsa-mir-622|hepatocellular carcinoma|down|microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
hsa-mir-625|breast cancer|down|miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
hsa-mir-625|colorectal cancer|down|Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-625|gastric cancer|down|Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.
hsa-mir-625|hepatocellular carcinoma|down|miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
hsa-mir-625*|non-small cell lung cancer|down|Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-625-3p|colorectal carcinoma|up|MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.
hsa-mir-626|glioblastoma|up|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-627|colonic adenocarcinoma|down|MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice.
hsa-mir-627|gastric cancer|up|A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-628-5p|prostate cancer|down|Circulatory miR-628-5p is downregulated in prostate cancer patients.
hsa-mir-629|gastric cancer|up|A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-630|breast cancer|down|MiR-630 suppresses breast cancer progression by targeting metadherin.
hsa-mir-630|colorectal cancer|up|MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
hsa-mir-630|hepatocellular carcinoma|down|MicroRNA-630 suppresses tumor metastasis through the TGF-?- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
hsa-mir-630|hepatocellular carcinoma|up|miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
hsa-mir-630|kidney cancer|up|miR-630 functions as a tumor oncogene in renal cell carcinoma.
hsa-mir-630|lung cancer|down|MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
hsa-mir-630|non-small cell lung cancer|down|miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.
hsa-mir-630|ovarian cancer|up|Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
hsa-mir-630|pancreatic cancer|down|Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-630|renal clear cell carcinoma|up|Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.
hsa-mir-632|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-634|cervical cancer|down|MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells.
hsa-mir-637|hepatocellular carcinoma|down|Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
hsa-mir-638|breast cancer|down|miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negative breast cancer.
hsa-mir-638|colorectal cancer|down|MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma.
hsa-mir-638|gastric cancer|down|MicroRNA profiling of human gastric cancer.
hsa-mir-638|gastric cancer|down|miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2.
hsa-mir-638|gastric cancer|down|MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma.
hsa-mir-638|malignant melanoma|up|miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
hsa-mir-639|bladder cancer|up|Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-642a-5p|prostate cancer|down|Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
hsa-mir-646|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-646|osteosarcoma|down|miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
hsa-mir-646|osteosarcoma|down|Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.
hsa-mir-646|renal cell carcinoma|down|Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
hsa-mir-650|gastric cancer|up|MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
hsa-mir-650|glioma|up|MicroRNA-650 expression in glioma is associated with prognosis of patients.
hsa-mir-650|hepatocellular carcinoma|up|Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
hsa-mir-652|gastric cancer|up|A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-652-3p|breast cancer|down|Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
hsa-mir-652-3p|non-small cell lung cancer|up|MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
hsa-mir-655|esophageal squamous cell carcinoma|down|Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.
hsa-mir-655|ovarian cancer|down|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-655-3p|hepatocellular carcinoma|down|MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and ?-catenin pathway in Hepatocellular Carcinoma.
hsa-mir-656|glioma|down|miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
hsa-mir-657|hepatocellular carcinoma|up|MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-?B pathways.
hsa-mir-660|lung cancer|down|Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
hsa-mir-661|glioma|down|MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT.
hsa-mir-661|ovarian cancer|up|MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression.
hsa-mir-663|gastric cancer|down|Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.
hsa-mir-663|glioblastoma|down|miR-663 suppresses oncogenic function of CXCR4 in glioblastoma.
hsa-mir-663|glioblastoma|down|MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-?1.
hsa-mir-663|lung cancer|up|MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation.
hsa-mir-663|nasopharyngeal carcinoma|up|MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
hsa-mir-663|papillary thyroid carcinoma|down|MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
hsa-mir-663a|hepatocellular carcinoma|down|miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
hsa-mir-663a|non-small cell lung cancer|down|MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
hsa-mir-664|cervical cancer|down|Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.
hsa-mir-664|cervical cancer|down|Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.
hsa-mir-664|hepatocellular carcinoma|up|MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-664|osteosarcoma|up|Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.
hsa-mir-668|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-671-5p|breast cancer|down|miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
hsa-mir-671-5p|invasive ductal carcinoma|down|miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
hsa-mir-675|breast cancer|up|Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.
hsa-mir-675|colon cancer|up|Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
hsa-mir-675|glioma|up|Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675.
hsa-mir-675|hepatocellular carcinoma|down|Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3?/Cdc25A signaling pathway.
hsa-mir-675-5p|non-small cell lung cancer|up|Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
hsa-mir-7|breast cancer|down|MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
hsa-mir-7|cervical cancer|down|Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.
hsa-mir-7|cervical cancer|down|MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.
hsa-mir-7|colorectal cancer|down|miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.
hsa-mir-7|epithelial ovarian cancer|down|Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-7|gastric cancer|down|MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
hsa-mir-7|glioblastoma|down|microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
hsa-mir-7|glioblastoma|down|Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-7|glioblastoma|down|miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
hsa-mir-7|glioma|down|MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
hsa-mir-7|glioma|down|MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
hsa-mir-7|hepatocellular carcinoma|down|Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.
hsa-mir-7|hepatocellular carcinoma|down|MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
hsa-mir-7|hepatocellular carcinoma|down|miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma.
hsa-mir-7|lung cancer|down|Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.
hsa-mir-7|lung cancer|up|EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
hsa-mir-7|non-small cell lung cancer|down|MicroRNA-7 inhibits the malignant phenotypes of non?small cell lung cancer in vitro by targeting Pax6.
hsa-mir-7|pancreatic cancer|up|Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells.
hsa-mir-7|prostate cancer|down|MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
hsa-mir-7|renal cell carcinoma|up|Identification of miR-7 as an oncogene in renal cell carcinoma.
hsa-mir-7-5p|glioblastoma|down|miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-7-5p|glioblastoma|down|MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1.
hsa-mir-7-5p|malignant melanoma|down|miRNA-7-5p inhibits melanoma cell migration and invasion.
hsa-mir-7-5p|malignant melanoma|down|microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-?B.
hsa-mir-708|hepatocellular carcinoma|down|MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
hsa-mir-718|esophageal squamous cell carcinoma|down|Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
hsa-mir-720|acute myeloid leukemia|down|[DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia].
hsa-mir-720|breast cancer|down|miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
hsa-mir-720|cervical cancer|up|MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells.
hsa-mir-720|colorectal cancer|up|Evaluation of miR-720 prognostic significance in patients with colorectal cancer.
hsa-mir-744|nasopharyngeal carcinoma|up|MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.
hsa-mir-744|nasopharyngeal carcinoma|up|Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma.
hsa-mir-744|pancreatic cancer|up|MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/?-catenin pathway.
hsa-mir-7515|lung cancer|down|The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met.
hsa-mir-761|hepatocellular carcinoma|up|MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2.
hsa-mir-761|non-small cell lung cancer|up|MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.
hsa-mir-761|ovarian carcinoma|down|miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
hsa-mir-762|breast cancer|up|microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.
hsa-mir-765|prostate cancer|down|Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer.
hsa-mir-766|colorectal cancer|up|MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer.
hsa-mir-770|hepatocellular carcinoma|up|Wnt/?-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
hsa-mir-802|breast cancer|down|MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.
hsa-mir-802|osteosarcoma|up|MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27.
hsa-mir-873|breast cancer|down|MiR-873 regulates ER? transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
hsa-mir-873|glioblastoma|down|MiRNA-873 Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1.
hsa-mir-874|breast cancer|down|MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.
hsa-mir-874|colorectal cancer|down|MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
hsa-mir-874|colorectal cancer|down|Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer.
hsa-mir-874|colorectal cancer|down|MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells.
hsa-mir-874|gastric cancer|down|miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.
hsa-mir-874|gastric cancer|down|miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
hsa-mir-874|head and neck squamous cell carcinoma|down|Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
hsa-mir-874|osteosarcoma|down|Decreased expression of tumor suppressive miR-874 and its clinical significance in human osteosarcoma.
hsa-mir-877|hepatocellular carcinoma|down|Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
hsa-mir-877|oral squamous cell carcinoma|down|Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-885-5p|hepatocellular carcinoma|up|Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-885-5p|laryngeal cancer|down|New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-885-5p|neuroblastoma|down|MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
hsa-mir-886-3p|thyroid cancer|down|MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
hsa-mir-886-5p|cervical carcinoma|down|MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
hsa-mir-887-5p|endometrial cancer|up|Changes in the Expression of Serum MiR-887-5p in Patients With Endometrial Cancer.
hsa-mir-892a|colorectal cancer|up|miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.
hsa-mir-892b|breast cancer|down|miR-892b Silencing Activates NF-?B and Promotes Aggressiveness in Breast Cancer.
hsa-mir-9|bladder cancer|up|miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
hsa-mir-9|cervical adenocarcinoma|down|Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.
hsa-mir-9|colorectal cancer|down|MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
hsa-mir-9|esophageal squamous cell carcinoma|up|MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
hsa-mir-9|gastric adenocarcinoma|down|Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.
hsa-mir-9|gastric cancer|down|Aberrant hypermethylation of miR-9 genes in gastric cancer.
hsa-mir-9|gastric cancer|down|Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.
hsa-mir-9|gastric cancer|down|microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1.
hsa-mir-9|gastric cancer|down|Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
hsa-mir-9|gastric cancer|down|Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-9|glioma|up|Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.
hsa-mir-9|glioma|up|[MiR-9 regulates the expression of CBX7 in human glioma].
hsa-mir-9|glioma|up|The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.
hsa-mir-9|hepatocellular carcinoma|down|Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
hsa-mir-9|hepatocellular carcinoma|up|Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-9|hepatocellular carcinoma|down|Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-?B in hepatocellular carcinoma.
hsa-mir-9|hepatocellular carcinoma|up|MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.
hsa-mir-9|laryngeal squamous cell carcinoma|up|MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.
hsa-mir-9|malignant melanoma|down|MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma.
hsa-mir-9|nasopharyngeal carcinoma|down|miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.
hsa-mir-9|non-small cell lung cancer|up|Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.
hsa-mir-9|non-small cell lung cancer|up|Oncogenic miR-9 is a target of erlotinib in NSCLCs.
hsa-mir-9|oral squamous cell carcinoma|down|MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/?-catenin signaling pathway.
hsa-mir-9|oral squamous cell carcinoma|down|Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
hsa-mir-9|osteosarcoma|up|Serum miR-9 as a prognostic biomarker in patients with osteosarcoma.
hsa-mir-9|osteosarcoma|up|miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.
hsa-mir-9|ovarian cancer|down|MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
hsa-mir-9|ovarian cancer|up|MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.
hsa-mir-9|uveal melanoma|down|MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-?B1 pathway.
hsa-mir-92|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-92|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-92|gastric cancer|up|MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR.
hsa-mir-92|medulloblastoma|up|The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-92|neuroblastoma|up|MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
hsa-mir-92|pancreatic cancer|up|MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-92a|acute promyelocytic leukemia|up|Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia.
hsa-mir-92a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-92a|breast cancer|down|Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.
hsa-mir-92a|breast cancer|down|Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-92a|breast cancer|down|MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-92a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-92a|cervical cancer|up|miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
hsa-mir-92a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-92a|cholangiocarcinoma|up|miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-92a|colorectal cancer|up|MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-92a|colorectal cancer|up|Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-92a|colorectal cancer|up|Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-92a|colorectal cancer|up|MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN.
hsa-mir-92a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-92a|esophageal squamous cell carcinoma|up|microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.
hsa-mir-92a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
hsa-mir-92a|hepatocellular carcinoma|up|Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
hsa-mir-92a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-92a|hepatocellular carcinoma|up|MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
hsa-mir-92a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-92a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-92a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-92a|malignant melanoma|up|Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-92a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-92a|non-small cell lung cancer|up|MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
hsa-mir-92a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-92a|ovarian cancer|up|Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
hsa-mir-92b|glioblastoma|up|The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
hsa-mir-92b|glioma|up|MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.
hsa-mir-92b|non-small cell lung cancer|up|MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.
hsa-mir-92b|non-small cell lung cancer|up|Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.
hsa-mir-92b|oral squamous cell carcinoma|up|MicroRNA-92b promotes tumor growth and activation of NF-?B signaling via regulation of NLK in oral squamous cell carcinoma.
hsa-mir-92b|osteosarcoma|up|miR-92b promotes tumor proliferation, migration, and invasion by targeting RECK in osteosarcoma.
hsa-mir-93|colon cancer|down|Clinical significance of microRNA-93 downregulation in human colon cancer.
hsa-mir-93|colorectal cancer|up|Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-93|colorectal carcinoma|down|MicroRNA-93 suppress colorectal cancer development via Wnt/?-catenin pathway downregulating.
hsa-mir-93|endometrial cancer|up|TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-93|esophageal squamous cell carcinoma|up|Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2.
hsa-mir-93|glioma|up|[Overexpressed microRNA-93 inhibits the proliferation and promotes apoptosis of A172 glioma cells].
hsa-mir-93|glioma|up|miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
hsa-mir-93|glioma|up|MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.
hsa-mir-93|head and neck squamous cell carcinoma|up|Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
hsa-mir-93|head and neck squamous cell carcinoma|up|Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-93|hepatocellular carcinoma|up|Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-93|laryngeal squamous cell carcinoma|up|MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
hsa-mir-93|lung cancer|up|miR-93 promotes TGF-?-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.
hsa-mir-93|nasopharyngeal carcinoma|up|MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
hsa-mir-93|non-small cell lung cancer|up|Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-93|osteosarcoma|up|microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.
hsa-mir-93|ovarian carcinoma|down|RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
hsa-mir-93-5p|hepatocellular carcinoma|up|Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-935|gastric cancer|down|miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression.
hsa-mir-937|lung cancer|up|miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.
hsa-mir-940|gastric cancer|up|MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.
hsa-mir-940|gastric cancer|down|Plasma miR-940 may serve as a novel biomarker for gastric cancer.
hsa-mir-940|hepatocellular carcinoma|down|MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
hsa-mir-940|prostate cancer|down|MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
hsa-mir-941|hepatocellular carcinoma|down|DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells.
hsa-mir-942|esophageal squamous cell carcinoma|up|miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/?-catenin signalling pathway.
hsa-mir-944|breast cancer|up|MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.
hsa-mir-944|cervical cancer|up|Novel functions and targets of miR-944 in human cervical cancer cells.
hsa-mir-944|lung cancer|up|Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
hsa-mir-95|colorectal cancer|up|MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-95|colorectal carcinoma|up|MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-95|non-small cell lung cancer|up|MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
hsa-mir-9500|lung cancer|down|The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.
hsa-mir-96|bladder cancer|up|Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.
hsa-mir-96|bladder cancer|up|MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-96|bladder cancer|up|Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-96|breast cancer|up|Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
hsa-mir-96|breast cancer|up|miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
hsa-mir-96|breast cancer|up|High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-96|chronic myelogenous leukemia|up|Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-96|colorectal cancer|up|Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-96|colorectal cancer|up|MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
hsa-mir-96|esophageal cancer|up|MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer.
hsa-mir-96|glioma|up|The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-96|glioma|up|MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.
hsa-mir-96|glioma|up|miR-96/HBP1/Wnt/?-catenin regulatory circuitry promotes glioma growth.
hsa-mir-96|hepatocellular carcinoma|up|Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
hsa-mir-96|hepatocellular carcinoma|up|OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
hsa-mir-96|hepatocellular carcinoma|up|Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-96|non-small cell lung cancer|down|Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.
hsa-mir-96|non-small cell lung cancer|up|miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9.
hsa-mir-96|ovarian cancer|up|The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-96|ovarian cancer|up|Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-96|pancreatic cancer|down|miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
hsa-mir-96|prostate cancer|up|miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-96|prostate cancer|up|miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.
hsa-mir-96|prostate cancer|up|Transforming growth factor-? promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.
hsa-mir-96|renal cell carcinoma|down|miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.
hsa-mir-96-5p|colorectal cancer|down|MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
hsa-mir-98|breast cancer|down|Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-mir-98|bronchioloalveolar carcinoma|down|let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-mir-98|colon cancer|down|let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-mir-98|esophageal squamous cell carcinoma|down|Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-mir-98|esophageal squamous cell carcinoma|down|Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-mir-98|esophageal squamous cell carcinoma|down|MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-98|gastric cancer|up|MicroRNA profiling of human gastric cancer.
hsa-mir-98|glioma|down|Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
hsa-mir-98|glioma|down|Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKK?.
hsa-mir-98|hepatocellular carcinoma|down|MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-98|hepatocellular carcinoma|down|MicroRNA-98 suppresses cell proliferation, migration and invasion by targeting collagen triple helix repeat containing 1 in hepatocellular carcinoma.
hsa-mir-98|lung cancer|down|Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-mir-98|lung cancer|down|Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-mir-98|lung cancer|down|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-mir-98|malignant melanoma|down|miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.
hsa-mir-98|nasopharyngeal carcinoma|down|MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-mir-98|neuroblastoma|down|LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-mir-98|non-small cell lung cancer|down|MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1.
hsa-mir-98|oral squamous cell carcinoma|down|miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
hsa-mir-98|ovarian cancer|down|EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.
hsa-mir-98|pancreatic ductal adenocarcinoma|down|let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-mir-98|papillary thyroid carcinoma|down|Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-99a|bladder cancer|down|microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.
hsa-mir-99a|bladder cancer|down|microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer.
hsa-mir-99a|breast cancer|down|MiR-99a suppress proliferation, migration and invasion through regulating insulin-like growth factor 1 receptor in breast cancer.
hsa-mir-99a|breast cancer|down|MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
hsa-mir-99a|breast cancer|down|MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
hsa-mir-99a|cervical cancer|down|miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.
hsa-mir-99a|cervical carcinoma|down|miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-99a|endometrial cancer|down|A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.
hsa-mir-99a|esophageal squamous cell carcinoma|down|MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-99a|gastric cancer|up|miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-99a|hepatocellular carcinoma|down|Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-99a|hepatocellular carcinoma|down|MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
hsa-mir-99a|lung adenocarcinoma|down|Clinic significance of microRNA-99a expression in human lung adenocarcinoma.
hsa-mir-99a|lung adenocarcinoma|down|miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.
hsa-mir-99a|mesenchymal cancer|down|MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-99a|non-small cell lung cancer|down|miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
hsa-mir-99a|non-small cell lung cancer|down|microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.
hsa-mir-99a|osteosarcoma|down|Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.
hsa-mir-99a|pancreatic cancer|up|Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.
hsa-mir-99b|cervical cancer|down|miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.
hsa-mir-99b|cervical carcinoma|down|miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-99b|esophageal cancer|up|Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-99b|hepatocellular carcinoma|up|miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
hsa-mir-99b|lung cancer|down|microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.
hsa-mir-99b-3p|oral squamous cell carcinoma|down|miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3? in oral squamous cell carcinoma Tca-8113 cells.
mir-17|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-17|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-17|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-17|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-17|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-17|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-17|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-17|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-17|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-17|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-18a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-18a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-18a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-18a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-18a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-18a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-18a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-18a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-18a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-18a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-19a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-19a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-19a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-19a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-19a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-19a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-19a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-19a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-19b|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19b|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-19b|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-19b|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-19b|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-19b|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-19b|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-19b|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19b|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-19b|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-20a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-20a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-20a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-20a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-20a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-20a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-20a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-20a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-20a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-20a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-92a|b-cell lymphoma|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-92a|breast carcinoma|up|MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-92a|colorectal cancer|up|MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-92a|esophageal squamous cell carcinoma|up|TNF-? is a novel target of miR-19a.
mir-92a|hepatocellular carcinoma|up|MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-92a|lung cancer|up|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-92a|lung cancer|up|Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-92a|lung cancer|up|MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-92a|mantle cell lymphoma|up|The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-92a|osteosarcoma|up|Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mmu-mir-290-3p|breast cancer|down|Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.
mmu-mir-290-5p|breast cancer|down|Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.